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Abstract 
Regional Characterization of the Knee Meniscus and Tissue Engineering 
with Dermal Stem Cells 
By 
Johannah Sanchez-Adams 
The knee meniscus plays an integral role in providing lubrication, load 
distribution, and shock absorption, yet is frequently compromised through 
traumatic injury or disease. Unfortunately, many of the injuries sustained by the 
meniscus are unable to heal, and current clinical therapies lack the ability to 
restore full tissue functionality. Tissue engineering efforts provide a possible 
solution to this problem. To engineer functional meniscal cartilage, however, 
researchers need specific design criteria from native tissue as well as an 
abundant cell source for tissue generation. Tissue engineering efforts must also 
take into account the complex geometry of the meniscus, as well as regional 
variations in biochemical and biomechanical properties. In this thesis, meniscus 
cells and tissue are characterized regionally to identify key parameters for tissue 
engineering, and an alternate cell source is evaluated for in vitro engineering of 
fibrocartilage. 
Towards understanding regional meniscus characteristics important for 
tissue engineering efforts, meniscus cells were characterized biomechanically 
and an effective method for isolating these cells for tissue engineering was 
determined. It was found that the meniscus contains cells that are 
biomechanically distinct, with outer meniscus cells showing higher stiffness than 
inner cells. It was also determined that meniscus cells as a whole were more 
biomechanically similar to ligament cells than to articular chondrocytes, indicating 
that tissue properties may correlate with cellular mechanics. In addition to 
showing regionally distinct biomechanical properties, enzymatic isolation of 
meniscus cells was found to cause varying phenotypic changes in cells from the 
inner, middle, and outer regions. A comparison of isolation techniques also 
indicated that sequential digestion of meniscus tissue with pronase and 
collagenase was able to yield more cells with higher viability than other 
techniques tested, and those isolated cells created stiffer and more 
glycosaminoglycan (GAG) rich constructs when used in a tissue engineering 
modality than cells isolated using only collagenase. The identification of an 
effective mode of isolating meniscus cells is of great use to tissue engineering 
efforts, as they often require a large cell numbers. These findings ·illustrate that 
known regional variations in meniscus cell phenotype and biochemical 
composition are also evident in cellular mechanics, and phenotypic responses of 
these cells to isolation are varied and distinct. 
To be successful tissue replacements, tissue engineered meniscus 
constructs must not elicit an immune response and must have sufficient 
mechanical properties to survive when implanted. To determine if allogeneic or 
xenogeneic implantation of scaffold-free meniscus constructs could be feasible, 
the immunogenicity of bovine and leporine meniscus cells and articular 
chondrocytes were determined in an in vitro model system. It was found that 
neither bovine nor leporine meniscus cells or articular chondrocytes caused 
activation of leporine immune cells, suggesting that they may serve as allogeneic 
or xenogeneic cell sources for meniscus engineering. Additional analysis of the 
mechanical role of meniscus GAGs indicated that they are mechanically 
important in all regions of the meniscus, but especially in the inner region where 
the relatively high GAG content affects both compressive and tensile properties. 
Therefore, tissue engineering efforts should try to recapitulate GAG content and 
distribution to enhance the functionality of meniscus replacements. 
As a major obstacle for meniscus engineering is the identification of an 
abundant cell source, this thesis also investigated the use of skin cells as an 
alternative to primary cells for tissue engineering. Previously identified 
chondroinducible dermis cells were found to have multilineage differentiation 
capacity, and were subsequently termed dermis isolated adult stem cells (DIAS). 
DIAS cells were also able to be expanded in monolayer without losing 
chondroinductive capacity, and were able to create constructs with cartilaginous 
properties which could be varied with growth factor application. Given the ease of 
expansion and ability of DIAS cells to form fibrocartilaginous tissue, these cells 
present an abundant cell source for meniscus tissue engineering. 
Together, the studies performed in this thesis 1) offer valuable design 
parameters for meniscus cells and tissue from different regions, 2) provide 
indications for the immunogenicity of possible cell sources for meniscus 
engineering, and 3) enhance the understanding and utility of DIAS cells for 
engineering the cartilage spectrum. 
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1 
Introduction 
The knee meniscus plays an integral role in the knee joint, providing 
stability, shock absorption, and redistributing load during normal activities such 
as standing or walking. However, despite its important function in the knee, the 
meniscus is prone to injury and has limited regenerative capacity. Tissue 
engineering efforts seek to address this problem by creating functional 
replacement tissue. For this goal to be achieved, a better understanding of the 
regional differences in meniscus cells and tissue is needed to provide design 
criteria for engineered constructs, and an abundant cell source for engineering 
the tissue should be identified. In an effort to meet these needs, this thesis has 
two global objectives: 1) to characterize regional variations in meniscus cells and 
tissue, and 2) to use a dermis-derived cell population for in vitro tissue 
engineering of the cartilage spectrum. These objectives are conducted under the 
following hypotheses. First, the knee meniscus will show regional variations at 
the cell and tissue level. Second, a sub-population of dermis cells can be used to 
engineer fibrocartilaginous tissue. These global objectives are achieved through 
the following three specific aims: 
1. To understand regional meniscus cell phenotype and mechanical 
properties. The first study of this aim measures the mechanical 
properties of single cells from the inner and outer meniscus regions 
and compares them to other musculoskeletal cells. It is hypothesized 
that cells from different meniscus regions will show regional variations 
in biomechanical properties. In the second study in this aim, changes 
2 
in meniscus cell phenotype is measured as a function of isolation 
technique and meniscus region. It is hypothesized that 1) cells from 
different meniscus regions will show distinct phenotypic responses to 
enzymatic isolation, and 2) the isolation technique yielding the highest 
number of cells can be used in a tissue engineering modality. 
Together, the studies in this aim will allow for better understanding of 
regional mechanical and phenotypic differences in meniscus cells, and 
identify an effective mode of isolating these cells for tissue 
engineering. 
2. To determine the immunogenicitv of meniscus cells and the 
contribution of sulfated glycosaminoglycans (GAGs) to meniscus 
mechanics. This aim is concerned with the translatability of engineered 
constructs formed from meniscus cells and provides design criteria for 
the functional generation of these constructs. The first study in this aim 
characterizes the in vitro response of leporine immune cells to leporine 
and bovine meniscus cells and articular chondrocytes to gain an 
understanding of the immunogenicity of these cells in a rabbit model. It 
is hypothesized that neither leporine nor bovine articular chondrocytes 
or meniscus cells will cause activation of leporine immune cells. The 
second study characterizes the contribution of sulfated GAGs to 
regional meniscus mechanics to understand the mechanical role of this 
matrix component to compressive and tensile meniscus mechanics. It 
3 
is hypothesized that GAGs will show regional variation in their 
contribution to meniscus tissue mechanics. 
3. To use dermis-derived cells as an alternate cell source for cartilage 
tissue engineering. This aim uses a phased approach to first evaluate 
methods of expansion, chondroinduction, and tissue engineering of a 
subpopulation of chondroinducible dermis cells. In this phase, it is 
hypothesized that expansion of chondroinducible dermis cells will not 
diminish their chondroinductive capacity. In the second phase, the 
most promising cell population from the first phase will be tested for 
multilineage differentiation capacity. It is hypothesized that these cells 
will show multilineage differentiation capacity. These cells will also be 
used for cartilage tissue engineering and growth factors will be used to 
modulate their cartilage-specific biochemical and biomechanical 
properties. It is hypothesized that different growth factors will cause 
varying biochemical and biomechanical effects on tissue engineered 
constructs. Identifying a method to expand and tissue engineer 
chondroinducible dermis cells may provide an abundant and potentially 
autologous cell source for meniscus engineering. 
The following chapters provide background of this work and explain the 
results related to each specific aim. Chapter 1 provides general background on 
the knee meniscus and what is currently known regarding its structure and 
function, and its biochemical and biomechanical attributes. Chapters 2 and 3 
detail methods of measuring single cell mechanics and discuss known 
4 
differences in regional meniscus cell morphology and phenotype. These chapters 
set the stage for the detailed analysis of meniscus cell mechanics and phenotype 
performed in aim 1. 
All work related to the completion of specific aim 1 is presented in 
chapters 4 and 5. Chapter 4 addresses the mechanical characterization of 
meniscus cells from different regions, and compares the mechanical properties of 
meniscus cells to those of articular chondrocytes and ligament cells. Chapter 5 
investigates the effects of isolation on meniscus cells from different regions and 
identifies an enzymatic digestion protocol to use for meniscus tissue engineering 
with primary cells. These studies enhance the understanding of the regional 
differences in meniscus cells which can inform further models or experimental 
designs for meniscus engineering. 
Background on pathophysiology of the meniscus is represented in chapter 
6 as an introduction to the work related to specific aim 2 (chapters 7 and 8). 
Chapter 7 investigates the potential immunogenicity of meniscus cells in an in 
vitro model system, indicating whether allogeneic or xenogeneic transplantation 
of meniscus cells could be a feasible process. Chapter 8 studies the mechanical 
contribution of GAGs in the knee meniscus with the goal of providing design 
parameters for engineered meniscus constructs. 
Chapters 9 and 10 provide an introduction to the studies performed in 
specific aim 3, reviewing previous work related to meniscus tissue engineering, 
and underscoring the importance of design criteria for the creation of functional 
tissue. Chapter 11 details the work related to the completion of specific aim 3. In 
5 
this chapter, methods to enhance the utility of chondroinducible dermis cells are 
identified, and the effects of growth factors on tissue engineered constructs 
formed from these cells are determined. 
The cumulative knowledge obtained through the completion of these 
specific aims is discussed in the Conclusions chapter. The significance of the 
work is presented, and future directions are proposed. 
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Chapter 1: Structure-Function Relationships of the Knee 
Meniscus 
Section 1.1: Anatomy and Development 
Anatomy of the knee meniscus 
Integrating vasculature, cells, and extracellular matrix molecules, the knee 
meniscus comprises two semicircular, wedge-shaped pieces fixed in place via a 
network of ligaments. The meniscus is a glossy white fibrocartilaginous tissue 
that is an important component in the normal joint, as shown in Figure 1. The 
human knee contains a medial meniscus and a lateral meniscus which are 
located between the femoral condyle and tibial plateau (see Figure 2). The main 
functions of the meniscus are to increase congruency of shape between the 
curved condyle and flat plateau, maintain stability, and bear and transfer load 
within the joint. Because it functions in a joint articulation it exhibits a smooth 
surface macroscopically and microscopically.1 Both the medial and lateral 
menisci are wedge-shaped and semilunar, but the medial meniscus is generally 
more circular in shape than the lateral meniscus. 
There is an array of ligaments that aid in stabilizing the meniscus within 
the knee joint during loading conditions, as shown in Figure 3. The ligaments of 
Chapter published as: Athanasiou, K. A., and Sanchez-Adams, J. "Part 1: 
Structure-Function Relationships of the Knee Meniscus." Engineering the Knee 
Meniscus. Morgan and Claypool Publishers. 2009. 
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Humphrey and Wrisberg connect the posterior horn of the lateral meniscus to a 
lateral insertion site on the medial femoral condyle. The Humphrey's and 
Wrisberg ligaments are located anteriorly and posteriorly to the posterior cruciate 
ligament (PCL), respectively. Studies on human cadaveric knees have shown 
that an estimated 50% of people have both of these ligaments, while 93% have 
either one or the other. The medial meniscus is connected on its periphery to the 
medial collateral ligament which connects the femoral condyle to the tibia.2 
The anterior portions of the meniscus are joined together by the 
transverse ligament, and each meniscus is anchored to the tibial plateau via 
anterior and posterior meniscal horns. The insertion sites of these horns are 
highly innervated and display four different zones that connect the meniscus to 
the underlying bone, thereby maintaining their position within the joint. They are 
the ligamentous zone, uncalcified fibrocartilage, calcified fibrocartilage, and bone. 
Coronary ligaments run along the periphery of each meniscus, providing an 
additional attachment to the tibial plateau.3 It is here in the periphery of each 
meniscus that the rest of the innervation is found, with no innervation present in 
the inner one-third of the tissue. Large nerve fibers run circumferentially along 
the tissue, while smaller fibers are positioned radially. The outer periphery of 
each meniscus is also covered by the synovial membrane, which imparts 
vasculature, and contains a highly fibrous matrix while the inner portion displays 
characteristics like those of hyaline articular cartilage, devoid of vasculature and 
innervation. 
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Development of the knee meniscus 
When first formed in the body, both the medial and lateral menisci are 
completely vascular. This widespread vascularity diminishes rapidly from 
gestation to birth and then more gradually to adulthood, when it is estimated that 
10-25% of the lateral meniscus and 10-30% of the medial meniscus contains 
blood vessels. This vascularity is confined to the outer periphery of the 
meniscus.4 
Understanding meniscus development can greatly enhance tissue 
engineering efforts by providing a basis for evaluating engineered construct 
maturation in vitro and in vivo. A 1983 study on the developing meniscus 
revealed that from early in gestation to 11 years after birth vasculature as well as 
cellularity changes dramatically, but contact area between the tissue and bones 
remains constant.5 Specifically, at 3.5 months gestation, the meniscus has little 
extracellular matrix but high cellularity and vascularity. The cells at this stage are 
similar to each other in that they have a high nucleus to cytoplasmic ratio, but are 
more compacted on the periphery of the tissue. By around 6 months' gestation, 
the cruciate ligaments are more defined and the collagen network is fairly well 
organized circumferentially, including some radial tie fibers. At this stage the 
meniscus is still completely vascularized. At 7.5 months gestation, the synovial 
membrane covering the meniscus is around three to four cell layers thick, the 
collagen organization is more pronounced, and the nuclear to cytoplasmic ratio of 
the cells has diminished. As the fetus grows larger and approaches 9 months 
gestation, the meniscus within the joint maintains a relatively constant ratio of 
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contact area with the tibial plateau, correlating with an increase in extracellular 
matrix around the meniscal cells. 5 Therefore, even before birth, the meniscus 
undergoes drastic changes in terms of its cellularity, vascularity, and size, which 
may be useful to mimic in tissue engineered constructs. 
After birth, the meniscus continues to grow along with the joint, and the 
collagen organization changes to accommodate biomechanical loading. At 3 
months after birth, vasculature can be identified throughout the meniscus but is 
more concentrated at the periphery. Vasculature in the inner one-third of the 
meniscus continues to diminish, and is almost completely gone by 9 months. As 
the tibia and femur develop, the meniscus continues to increase in collagen 
organization and size in concert with the increasing femoral and tibial surfaces. 
From 3 to 11 years, the synovial membrane decreases in thickness to one to two 
cell layers, and the collagen organization within the meniscus develops to contain 
not only circumferentially and radially oriented fibers but also vertically oriented 
fibers. The vasculature during this period continues to recede to the periphery of 
the tissue (see Figure 4).5 
Through adulthood, the meniscus decreases in vascularity and cellularity, 
eventually becoming avascular in the inner one-third of the tissue. This change in 
vascularity is directly related to a 20 kDa portion of the C-terminal region of 
collagen type XVIII called endostatin, which acts as an inhibitor of vascular in-
growth through inactivation of vascular endothelial growth factor.6• 7 Early in 
development collagen type XVIII is homogeneously distributed throughout the 
meniscus, but as the aging process continues levels increase in the inner two-
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thirds of the tissue and decrease in the outer one-third, creating a favorable 
environment for vascularization in the peripheral meniscus.6 During early 
maturation (less than 20 years of age), the rate of proteoglycan production in the 
meniscus is 1-5 mM sulfate per hour per milligram of DNA and then gradually 
decreases with aging to around 1120 of its initial rate.8 The adult meniscus has a 
high degree of collagen organization allowing for specialized load transmission 
from the curved femoral condyles to the flat tibial plateau (see Section 1.3). 
As the body moves through adulthood and begins to age, the meniscus 
undergoes degenerative changes. Collagen concentration increases from birth to 
30 years and allows for the creation of a highly organized matrix. It then reaches 
a plateau from 30 to 80 years of age, and finally begins to decline.9• 10 Around 
this time of decline there is an observed increase in ratio of chondroitin-6-sulfate 
to chondroitin-4-sulfate, and an increase in keratin sulfate to chondroitin sulfate, 
characteristics also seen in hyaline cartilage aging. 11 These degenerative 
changes may increase the risk of the meniscus to become injured (more 
discussion in Chapter 6). 
Concepts 
The knee meniscus is comprised of two semi-lunar, wedge-shaped tissues 
that act to stabilize, absorb shock, bear load, and transfer stresses within the 
joint. During articulation of the bones, these tissues are held in place by a 
network of ligaments. Direct ligamentous attachments that integrate the 
meniscus to the tibial plateau are made by the horns of the meniscus, which 
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contain both cartilaginous and calcified regions. During the initial stages of 
meniscal development, the tissue is completely vascularized, but with maturation 
blood vessels are restricted to the outer periphery. Marked differences in cell 
density and collagen organization can be seen as the tissue matures, as the 
meniscus contains condensed cells with little extracellular matrix early on, and 
fewer cells surrounded by abundant organized matrix in adulthood. Meniscal 
aging is apparent through a decline in collagen and an increase in chondroitin-6-
sulfate and keratin sulfate relative abundances. 
Section 1.2: Biochemical composition, structure, and function 
Regional variation 
While the meniscus contains blood vessels and nerves, these are only 
found peripherally in the tissue, and therefore the meniscus is generally 
considered in terms of two regions. The vascularized and innervated (red) region 
is located exclusively in the outer periphery, and the non-vascularized (white) 
region makes up the inner portion of the tissue (see Figure 5).9• 12• 13 These two 
regions are joined together by a transitional region called the red-white region, 
which exhibits both red and white properties. The capacity for a region to self-
repair correlates directly with the amount of vasculature present, giving the red 
region the highest regenerative potential. The red and white regions also differ 
greatly in terms of biochemical content, mechanical properties, and cell type. 
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Biochemical content 
Overall, the meniscus is composed of approximately 70% water and 30% 
organic matter.3 Of the organic matter, 75% is collagen. Although collagen is 
present throughout the meniscus, different types are prevalent in different 
regions. In the red region of the meniscus, collagen type I is the main collagen 
present while in the white region, both collagens type I and II are in abundance.3· 
12 Other collagens present in the meniscus are types Ill, IV, V, VI, and XVIII but 
to a much smaller degree than types I and 11.6• 12 The outer portion of the 
meniscus is 80% collagen by dry weight and is almost exclusively type I, with 
less than 1% of other collagen types. 14 In contrast, the inner portion of the 
meniscus is 70% collagen by dry weight. Of this collagen, 60% is type II and 40% 
is type 1.14 Therefore, the outer portion of the meniscus is more fibrous and the 
inner portion of the meniscus, containing collagen type II, has some hyaline 
cartilage-like properties. 
As the largest fraction of the extracellular matrix, collagen has an 
important role in the functionality of the meniscus. Being a fibrillar protein, 
collagen type I is able to confer various types of mechanical integrity based on its 
structural organization. The alignment of collagen fibers in the meniscus varies 
from being mostly random within the superficial and lamellar layers, to oriented 
circumferentially in the deep layer and with radially oriented "tie" fibers present 
throughout (Figure 6).12 This alignment allows for the meniscus to withstand hoop 
stresses generated by normal loading of the tissue. 
-- - ---------------
13 
While the overwhelming majority of fibers in the meniscus are collagens, 
elastin has also been found in the matrix, though it comprises 1% or less of the 
dry weight (Figure 7). The presence of even such a small degree of elastin is 
thought to provide resiliency to the tissue, as it is known for being able to recover 
its original shape after withstanding large strains. It has been proposed that 
elastin interacts directly with the collagen network during loading to impart 
resiliency to the matrix. 15 
The remaining 25% of the organic matter in the human meniscus is made 
up of proteoglycans (-15%), cellular DNA (-2%), and adhesion glycoproteins 
(<1%) (Figure 7).12• 16 This breakdown can vary regionally within the meniscus. 
Proteoglycans are molecules consisting of a core protein that is decorated with 
glycosaminoglycans (GAGs), and are commonly classified based on the GAGs 
present. Of the GAGs that are found in the meniscus, 40% are chondroitin-6-
sulfate, 10-20% are chondroitin-4-sulfate, 20-30% are dermatan sulfate, and 15% 
are keratin sulfate.16 GAGs are negatively charged and therefore play a central 
role in attracting water into the tissue, imparting both hydration and compressive 
stiffness. Due to the need for compressive integrity, cells from the inner two-
thirds of the meniscus produce more proteoglycans than the outer one-third.17• 18 
Biglycan, which is theorized to protect cells during loading, is at its highest 
concentration in the inner one-third of the meniscus.17 In addition, decorin, which 
helps collagen fibril organization, is found mostly in the outer one-third of the 
tissue where collagen organization is highest.17 Due to its wedge shape, the 
highest compressive loading on the meniscus is borne by the inner portion, while 
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the outer portion experiences a tensile hoop stress (more discussion ensues in 
Section 1.3). The spatial organization of proteoglycans within the meniscus 
therefore allows the tissue and the cells within it to withstand compressive 
loading and to organize collagen fibrils to bear tensile loads. 
Adhesion glycoproteins are a specialized class of molecules that aid in 
binding matrix molecules to one another and to cells. Within the meniscus type VI 
collagen, fibronectin, and thrombospondin have been identified.9 All of these 
molecules contain the Arginine-Glycine-Aspartic acid (RGD) amino acid 
sequence which aids in cell attachment and which allows for cellular and 
extracellular matrix connections. 
Concepts 
Water is the main component of the knee meniscus, comprising 70% of 
the total wet weight of the tissue. The dry weight contains 75% collagen, mainly 
types I and II, and 25% proteoglycans, cells, and adhesion glycoproteins. The 
main GAG present in the meniscus is chondroitin sulfate (50-60%), followed by 
dermatan sulfate (20-30%), and keratin sulfate (15%). Collagen is preferentially 
organized in the circumferential direction, with radial fibers dispersed throughout 
in order to bear tensile loads generated from joint movement. Given this general 
collagen organization, clear differences can be seen in the biochemical makeup 
of the outer and inner portions of the meniscus. In the outer portion of the 
meniscus collagen type I is dominant, but in the inner portion type II collagen is 
slightly more prevalent than type I. Proteoglycans are also more abundant in the 
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inner portion of the meniscus, allowing for high compressive loads to be borne. 
Resiliency of the knee meniscus is imparted to the tissue through the slight 
presence of elastin (<1% of dry weight). Cells are dispersed throughout the 
matrix and are anchored to it via adhesion glycoproteins which contain RGD 
peptides. Biochemical composition of the knee meniscus varies regionally, and 
allows for the specialized function of the tissue. 
Section 1.3: Biomechanical properties and evaluation techniques 
Geometrical considerations 
Because the main functions of the knee meniscus are load transmission 
and stability, this tissue must withstand many different forces including shear, 
tension, and compression. The structure and composition of each semicircular 
meniscus is well-suited to this task, as evidenced by its unique biomechanical 
properties. 
On a macroscopic level, the geometry of the meniscus gives the first 
indication of its function. The meniscus is both semilunar and wedge-shaped. In 
terms of its semilunar geometry (as shown in Figure 8), the medial and lateral 
menisci can be measured anteroposteriorly (lengthwise), and mediolaterally 
(widthwise). Typical dimensions for the medial meniscus are 40.5-45.5 mm in 
length, and 27 mm in width. 19· 2° For the lateral meniscus, length and width 
dimensions are typically 32.4-35.7 mm and 26.6-29.3 mm, respectively. 19· 20 The 
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circumferential dimension for the medial meniscus is approximately 90-110 mm, 
while for the lateral meniscus it is slightly shorter (approximately 80-100 mm). 19 
As the tissue is wedge-shaped, thick on the outer periphery and thin 
toward the middle of the joint, it is ideally suited to stabilize the femoral head as it 
articulates with the tibial plateau by increasing congruency between the two 
surfaces. Additionally, as load is applied from the femur to the tibia, the meniscus 
draws upon its unique shape to deform radially, thereby bearing some of the load 
that would otherwise be transmitted to the tibial cartilage. The radial 
displacement, opposed by posterior and anterior attachments on the tibial plate, 
results in a hoop stress in the tissue. 
Norma/loading conditions 
During normal activities such as walking or ascending stairs, the knee joint 
experiences loads of 2.7-4.9 times body weight.21 Overall, it is estimated that the 
knee meniscus bears anywhere from 45% to 75% of this total joint load, varying 
with degree of joint flexion, animal model, as well as health of the tissue.22 As the 
knee flexes, the contact area between the bones in the joint decreases by 4% for 
every 30°, accounting for some of the variability in load-bearing capacity of the 
meniscus.23 It has been shown that at full extension, the lateral meniscus bears 
almost all of the load on the lateral side, while the medial meniscus bears about 
50% of the medialload?4 The meniscus not only acts to increase congruence in 
the joint, it also acts as a spacer creating 1 mm of space between most of the 
articulating femoral and tibial surfaces and allowing only 10% of these surfaces 
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to contact.24 Without the meniscus tissue, the support of the femoral condyles is 
dramatically reduced and the joint force is concentrated on the hyaline cartilages, 
increasing the stress on the tissue to 2 to 3 times higher than normal. 25 It is 
therefore evident that the load-bearing capacity of this structure and its role in 
protecting the hyaline cartilage surfaces of the femur and tibia act to prevent joint 
injury. Both geometry and anatomical anchors play an important role in the 
stabilizing, load-bearing, and protective functions of the meniscus. 
Shock absorption 
The meniscus also plays a distinct role in absorbing shock within the joint. 
Studies on the bovine meniscus have shown that this tissue has 1/2 the stiffness 
and 1/10 the permeability of hyaline cartilage_26· 27 Additionally, as the collagen 
fibers within the meniscus have varying diameters, they are suited to absorb a 
variety of different frequencies.28 These features make it easier for the meniscus 
to absorb shock and deform in response to joint movement. 
Collagen organization 
On a microscopic level an even more refined architecture can be 
distinguished that allows these specialized functions to be realized. As discussed 
previously, throughout the developmental process the collagen matrix in the 
meniscus becomes increasingly organized. This organization varies with depth in 
the tissue, imparting both tensile stiffness and resistance to splitting.29· 30 
Collagen orientation can be considered in three layers: superficial, lamellar, and 
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deep, which describe the tissue from surface to core. As shown in Figure 9, 
collagen fibers are amorphous in the superior superficial layer, but are more 
radially oriented in the inferior superficial layer, closest to the tibial plateau. 31 
Amorphous collagen organization persists through the lamellar layer, but is 
distinguished from the superficial layer in that it contains short, radially oriented 
fibers only at the posterior and anterior horns. 30 In the deep layer, collagen is 
predominantly oriented circumferentially, with a few radially oriented fibers.9• 28• 31 • 
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As described previously, during normal loading conditions the femur 
presses down on the meniscus, creating radial displacement that is opposed by 
anterior and posterior anchors. This displacement is translated within the tissue 
to hoop stresses, radial tension, shear, and compression which are borne by the 
special organization of collagen fibers and proteoglycans, as shown in Figure 10. 
In the superficial and lamellar layers, amorphous and radial collagen fibers act to 
resist mediolateral splitting of the meniscus and in the deep zone 
circumferentially oriented fibers work in tension as a result of hoop stresses.10 
Shear forces generated by the femur deforming the tissue are opposed by matrix 
molecule interactions, and negatively charged proteoglycans in the meniscus 
impart compressive integrity by resisting fluid loss.12 
Biphasic behavior 
Due to its makeup, the meniscus is considered biomechanically as a 
biphasic tissue. The first phase consists of the porous and permeable collagen 
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and proteoglycan solid matrix, while the second phase is made up of water and 
salts that are present throughout the matrix.26· 33 While the solid matrix makes up 
only about 30% of the total tissue, it is the interplay between the solid and fluid 
phases that imparts viscoelastic properties to the meniscus (see Figure 11).34 As 
a viscoelastic tissue, the mechanical behavior of the meniscus depends on both 
the magnitude and rate of loading. Frictional drag is produced by fluid being 
forced from the tissue during load application, producing creep and stress-
relaxation responses. 26 When subjected to a constant force or stress applied 
suddenly as a step, the meniscus displays elastic-like properties immediately 
after loading. This initial behavior is controlled by the hydrostatic pressure 
developed in the interstitial fluid portion of the tissue. After this initial phase, still 
under constant stress, the tissue continues to deform, but at a slower rate as the 
fluid phase is expelled from the matrix, with the solid matrix resisting more of the 
load. This deformational behavior under a constant, step load is called the creep 
response.33 
A similar behavior can be observed when a step strain or displacement is 
placed on meniscal tissue. Initially, the solid matrix responds elastically by 
creating a reaction force that is linearly related to the applied displacement. Over 
time, this reaction force diminishes exponentially as the fluid is expelled from the 
matrix and the load is shared by both fluid and solid, until eventually only the 
solid matrix supports the applied load. This behavior is called stress-relaxation. 33 
Following load removal within the joint, the fluid that was expelled during loading 
is able to rehydrate the tissue, initiated by the negatively charged proteoglycans 
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in the matrix, resulting in recovery behavior. This fluid flow also functions to 
transport nutrition throughout the tissue and surrounding hyaline cartilage, 
remove waste, and provide lubrication. 32 Therefore, the mechanical behavior of 
the meniscus is not only vital to ensure proper load distribution, but is also 
instrumental in the overall health and lubrication of the joint. 
Biomechanica/ evaluation 
A number of mechanical tests are used to quantify just how mechanically 
robust this tissue is when subjected to tensile, compressive, and shear loading. 
Due to the variation in collagen alignment and the asymmetrical shape of the 
meniscus, a complete picture of the mechanical properties of the meniscus must 
consider specimens that vary spatially within the tissue and are oriented along 
and perpendicular to the preferred collagen alignment. Figure 12 details the 
various directions and regions that are important in meniscus characterization. 
The most common methods used to characterize the mechanical properties of 
meniscal tissue are tensile and compressive tests. It is important to note that as 
the availability of human tissue is limited, some mechanical characterization data 
are only available for other animals such as the cow, pig, or sheep. 
Tension 
For tensile testing, tissue can be harvested from the meniscus at a 
prescribed depth perpendicular to or parallel with the circumference of the 
meniscus. It is crucial to maintain consistency amongst samples with regard to 
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position and orientation because the meniscus is known to have anisotropic 
properties.29• 32 Tensile tests are usually performed using a constant strain rate of 
0.005 sec-1, and the samples may or may not be preconditioned.30• 32 This small 
strain rate is used to minimize the effects of frictional drag from interstitial fluid 
flow out of the solid matrix, and to neglect the viscoelastic properties of the 
collagen and proteoglycan matrix.30 
When considering specimens from the anterior, central, and posterior 
meniscus it can be seen that the circumferential Young's modulus varies 
spatially, and that the lateral meniscus has a higher average tensile 
circumferential modulus than the medial meniscus (see Table 1).32 When testing 
the bovine meniscus in the radial direction, its modulus is highest closest to the 
posterior region of the meniscus, and decreases moving toward the anterior 
horn.30 There is evidence that the tie fibers in the posterior region of the bovine 
meniscus are closely packed and form sheets, which may explain the higher 
modulus found there.30 In tension, the properties of the meniscus vary from being 
isotropic on its surface, to anisotropic in deeper layers due to the variation in 
collagen fiber alignment. These collagen fibers provide the tissue a robust tensile 
stiffness of up to 300 MPa.32 In the superficial layer, the tissue fails at high 
stresses and low strains with no preferred direction. In the deeper zones, the 
tensile modulus in the circumferential direction can be 3 to 10 fold higher than in 
the radial direction, owing to the abundance of circumferential collagen fibers 
relative to radial fibers.30• 32 Comparing tensile properties of the superior medial 
bovine meniscus, the layer 0.6-1 mm from the surface has the highest stiffness 
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circumferentially and is about 4-fold stiffer than the layer 0-0.2 mm from the 
surface.27 This 0-0.2 mm layer of the bovine meniscus is about 3-fold stiffer than 
the layer 1.4-1.8 mm from the surface.27 
Compression 
Methods for compressive testing of meniscal tissue include confined or 
unconfined compression and creep indentation?7• 35-37 The creep indentation 
apparatus is depicted in Figure 13. 
Both compressive testing and creep indentation can yield the aggregate 
modulus and permeability, but creep indentation can additionally allow for the 
calculation of the Poisson's ratio, and thus, shear modulus of the tissue. This 
type of testing has shown that different regions in the meniscus have varying 
compressive properties, which is a result of their biochemical makeup and 
organization (see Table 2). Using the creep indentation apparatus, it has been 
shown that the aggregate modulus of the human meniscus is greatest in the 
anterior region of the meniscus (around 150 kPa), as compared to the central 
and posterior regions (around 100 kPa). 37 Also notable is that the permeability 
and shear modulus measured within the meniscus are relatively constant 
amongst all regions.37 In unconfined compression at 20% strain, the meniscus 
again displays anisotropic behavior with the highest compressive Young's 
modulus in the vertical direction being twice as high as in the circumferential and 
radial directions. 36 This high stiffness in the vertical direction may be attributed to 
proteoglycans in the matrix of the tissue resisting fluid loss, thereby opposing the 
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vertical force. 35• 36 The compressive integrity of the meniscus allows for axial 
loading from the femur to be resisted, and because of the geometry of the tissue, 
some of this vertical loading is translated into circumferential, radial, and shear 
stresses. 
Shear 
For specifically testing the meniscus in shear, dynamic oscillatory or 
constant shear strain is applied to the specimen which can measure the dynamic 
shear modulus as well as the transient shear modulus relaxation function.34 As 
mentioned previously, creep indentation can also be used to yield the shear 
modulus of a meniscus sample, though it is an indirect method of doing so. It has 
been shown that the dynamic shear modulus of the meniscus is frequency 
dependent and anisotropic (see Table 3). The frequency dependence again 
points to the viscoelastic nature of the tissue, while the anisotropy of the modulus 
indicates that collagen organization and interactions between collagen and 
proteoglycans are central to shear resistance.34 The normal human meniscus 
has a shear modulus on the order of 120 kPa at 1.5 Hz and 10% strain.32 The 
orientation of collagen fibers within the meniscus has a profound impact on shear 
modulus at low compressive strains. The shear modulus of a bovine meniscus 
sample that undergoes a dynamic shear test in the circumferential direction is 20-
36% higher than a sample sheared in the radial direction, and depends on the 
amount of strain applied (up to 10%).34 With compressive strains higher than 
10%, these differences diminish.34 
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Concepts 
Because of its geometrical shape and anchoring, the meniscus 
experiences tension, compression, and shear while bearing load or stabilizing the 
joint. Collagen and proteoglycans play an important role in imparting robust 
tensile, compressive, and shear properties to the meniscus and their anisotropic 
organization is vital to this function. The meniscus is modeled as a biphasic 
material, displaying viscoelastic behaviors when subjected to step stresses or 
strains. Biomechanical testing of the tissue reveals that the tissue has a tensile 
modulus on the order of 100-300 MPa in the circumferential direction, which is 
1 0-fold higher than in the radial direction. It is also well-suited to resist 
compression axially, given an aggregate modulus of 100-150 kPa. In shear, the 
tissue exhibits a shear modulus on the order of 120 kPa. 
Section 1.4: Cell types 
Cell classification 
Development of the meniscus begins with the condensation of a vast 
number of cells that are largely indistinguishable from one another. After the 
tissue has matured, however, the cells in the different meniscal layers are 
morphologically distinct. In the superficial layers of the meniscus, cells appear 
oval and fusiform, similar to fibroblasts.38-4° In the deeper zones, however, cells 
are found to be more rounded in nature which is more similar to chondrocyte 
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morphology.1· 38-4° These variations have made the classification of these cells 
difficult. Researchers have used various terms to describe them including 
fibroblasts, fibrocytes, chondrocytes, fibrochondrocytes, and meniscus cells. 1 • 38• 
39
• 
41
-43 While the meniscus is made up of predominantly collagen type I, it is 
natural to expect fibroblast-like cells to inhabit it, and indeed the morphology and 
gene expression patterns of cells in the meniscus exhibit some fibroblastic 
characteristics; they also exhibit chondrocyte-like characteristics. These cells 
cannot be strictly classified as chondrocytes either because instead of 
exclusively producing collagen type II they are known to produce collagen type I 
as well. The term meniscal fibrochondrocytes has been used to collectively 
describe these heterogeneous cells, encompassing both their fibroblastic and 
chondrocytic natures, and studies have been performed to further characterize 
them.40 In this book, we use the terms meniscal fibrochondrocytes and meniscus 
cells interchangeably. 
Diversity of meniscus cells 
In the rabbit meniscus, as many as four distinct cell types have been 
identified in various locations in the tissue based on morphology and the 
presence of gap junctions (Figure 14).38 In the inner one-third of the tissue, cells 
with a rounded shape closely resembling chondrocytes have been found, while in 
the outer portion of the meniscus two cell types that display many cell processes 
are present. 38 Another cell type is found in the superficial zone of the meniscus 
and has a spindle-shaped morphology.38 The cell types in the outer portion 
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contain gap junctions, while cells from the inner portion and superficial zone of 
the meniscus do not contain these processes. 38 In addition to fibrochondrocytes, 
endothelial cells are present to maintain the microvasculature of the outer 
meniscus.44 These cells are distinct from fibrochondrocytes as they are found 
only in the lumen of meniscal vasculature. 
Cell synthetic properties 
Meniscus cells from all regions work in concert to produce the appropriate 
proteins needed to maintain healthy tissue. Total collagen synthesis does not 
vary amongst the regions of the meniscus, but the main types of collagens 
produced are types I and II. A lower degree of synthetic activity can be detected 
for collagen types Ill, IV, V, and VI by these cells. 18• 45 The GAGs produced by 
meniscal cells are predominantly chondroitin sulfate and, to a lesser degree, 
keratin sulfate.46 Comprehensive gene expression profiles for meniscal 
fibrocartilage as a whole have been compared to hyaline cartilage, identifying 
common genes and genes specific to each cartilage type.47 While there are 
numerous genes that hyaline and meniscal cartilages have in common, there are 
some genes that are more highly expressed in one cartilage type than the other. 
When compared to human mesenchymal stem cells (which are considered 
precursors to cartilage cells), certain genes are more highly expressed in 
chondrocytes than fibrochondrocytes, and vice versa, as shown in Table 4. This 
type of analysis allows for a better characterization of the tissue and highlights 
the differences between these two distinct cartilages at a molecular level. 
--------------------
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Regional variation in synthetic profiles 
Fibrochondrocytes from the inner and outer meniscus have distinct protein 
synthetic profiles and gene expression patterns, giving rise to the heterogeneous 
makeup of the meniscus (see Table 5). In the inner meniscus, cells display a 
mostly rounded morphology similar to chondrocytes and stain positively for a-
smooth muscle actin which imparts contractile behavior to the cells.42· 48• 49 These 
cells also tend to produce more proteoglycans than the polygonal and fusiform 
cells of the outer region. 18 Inner region cells can be characterized by higher gene 
expression and production of collagen type II and aggrecan, as well as negative 
staining for the cell surface marker CD34, which functions in cell to cell 
adhesion.45· 50-53 Cells in this region also have high gene expression for nitric 
oxide synthase (NOS2), which is implemented in nitric oxide production and has 
been shown to regulate meniscus cell biosynthesis. 53· 54 
In contrast, cells of the outer region of the meniscus are characterized by 
high gene and protein expression of collagen type I, proteases MMP2 and 
MMP3, and stain positively for the cell surface marker CD34.38• 45· 51 • 53 The gene 
profile of these cells is more reminiscent of fibrous tissue due to the high degree 
of collagen I expression and the expression of proteases which can aid in cellular 
migration and remodeling of the tissue following injury. 
Mechanosensitivity of meniscus cells 
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Gene expression and protein synthesis of meniscal cells can vary with age 
and region in the tissue, but are also sensitive to mechanical cues (see Table 6). 
Cells from the inner and outer meniscus are exposed to different cytomechanical 
environments.55 Using finite element modeling of the meniscus, it has been 
predicted that the round, inner meniscus cells experience tensile strains on the 
order of 7% under normal loading conditions.55 More elongated, outer meniscus 
cells, however, are predicted to experience strains ranging from 2-4%.55 These 
differences highlight that elongation of a spherical cell will result in a more 
pronounced shape change than the same deformation of an already elongated 
cell. When subjected to biaxial strains of 5% in vitro, all cells regardless of region 
increase their total protein synthesis.56 There is also a marked increase in nitric 
oxide levels, but this is not accompanied by an upregulation of the NOS2 gene. 56 
Therefore, cells from all regions of the meniscus respond similarly to biaxial 
strain in vitro, but may differ in vivo due to cues from various matrix molecules 
present. 56 
Cells from the meniscus change their gene expression profiles in 
response to different regimens of compressive loading.57 Under static 
compressive loading of meniscal tissue, gene expression of decorin and collagen 
types I and II decrease 3- to 4- fold, while mRNA levels increase 2- to 3- fold for 
MMP-1.57 Under dynamic compressive loading (-1 MPa, 0.5 Hz), decorin 
expression decreases 2-fold, collagen type II expression decreases 4-fold, and 
nitric oxide (NO) levels increase. 57· 58 
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In vivo, joint immobilization at 90° flexion results in a 2- to 5-fold decrease 
in gene expression for aggrecan, the major proteoglycan of the meniscus, 
indicating that meniscal cells are dependent upon mechanical cues for normal 
function.59 These observations suggest that mechanical stimuli, whether in the 
form of static or dynamic tensile or compressive stresses, can alter cellular 
processes to either increase or decrease protein synthesis. Additionally, 
mechanical cues may be another way for cells to assess the need to create or 
destroy their surrounding matrix, resulting in macroscopic changes in the tissue. 
Concepts 
Having both chondrocytic and fibroblastic characteristics, cells of the 
meniscus have been historically difficult to classify. The term meniscal 
fibrochondrocytes has been used to highlight the complex nature of the cells. As 
many as four distinct cell morphologies have been identified in the rabbit 
meniscus with rounded cells in the inner region, cells with increasing numbers of 
processes toward the outer region, and spindle-shaped, flattened cells in the 
superficial region. 
Different cell synthetic profiles have been detected based on region within 
the tissue. Cells of the inner meniscus synthesize both collagen types I and II, 
while the outer meniscus cells synthesize collagen type I, as well as MMPs 2 and 
3 for matrix remodeling.38• 45• 51 • 53 Normal meniscus cell functions are also 
dependent on mechanical stimulation, as joint immobilization has proved to 
decrease gene expression for aggrecan 2- to 5-fold.59 Cells in the meniscus are 
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subject to varying loading conditions, with the outer meniscus cells experiencing 
tensile strains of 2--4%, and inner meniscus cells experiencing 7%. In response 
to static compression, meniscus cells decrease gene expression for matrix 
molecules and increase expression for MMPs, and dynamic compression also 
decreases collagen and decorin expression but increases nitric oxide levels. 57 
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Tables 
Table 1: Tensile properties of the native meniscus 
Region Direction Animal Stiffness Reference {±SO; MPa} 
Meniscus Circumferential Cow 32 
Superior 59.8 
Deep 198.4 
Inferior 138 
Lateral Circumferential Human 32 
Anterior 159.07 ± 47.4 
Central 228.79 ± 51.4 
Posterior 294.14 ± 90.4 
Medial Circumferential Human 32 
Anterior 159.58 ± 26.2 
Central 93.18 ± 52.4 
Posterior 110.23 ± 40.7 
Medial (from superior Circumferential Cow 27 
surface) 
0-0.2mm 48.3 ± 29.2 
0.6-1 mm 198.4 ± 87.5 
1.4-1.8 mm 139 ± 79.2 
Meniscus Radial Cow 32 
Superior 59.8 
Deep 2.8 
Inferior 4.6 
Medial Radial Cow 30 
Anterior 10-20 
Central 20-40 
Posterior 20-70 
Medial (from superior Radial Cow 27 
surface) 
0-0.2mm 71.4 ± 41.6 
0.6-1 mm 2.8 ± 1.2 
1.4-1.8 mm 4.6 ± 2.1 
-------------------~-------------
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Table 2: Compressive properties and permeability of the native meniscus 
using creep indentation or confined compression 
Aggregate Permeabili~ 
Region Animal modulus (± SD; 10-1 Ref. 
(±SO; MPa) m4 N-1 s-1) 
Medial superior Human Creep indentation 37 
Anterior 0.15 ± 0.03 1.84 ± 0.64 
Central 0.10 ± 0.03 1.54 ± 0.71 
Posterior 0.11 ± 0.02 2.74 ± 2.49 
Medial inferior 37 
Anterior 0.16 ± 0.05 1.71 ± 0.48 
Central 0.11 ± 0.04 1.54 ± 0.49 
Posterior 0.09 ± 0.03 1.32 ± 0.61 
Medial superior Cow 37 
Anterior 0.21 ± 0.06 6.22 ± 2.55 
Central 0.14 ± 0.05 5.73 ± 6.19 
Posterior 0.11 ± 0.04 4.73 ± 2.56 
Medial inferior 37 
Anterior 0.16 ± 0.06 5.79 ± 4.31 
Central 0.11 ± 0.03 5.65 ± 4.13 
Posterior 0.13 ± 0.06 5.40 ± 5.36 
Medial superficial Cow Confined 27 
compression 
Anterior 0.39 ± 0.11 0.76 ± 0.47 
Central- 0.42 ± 0.07 0.83 ± 0.39 
anterior 
Central- 0.37 ± 0.08 0.78 ± 0.38 posterior 
Posterior 0.44 ± 0.11 0.63 ± 0.47 
Media/deep 27 
Anterior 0.49 ± 0.04 0.91 ± 0.52 
Central- 0.41 ± 0.05 0.86 ± 0.51 
anterior 
Central- 0.38 ± 0.09 1.03 ± 0.58 posterior 
Posterior 0.38 ± 0.04 0.74 ± 0.14 
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Table 3: Shear properties of the native meniscus using creep indentation 
or dynamic oscillatory strain 
Region Animal Shear modulus Reference {± SD; MPa} 
Medial superior Human Creep indentation 37 
Anterior 0.08 ± 0.01 
Central 0.05 ± 0.01 
Posterior 0.05 ± 0.01 
Medial inferior 37 
Anterior 0.08 ± 0.02 
Central 0.06 ± 0.02 
Posterior 0.05 ± 0.01 
Medial superior Cow 37 
Anterior 0.11 ± 0.03 
Central 0.08 ± 0.02 
Posterior 0.06 ± 0.02 
Medial inferior 37 
Anterior 0.08 ± 0.03 
Central 0.06 ± 0.02 
Posterior 0.07 ± 0.03 
Medial Cow Dynamic (1 0% strain, 10 rad/s) 34 
Axial 0.067 ± 0.024 
Circumferential 0. 087 ± 0.023 
Radial 0.061 ± 0.028 
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Table 4: Genes related to hyaline and meniscal cartilages: Fold-increased 
expression relative to human mesenchymal stem cells* 
Hyaline Meniscus Gene Gene name ex~ression ex~ression slmbol 
>2 <0.5 IGF2 insulin-like growth factor 2 (somatomedin A) 
>2 <0.5 IGL@ immunoglobulin lambda locus 
>2 <0.5 RTN4R reticulon 4 receptor (Nogo receptor) 
>2 <0.5 EPHX2 epoxide hydrolase 2, cytoplasmic 
>2 <0.5 CREG cellular repressor of E1A-stimulated genes 
>2 <0.5 FLJ13840 Homo sapiens eDNA FLJ 13840 fis, 
clone THYR01 000783 
>2 <0.5 BCL7A 8-cell CLUiymphoma 7 A 
>2 <0.5 PLA2G2A phospholipase A2, group IIA (platelets, synovial fluid) 
>2 <0.5 CTSC cathepsin C 
>2 <0.5 RBP4 Retinol-binding protein 4, interstitial 
>100 -15 COL2A1 collagen, type II, alpha 1 
<0.5 >2 HPCAL1 hippocalcin-like 1 
<0.5 >2 FLJ20831 hypothetical protein FLJ20831 
<0.5 >2 PDLIM1 PDZ and LIM domain 1 (elfin) 
<0.5 >2 C1QR complement component C 1 q 
receptor 
<0.5 >2 COL1A1 collagen, type I, alpha 1 
<0.5 >2 COL1A2 collagen, type I, alpha 2 
<0.5 >2 CA12 carbonic anhydrase XII 
From Ochi et al. 
Table 5: Properties of inner and outer meniscus cells 
Property Associated cell type Reference 
Collagen type II Inner 39, 45, 5o, 53 
Aggrecan Inner 53 
NOS2 Inner 53• 54 
Collagen type I 
CD34 
MMP2 
MMP3 
Throughout 
Outer 
Outer 
Outer 
39,45,50,53 
51 
53 
53 
35 
36 
Table 6: Effects of mechanical loading on meniscus cells 
Stimulus Details Effect Ref. 
Norma/loading Finite element Strain: inner cell (-7%), outer cell 55 
model (-2--4%) 
Biaxial cellular Cyclic, 5%, Increased protein synthesis (larger for outer cells than for inner cells), 56 
strain, in vitro 0.5 Hz, 24 hrs increased NO levels 
3- to 4-fold decrease in expression 
Static tissue 0.1 MPa, of decorin, collagen type I, II; 2- to 57 
compression 24 hrs 3-fold increase in MMP-1 
expression 
Dynamic tissue 0.08-0.16 2-fold decrease in decorin MPa, 0.5 Hz, expression, 4-fold decrease 57 
compression 24 hrs collagen type II expression 
Dynamic tissue 0-0.1 MPa, 0.5 Hz square Increased NO levels 58 
compression wave, 24 hrs 
Joint In vivo 2- to 5-fold decrease in aggrecan 59 immobilization expression 
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Figures 
Figure 1: The native knee meniscus. Bovine knee joint showing the white, 
semicircular cartilages that make up the knee meniscus. The meniscus increases 
congruence between the femoral condyle and tibial plateau, and aids in normal joint 
function. 
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Figure 2: Anterior vie)N of the knee joint and location of the meniscus. The 
meniscus is located between the femoral condyles and tibial plateau within the 
knee joint. It is made up of two parts, medial and lateral, which are attached to 
each other by the transverse ligament. Various ligaments within the joint space 
and on its periphery help to restrict bone movement, and maintain normal joint 
functionality. These include the posterior cruciate ligament, anterior cruciate 
ligament, lateral collateral ligament, and medial collateral ligament. 
Lateral --+ 
meniscus 
Horn 
plateau 
Transverse 
ligament 
Ligament 
ofWrisberg 
Ligament 
of Humphrey 
+-Medial 
meniscus 
39 
Figure 3: Superior view of the tibial plateau showing meniscal attachments. 
The medial and lateral menisci rest atop the tibial plateau and are affixed to the 
tibia via horn attachments and to each other via the transverse ligament. Other 
ligaments in the joint space help to restrict movement such as the ACL, PCL, and 
ligaments of Wrisberg and Humphrey. 
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Figure 4: Decrease in meniscus vascularity during development. Before 
birth , the developing meniscus is completely vascularized. After birth , this 
vascularity begins to recede rapidly toward the outer periphery during the first 9 
months, and then more gradually until approximately 11 years. At this stage, the 
inner one third of the meniscus is completely avascular. 
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Figure 5: Locations of the three regions of the meniscus. Vascularity defines 
regions radially in the meniscus. Closest to the synovial membrane is the red 
(outer) region, which is highly vascularized. Moving toward the center of the joint 
space, blood vessels become more sparse in the red-white (transitional) region, 
and are absent in the white (inner) region. 
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Figure 6: Collagen orientation within the meniscus. The meniscus displays 
different collagen organization with depth in the tissue. Here, a vertical cross-
section of the meniscus is labeled with the three meniscus zones: superficial, 
lamellar, and deep. Collagen fibers are randomly oriented in the superficial zone 
and throughout most of the lamellar zone. Some radial fibers can be detected in 
the posterior and anterior horns of the lamellar layer. The deep layer is 
characterized by circumferentially oriented fibers, with some radial fibers 
dispersed throughout. 
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Figure 7: Schematic diagram of meniscus biochemistry. A hierarchical 
structure of the overall contents of the meniscus is shown in which water is the 
largest component. Within the solid fraction, collagens comprise the majority, 
followed by glycosaminoglycans. DNA, adhesion glycoproteins and elastin form a 
small fraction of organic matter. Variations in meniscus composition can be 
observed in different locations within the tissue. 
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Figure 8: Geometrical measurements of the meniscus. Typical 
circumferential measurements for the human meniscus range from 80-100 mm 
and are shorter for the lateral meniscus than for the medial meniscus. Lengths 
and widths range from 32.4-35.7 mm and 26.6-29.3 mm, respectively. 
Radial 
Random 
lamellar 
Circumferential 
deep 
45 
Figure 9: Collagen architecture of the knee meniscus. From core to surface, 
collagen arrangement changes from structured to unstructured. Collagen 
orientations in the meniscus are of three main types: circumferential , radial , and 
random. Circumferential fibers are the most abundant in the tissue and are found 
in the deep zone. Radial fibers are dispersed throughout the deep zone and are 
present on the periphery and at the horns of the meniscus in the lamellar zone. 
Despite the presence of radial fibers , random fiber orientation dominates the 
lamellar zone. In the superficial zone, fiber orientation is typically random in the 
superior region and more radially oriented in the inferior region . 
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Figure 10: Free body diagram of forces acting on the meniscus during 
loading. As the femur presses down on the meniscus during normal loading, the 
meniscus deforms radially but is anchored by its anterior and posterior horns (Fant 
and Fpost). During loading, tensile, compressive, and shear forces are generated. 
A tensile hoop stress (F cir) results from radial deformation, while vertical (Fv) and 
horizontal (Fh) forces result from the femur pressing on the curved superior 
surface of the tissue. A radial reaction force (Frad) balances the femoral horizontal 
force (Fh). 
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Figure 11: Biphasic behavior of meniscal tissue. (i) GAGs (black lines) and 
water (blue dots) coexist in the matrix, (ii) as the meniscus is loaded, water is 
forced from the matrix, and (iii) when the load is released, the negatively charged 
GAGs attract water back into the matrix, rehydrating the tissue. 
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Figure 12: Regions and directions of the meniscus. Because meniscal 
properties vary with location in the tissue, defining different regions, depth zones, 
and directions is useful. The meniscus can be divided into anterior, central , and 
posterior regions based on location in the joint, and into superficial , lamellar, and 
deep zones that vary with depth in the tissue. Directions such as inner and outer, 
as well as inferior and superior describe the tissue from the center of the joint to 
its periphery, and from the tibial plateau to the femoral condyle, respectively. Also 
of importance are the circumferential and radial directions, which indicate that the 
meniscus is semi-circular in nature. 
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Figure 13: Creep indentation apparatus. To test a specimen using creep 
indentation, it is submerged in a buffer solution on the sample mounting stage (a) 
which is adjusted such that the specimen surface is directly under and 
perpendicular to the indentation tip (b). An LVDT (c) provides positional feedback 
to a computer to detect when equi librium conditions are met after the system 
receives a step load from the loading stage (d). The entire system is suspended 
by a pulley (e) which relies on frictionless bearing movement provided by 
compressed air. 
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Figure 14: Cell types of the meniscus, distribution, and morphology. 
Superficial zone cells are flattened (a), red zone cells display many cell 
processes (b), red-white zone cells display some cell processes (c), and white 
zone cells are rounded and chondrocyte-like (d). 
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Chapter 2: Biomechanical Characterization of Single 
Chondrocytes 
Abstract 
Normal cartilage functions to cushion and distribute loads throughout the 
joint. The tissue's constitutive cells, chondrocytes, experience a variety of 
stresses as a result of these functional aspects, but the effects of these stresses 
on the individual cells are largely unknown. To understand the mechanical 
integrity of chondrocytes and how these properties change in response to various 
stimuli, mechanical testing systems for single cells have been developed. These 
systems are able to apply a wide variety of load types to characterize cellular 
biomechanics, and must rely on complex mathematical models to calculate these 
properties. This chapter reviews the five major mechanical testing systems that 
are used to test single chondrocytes, their distinct advantages, and discusses the 
salient results they have produced relating to chondrocyte mechanics and 
mechanosensitivity. Using these testing systems, it is clear that mechanical 
signals play a major role in chondrocyte gene expression, and these changes are 
essential to understand when developing functional cartilage replacements. 
Chapter published as: Sanchez-Adams, J., and Athanasiou, K.A. "Biomechanical 
Characterization of Single Chondrocytes." Studies in Mechanobiology, Tissue 
Engineering and Biomaterials. Gefen, A., ed. Springer, 2010. ISSN: 1868-2006. 
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Introduction 
Beginning with Aristotle's book On the Movement of Animals, 
biomechanics has sought to explain the complex processes of locomotion. As 
our understanding of the inner workings of the human body increased, a subset 
of the field emerged to closely investigate the mechanical role of individual 
tissues and cells. By focusing in on smaller and smaller subcomponents, 
biomechanics is able to explain how mechanical perturbations affect the normal 
and diseased states of tissues and how these stimuli can be employed in tissue 
engineering strategies. Employing this micro-scale approach is especially useful 
in studying tissues such as articular cartilage, given its major mechanical role in 
the body, inability to self-repair following injury, and need for functional 
replacement therapies. 
The Mechanical Role of Cartilage 
Lining the ends of bones in articulating joints such as the knee, articular 
cartilage facilitates smooth joint movement as well as bearing and distributing 
mechanical loads. Within the knee joint, cartilage routinely experiences 
compressive loads of three times body weight depending on the joint flexion 
angle and activity. Shear forces in the knee are also significant, and can reach a 
third of body weight at a knee flexion angle of 40°.60 These forces are further 
magnified during activities such as running or jumping. As the articular cartilage 
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lining is only between 1 and 2.55 millimeters thick in the joints of the lower limb, 
the tissue must be highly specialized to withstand its mechanical environment. 51 
To achieve mechanical integrity, articular cartilage relies on a network of 
collagen and proteoglycans produced by its constitutive cells, chondrocytes. The 
collagen present in the tissue is mainly type II and provides tensile strength, 
while negatively charged proteoglycans such as aggrecan attract water 
molecules and resist tissue compression. Containing mostly water and proteins, 
the tissue can be modeled as biphasic material.62-65 Mechanical testing of the 
tissue reveals that the tensile and compressive moduli of articular cartilage vary 
with depth and joint type, with the aggregate compressive modulus ranging from 
0.8 to 2 MPa, and tensile modulus between 5 and 25 MPa.66-72 But as 
mechanically robust as cartilage is, injury and disease can compromise its 
integrity and, lacking vasculature, the tissue is unable to self-repair. In response 
to this problem, tissue engineering strategies and biomechanical characterization 
techniques have emerged to further understand the role of chondrocytes in 
cartilage and to apply this knowledge to cartilage replacement and repair 
strategies. 
Functional Tissue Engineering 
Due to the aforementioned forces it must bear, engineered cartilage must 
reflect the native tissue's functional characteristics, especially its compressive 
and tensile integrity. To this end, the field of functional tissue engineering has 
emerged and spurred the creation of mechanical stimulation bioreactors to 
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produce mechanically robust engineered tissue, and enhance purely biochemical 
approaches to tissue engineering cartilage. These bioreactors use hydrostatic 
pressure, direct compression, shear, and combinations thereof to recapitulate the 
native mechanical environment in vitro and cause engineered constructs to 
become more like native cartilage. 73-77 While these mechanical stimulation 
strategies have improved matrix deposition and mechanical strength, the exact 
mechanisms of their action are ill-understood and optimal parameters for 
stimulation have yet to be determined. It is clear, however, that construct 
changes in response to mechanical stimuli are caused by cells, the most basic 
functional unit of any engineered tissue. Therefore, by studying individual cells it 
is possible to tease out the microscopic phenomena that, in combination, give 
rise to macroscopic changes in engineered constructs. 
Applying the functional unit approach to understand the effects of 
mechanical stimulation begins with mechanically characterizing single cells. By 
determining the mechanical properties of single chondrocytes, the material 
limitations of the cells can be used to define the upper and lower limits of 
stimulation. Using these limits, the effects of various mechanical perturbations on 
the gene expression of single cells can be studied. And finally, mechanical 
stimulation parameters resulting in ideal gene expression changes can be 
applied to more complex arrangements of cells in tissue engineered constructs. 
Thus, understanding the response of the single cell to various mechanical stimuli 
can provide useful information for developing tissue engineering strategies. 
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Mechanical Testing of Single Cells 
A variety of techniques have been developed to study the unique 
mechanical characteristics of single chondrocytes. Because the chondrocyte's 
diameter is on the order of 10 IJm, mechanical testing machines must be 
especially sensitive to small changes in force and displacement. For compressive 
and shear testing, this is often achieved by the use of a cantilever to probe the 
cell and some mechanism to detect the cantilever's position over time. To test 
the tensile properties of chondrocytes, micropipette aspiration is the most 
common method and relies on pressure differentials to deform the cell. The 
following sections will explore in more detail the most prominent techniques used 
to elucidate single chondrocyte compressive, shear, and tensile mechanics. 
Compression 
Physiologically, cartilage tissue undergoes compressive forces on a 
regular basis. According to its viscoelastic nature, compressive loads are initially 
borne by the fluid within the tissue, but over time this load transfers to the solid 
portion of the matrix as the fluid is forced out. 64 Trapped within their collagen and 
proteoglycan matrix, chondrocytes also deform under the load. Three major tools 
have been used to test the compressive properties of single chondrocytes: the 
Cytocompressor, Cytoindenter, and the Atomic Force Microscope. The basic 
principles of these three apparatuses will be detailed in this section. 
Cvtocompressor 
The Cytocompressor device is a tool to determine the compressive 
properties of single cells, and has been used extensively to characterize the bulk 
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mechanical behavior of chondrocytes. In this setup, unconfined compression is 
applied to single cells seeded on a glass slide via a large, flat, nonporous probe 
of around 50 !Jm in diameter. This probe is attached to the end of a cantilever 
beam, which is controlled by a piezoelectric actuator (Figure 1 ). 
For each test, the probe is positioned directly over the cell which is 
determined by concurrent focusing of the cell and probe in the microscope. With 
the probe positioned over the cell, the piezoelectric actuator moves the cantilever 
a set distance toward the cell surface, causing the probe to compress it. This 
position is held until the cell reaches equilibrium. The cantilever is then retracted 
from the cell surface, and the volume recovery of the cell is observed. The entire 
compression event is recorded via a CCD camera. Video post-processing of 
each compression event allows for the measurement of key parameters, namely 
the initial, compressed, and recovery geometries of the cell at different time 
points, and the position of the probe. These measurements allow for the 
determination of the cell's compressive modulus, Poisson's ratio, and recovered 
volume fraction, among others. 
To determine the compressive modulus of the cell, the relationship 
between stress and strain must be known. The following equations are used to 
determine the cell's stress (a) from a cytocompression experiment: 
where E and I are the Young's modulus and moment of inertia of the cantilever, L 
is the length of the cantilever, Llx is the difference between actual and prescribed 
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translation of the cantilever, and A is the contact area of the cell and probe. The 
strain can be written as: 
where h; is the initial height of the cell, and h, is the height of the cell at maximum 
compression. Using the Cytocompressor, a range of strains can be applied to 
single cells, and the resultant stresses can be calculated from the deformation of 
the cantilever beam and the contact area of the probe with the cell. These 
stresses and strains can then be plotted and fitted with a line, the slope of which 
gives the compressive modulus of the cell.78-80 
In addition to the modulus of the cell, the geometric data during the 
compression event allow for the determination of the cell's compressibility and 
recovery behavior over time. The apparent Poisson's ratio (v) for the cell can be 
calculated as follows: 81 
WI -1 
W· 
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h; 
where w; and h; are the cell's initial width and height, and w, and h, are the cell's 
width and height at equilibrium compression. Recovery behavior can be 
determined by tracking the volumetric changes of the cell over time, and can 
indicate whether the cell was permanently changed as a result of the applied 
force. For chondrocytes, which remain mostly rounded after initial seeding, cell 
volume can be approximated as an ellipsoid with two identical axes. 
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Approximating the cell's volume initially and after it has recovered from the 
compression, a measure of recovered volume fraction (V,) can be determined as 
follows: 
V. -VI v =-'-.....::__ 
r V. 
I 
where V;and v, are the cell's initial and final volume, respectively. 
By measuring the compressive stiffness, apparent Poisson's ratio, and 
recovered volume fraction, the Cytocompressor is able to provide quantitative 
data to help understand not only the mechanical behavior of cells themselves, 
but also their ability to recover from mechanical stresses. It is a system that is 
capable of applying varying stresses to cells, at varying rates, and can even be 
programmed to apply dynamic strain. This system is also unique in that it 
performs unconfined compression on single cells. This test is particularly relevant 
to chondrocytes, as these cells live in a tissue that is regularly compressed. 
It is important to note, however, that the Cytocompressor has some 
limitations. Because its mechanism tests cells in a semi-rounded morphology, for 
cells that do not normally exist in this geometry the data may not be as relevant. 
Moreover, teasing out the mechanical characteristics of cells using this setup 
requires that some approximations in geometrical models be made. These 
approximations undoubtedly introduce error into the calculations, and careful 
measurements must be made in order to minimize this error. 
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Cvtoindenter 
Closely related to the Cytocompressor is the Cytoindenter (Figure 2). This 
apparatus applies many of the same principles as the Cytocompressor, but there 
are a few key differences. Like the Cytocompressor, the Cytoindenter uses a 
probe attached to a cantilever beam controlled by a piezoelectric actuator for 
load application, but here the probe is much smaller than the cell (approximately 
one quarter of its diameter). Unlike the Cytocompressor, the Cytoindenter does 
not rely on video capture to determine probe position and deflection. Originally 
these measurements were made using a dual photodiode detector, a technique 
that is used in the Cytodetacher apparatus and will be discussed in more detail 
later.82· 83 The current system, however, monitors the displacement of the 
cantilever via a laser reflected off the free end of the cantilever.84 This information 
is transmitted to the control system and integrated with the displacement data of 
the piezoelectric actuator. Together, the laser displacement meter and 
piezoelectric actuator are able to keep constant the force applied to the cell, 
resulting in creep indentation testing. 
As the system does not measure force outright, it must be calculated 
based on the measured cantilever displacement by the laser and the intrinsic 
geometry of the apparatus. This is achieved by combining laser displacement 
data with the force equation for a cantilever beam, as shown below:84 
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where E is the Young's modulus of the cantilever, I is its moment of inertia, Lt 
and L2 add up to the length of the cantilever and are determined by the position 
of the probe, and Llx is the deflection of the cantilever beam, as measured by the 
laser micrometer. This equation is similar to that for pure end-loading of a 
cantilever, but is complicated by the fact that the force is applied a short distance 
from the end and the laser micrometer measures the displacement of the beam 
at its end. Nevertheless, using this equation the force can be monitored in real 
time and used to apply creep indentation to single chondrocytes. 
Once a creep curve is produced, it must be analyzed using a 
mathematical model in order to obtain the material properties of the cell. To 
model cell indentation, the punch problem can be used in which the cell is 
assumed to be a linearly elastic, isotropic, and homogeneous half-space which is 
indented with a flat, rigid punch. The basic equations for this model have been 
adapted by Koay et al. to account for viscoelasticity in the cell. 84 The resultant 
equations from this analysis can define three material properties of the cell: the 
apparent viscosity (J.l), instantaneous modulus (Eo), and relaxed modulus (Eoo). 
These properties are determined by fitting the following equation to the 
displacement vs. time curve from each experiment: 
( 
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where R is the radius of the indenting probe and Ex is an elastic constant. The 
relaxed modulus can then be calculated from the following equation: 
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where the variables are as mentioned previously. 
The Cytoindentation apparatus possesses several advantages that allow it 
to characterize the mechanical behavior of individual chondrocytes. Most 
importantly, it is capable of performing creep indentation on single cells, a test 
that is able to elucidate the viscoelastic properties of single cells. Due to the 
simplicity of sample preparation in this setup, any type of anchorage dependent 
cell type may be tested. The system may also be adapted to use different shaped 
probes to apply different types of load to the cell. These characteristics all 
contribute to the system's versatility and applicability. 
Along with its many advantages, there are some limitations that must be 
considered when using the Cytoindenter. As with the Cytocompressor, 
assumptions about the geometry and homogeneity of the material must be made 
in order to solve for material properties. In the case of indentation of single cells, 
the assumption of cell homogeneity may not be accurate as the mechanical 
properties of subcellular components can vary. Additionally, this system is unable 
to record recovery data for mechanical tests due to inherent noise in the system. 
Cell analysis using cytoindentation must be therefore be combined with recovery 
data from the Cytocompressor. 
Atomic Force Microscopy 
Atomic force microscopy (AFM) has a wide variety of applications 
including scanning material surfaces, measuring intermolecular forces, and 
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testing the mechanical properties of single cells. This technology relies on the 
use of a cantilever beam, similar to the Cytocompressor and Cytoindenter, but 
the tip of the cantilever on the AFM is much smaller (Figure 3). For use in testing 
single chondrocytes, a 5 1-1m diameter spherical tip is attached to AFM cantilevers 
and used for indentation of the cell surface.85· 86 The deflection of the cantilever 
as it indents the cell is monitored via a laser reflecting off the cantilever into a 
photodiode detection system. Small changes in the position of the laser beam on 
the photodiodes indicate how far the cantilever is deflected, thereby allowing for 
the calculation of applied strain on the cell. For stress-relaxation testing using the 
AFM, a feedback loop is used to apply a set strain and measure the deflection of 
the beam over time. Using the appropriate model to fit the data, it is possible to 
gain both stress and strain data from these tests, and ascertain single cell 
mechanical properties. 
Taking into account the shape and hardness of the indenting probe, and 
viscoelastic nature of cells, Darling et al. developed a model to fit the data 
obtained from AFM stress-relaxation tests of single chondrocytes.86 Beginning 
with a modified Hertz equation for the force of a rigid sphere on a deformable 
substrate, the elastic and viscoelastic stress-strain relationships are derived 
assuming the cell surface is isotropic and incompressible. Combining the 
viscoelastic and elastic responses and specifying a step displacement for the 
stress-relaxation test, the following force equation can be obtained: 
F(t)= uo R l+l"u-l"ee/Te 4R ll2 s:312E ( -t/ J 
3(1- v) l"e 
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where R is the relative radius of the probe tip and cell, ER is the relaxed modulus 
of the cell, Oo is the prescribed step displacement, vis the cell's Poisson's ratio, 
and re and Ta are relaxation time constants under constant deformation and load. 
This equation can then be fit to a force displacement curve to obtain viscoelastic 
properties such as the instantaneous and Young's moduli of the cell. The 
equations for these properties are as follows: 
3 Ey =-ER 
2 
where Eo is the instantaneous modulus, and Ev is the Young's modulus of the 
cell. 
AFM technology allows for very precise measurement of forces, and has 
been used to study many types of materials and surfaces.87· 88 The system is 
capable of testing in a variety of modalities including scanning, tapping, and 
controlled displacement, and can accommodate many tip geometries including 
conical and spherical. The tips have even been functionalized to study interaction 
forces between molecules, demonstrating the AFM's ability to study nanoscale 
events on a cell's surface or between a cell and a substrate.89-91 Indenting cells 
with the AFM can produce data that, when combined with an appropriate 
mathematical model, is a powerful characterization tool. 
The development of a mathematical model to describe single cell testing 
with the AFM can be a challenging task. As all variables cannot be controlled, 
assumptions about the cell's geometry, homogeneity, and compressibility must 
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be made in order to solve the constitutive equations involved. Because the cell 
contains organelles and cytoskeleton, and may assume different shapes when 
attached to a surface, these assumptions may introduce error in calculating the 
mechanical properties. Careful consideration must be made, therefore, to ensure 
the applicability of various models to single cell AFM mechanics data. 
Shear 
In addition to compressive forces, chondrocytes also experience shear as 
loads are distributed within the joint space. Understanding the shear 
characteristics of single chondrocytes will allow for a better understanding of their 
contribution to the tissue as a whole. In this section, two related systems will be 
reviewed that are able to measure cell adhesion and the apparent shear modulus 
of single chondrocytes. 
Cvtodetacher and Cvtoshear 
The Cytodetacher was first developed to measure adhesion forces of cells 
to various substrates, and has since broadened its applications to measure the 
bulk shear properties of chondrocytes and other cells.83 The system consists of a 
75 IJm diameter horizontal cantilever probe attached at the top to a piezoelectric 
actuator setup (Figure 4). 
Once the horizontal cantilever is positioned at the edge of a cell attached 
to a flat vertical substrate, the piezoelectric actuator moves a precise distance 
across the cell-seeded surface, detaching the cell from its substrate. The 
displacement of the probe is measured by a dual photodiode which detects small 
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changes in the transmitted light in the microscope's view field resulting from the 
movement of a carbon filament attached to the side of the vertical probe. Using 
the displacement data from the photodiode, and the mechanical properties of the 
cantilever probe itself, it is possible to calculate the reaction force of the cell 
during detachment. From cantilever beam theory, this force can be written as: 
where E is the material stiffness of the horizontal probe, I is the probe's moment 
of inertia, Llx is the difference between the actual displacement of the probe and 
its prescribed displacement, and L is the length of the probe. 
While the elements of data analysis remain the same, this system has 
been modified to allow for cells to be seeded on a horizontal surface.92 This 
modification was achieved by rotating the probe 90° while maintaining the carbon 
filament horizontal to the cell seeded surface for photodiode detection. This 
provided a significant improvement in the system's ease of use, and initiated 
further modifications to enhance its ability to measure cell stresses and strains. 
This system has most recently been modified to measure the shear 
properties of cells.93 In this modification, the vertical probe is represented by a 
50.8 J,Jm diameter tungsten wire and displacement measurements are made by 
analyzing individual frames from video-captured shear events. As in the first 
iteration of this system, cantilever beam theory is used to calculate applied force 
from the apparent and prescribed displacements. In the case of cell shearing, 
however, the probe is placed a set distance from the substrate and translated 
resulting in shearing of the cell rather than simple detachment. The necessary 
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data for the cellular deformation are also provided via analyzing frames extracted 
from video-captured events. Throughout the shearing event the cell's leading 
edge, trailing edge, and the probe are tracked providing data to calculate the cell-
probe contact area (needed to calculate stress), and the cell's elongation. The 
contact area of the probe on the cell can be calculated by assuming the area is a 
half-ellipse: 
where We represents the width of the cell, and he-hp denotes the difference in 
height of the cell and probe from the surface, respectively. Using this contact 
area and the applied force from cantilever beam theory, a measure of the applied 
stress can be calculated using the relation: 
F 
a=-
A 
To calculate the shear strain (E) experienced by the cell throughout the shearing 
event, the following relationship can be used: 
where w; denotes the indentation depth of the probe into the cell, and We is the 
initial cell width as before. By plotting the stress versus strain curve and fitting a 
line to the data, it is possible to calculate the apparent shear modulus of the cell. 
All of the modifications of the Cytodetacher have provided some 
improvement in the ability to quantify cell adhesion forces and shear properties. 
As chondrocytes rapidly de-differentiate in monolayer, adhesiveness of these 
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cells to various substrates can provide a quantitative measure of phenotypic 
changes over time. Adhesion forces of chondrocytes to various substrates is also 
an important measure of the cell's interaction with materials used in tissue 
engineering strategies. The modification of the Cytodetacher for measurement of 
the apparent shear modulus of chondrocytes also provides a useful tool to 
measure the biomechanical properties of the cell itself. This method allows for 
measurement of the apparent shear modulus, which can be used to ascertain 
characteristics of the cell under a biomechanically relevant load. 
The Cytodetacher, while useful for studying anchorage-dependent cells, 
was not designed to study floating cells given that its setup necessitates cell 
adhesion to a substrate. Additionally, care must be taken to apply the correct 
geometrical model to each experiment as different cell types may appear more 
rounded than others when adhered to a surface. 
Tension 
Chondrocytes also experience tensile forces from matrix proteins around 
them pulling in the direction of local compressive or frictional loads. Tensile 
forces may also be generated in mechanical stimulation of tissue engineered 
cartilage constructs. In this section, the use of micropipette aspiration will be 
examined as it relates to chondrocyte biomechanics. 
Micropipette Aspiration 
Micropipette aspiration uses pressure differentials to calculate the force 
the cell experiences, and relates that to the observed strain, as seen in Figure 5. 
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To perform this type of experiment, a cell is suspended in fluid of pressure 
p1 and a micropipette is placed on the cell membrane. The pressure within the 
pipette is then reduced to p0 and the cell membrane extends into the pipette at a 
distance lp. Given the radius of the micropipette, rp, the relationship between 
stiffness and pressure differential for an infinite homogeneous half-space 
aspirated into a pipette is: 
where LJ.P is the pressure differential between Po and p1, E is the Young's 
modulus of the cell, and q> is approximately 2.1 and depends on the geometric 
properties of the pipette itself.94 Solving for the Young's modulus, and 
substituting for q>, this equation reduces to: 
Another useful parameter to gain from micropipette aspiration experiments 
is the viscosity of the cell. Given that cells are viscoelastic materials, cell viscosity 
can be a useful measure of its phenotype. Modeling the cell as a homogeneous, 
semi-infinite half-space, to calculate cell viscosity (~) in this setup the following 
equation may be used:95 
where LJ.P, rp, and lp are the same as before, and rc is the radius of the cell 
outside of the micropipette. In this equation, the rate of change of membrane 
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extension into the pipette (dlpldt) must also be measured, and can be attained by 
varying the pressure within the micropipette and recording the resulting 
deformation with time. This method can also be used to obtain the instantaneous 
and relaxed modulus of the cell.86 
Micropipette aspiration can be used on both anchorage dependent and 
floating cells, making it a widely useful mechanical testing tool. It can produce 
forces between 10 pN and 104 nN, and can reach pressures as low as 0.1 
pN/1Jm2 .96 This method can also determine whether a cell behaves as a liquid 
drop or a solid, which becomes useful when deciding on a model for further 
analysis of cell biomechanics. Mechanical parameters drawn from micropipette 
aspiration tests can be used to characterize cells and understand their 
mechanical role in the body. 
Along with the many attributes to this method, there are some important 
considerations that must be made when analyzing its resulting data. Due to the 
nature of the experiment, measures of viscosity and stiffness are heavily 
influenced by the mechanical properties of the cell membrane, and thus may not 
reflect the bulk properties of the cell. Given the microenvironment of the 
chondrocyte, and that its deformation occurs mostly in compression, testing a 
portion of the cell in tension will provide some indication of cell properties, but 
those properties may not be as physiologically relevant. 
Chondrocyte Biomechanics 
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All of the aforementioned single cell mechanical testing systems have 
been used to mechanically characterize chondrocytes, providing information on a 
wide variety of previously unknown cellular properties. Considering the 
mechanical properties of chondrocytes can help to understand the mechanical 
limitations of the cells within their native environment. 
Mechanical Properties of Single Chondrocytes 
Often, the same mechanical property can be obtained using a variety of 
different testing methods. The properties that do overlap, however, do not always 
match between systems. For example, the instantaneous modulus of 
chondrocytes using the AFM is around 0.29 kPa, while the same parameter 
measured using cytoindentation is around 8 kPa.84· 86 Similar disparities are 
observed in relaxed modulus, viscosity, and equilibrium time constant 
measurements between systems. From Table 1, it is apparent that the AFM 
measures relatively low viscosity compared to measurements from micropipette 
aspiration, while the viscosity measured by cytoindentation falls between the two. 
Moreover, equilibrium time constants, when measured with micropipette 
aspiration can be more than an order of magnitude higher than values obtained 
from cytoindentation. This wide range could be a result of many different factors, 
including the constitutive model used, geometric assumptions, biological 
variability, the source of the tested chondrocytes, and of course the fact that the 
cell may or may not be anchored during testing. 
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Perhaps the biggest contributor to these apparent inconsistencies, 
however, is the type of test performed on the cell. Though literature for 
chondrocyte mechanics may report the same cellular properties, the 
particularities of each apparatus and the mathematical model used to calculate 
those values may only yield a certain aspect of those properties. For example, 
while the cell's instantaneous modulus can be obtained by AFM and 
cytoindentation, the different probe geometries and testing modalities may be 
testing different areas of the cell. More research must be done to better 
understand these differences, which will inevitably be helped by more rigorous 
mathematical models for the approximation of the cell. 
Contributors to Chondrocyte Mechanics 
Though comparing properties from different mechanical testing modalities 
may not yield meaningful results, comparing cells tested in one modality is a 
powerful tool and has been used to understand the source of chondrocyte 
mechanical integrity. Using the Cytocompressor, Ofek et al. showed that 
knocking out different cytoskeletal components within the chondrocyte can vary 
the mechanical properties of the cell. Specifically, actin filaments emerged as the 
greatest contributor to compressive stiffness as actin disruption decreased the 
compressive modulus of the cell by nearly 40%. Additionally, absence of any of 
the cytoskeletal components doubled the residual strain of the cell following 
compression, indicating that the cell's cytoskeleton is important for recovery from 
mechanical perturbation. This study also showed that cytoskeletal components 
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greatly influence the apparent Poisson's ratio. The results indicate that at a 
certain strain threshold, the microtubules that normally serve as rods holding the 
cell shape are broken down, reducing cell volume and Poisson's ratio.80 Termed 
the critical-strain threshold, this change in mechanical behavior of the cell with 
applied strain may indicate modifications in gene expression and matrix 
production in response to, or as a result of, cellular deformation. 
Along with the cytoskeleton, the nucleus can contribute largely to the 
overall mechanical integrity of the cell. Chondrocytes, because they exist in a 
rounded morphology, also have rounded nuclei which respond to loading by 
changing volume and modifying gene expression. 97 Therefore, nuclear 
deformation may be necessary for the cell to respond to mechanical load, and 
the determination of its stiffness could play a major role in identifying effective 
cartilage stimulation regimens. Nuclear mechanical properties have been 
measured with a few different methods. Using micropipette aspiration, the free-
floating nucleus appears to be 3 to 4 times stiffer than the cell, while modeling 
techniques used to fit chondrocyte cytocompression data indicate that the 
nucleus may be only about 1.4 times stiffer than the rest of the cell.98· 99 Despite 
the inconsistencies between micropipette aspiration data and theoretical 
modeling of nuclear stiffness, the methods do agree that the nucleus is 
somewhat stiffer than the rest of the cell, and therefore can affect its overall 
mechanics. With more investigation, nuclear mechanics data may prove to be a 
powerful tool in understanding the underlying mechanotransduction of stimulated 
chondrocytes. 
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Chondrocyte Mechanosensitivity 
Chondrocytes are known to modify gene expression patterns in response 
to both biochemical and mechanical perturbations. While research in the area of 
chondrocyte mechanosensitivity is still in its early stages, the present data 
indicate that these cells are particularly sensitive to mechanical loading. 
Both loading type and loading duration can cause shifts in gene 
expression of single chondrocytes. When subjected to varying forces applied in 
unconfined creep compression, chondrocytes display a dose-dependent 
decrease in collagen type II expression with increasing load, and aggrecan gene 
expression decreases sharply when force is increased from 25 nN to 50 nN of 
load. Accompanying the decrease in matrix protein expression with load, an 
increase in tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression 
levels is observed.97 Together, these data indicate that when loaded in this 
manner, chondrocytes adapt their gene expression profiles from matrix 
production to matrix maintenance. Similar results are observed when 
chondrocytes are statically loaded with forces of 50 and 100 nN, but these forces 
applied dynamically result in matrix molecule gene expression recovered to 
control states.100 These results suggest that the way a load is applied (static or 
dynamic) can profoundly affect the chondrocyte gene expression, and can 
provide valuable insight into useful modes of engineered cartilage stimulation. 
Gene expression and mechanics of loaded chondrocytes are also affected 
by the biomolecules present. In the same creep compression experiment, Leipzig 
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et al. showed that the application of transforming growth factor beta-1 (TGF-(31) 
or insulin-like growth factor-1 (IGF-1) throughout the experiment significantly 
decreased the strain experienced by the cell, and resulted in differing gene 
expression profiles than stimulated cells without growth factors.97 Applying TGF-
(31 increased aggrecan gene expression over controls in most cases, while 
adding IGF-1 kept TIMP-1 levels relatively constant for all loads. It has also been 
shown that these two biomolecules are able to stiffen cells significantly, resulting 
in altered deformation patterns under the same loading conditions?8• 101 
Biomolecules are therefore important regulators of chondrocyte 
mechanosensitivity. In fact, as chondrocytes in the presence of growth factors 
such as IGF-1 are known to both stiffen the cells and increase gene expression 
for collagen type II and aggrecan, they can provide a mechano-protective effect 
by inhibiting both deformation and gene expression changes caused by 
mechanical loading.78• 102 More studies need to be performed to determine the 
precise ways biomolecules and mechanical stimulation can combine to affect 
chondrocyte gene expression and mechanics. This information will inevitably 
prove useful when designing cartilage engineering strategies such that they can 
harness the synthetic capabilities of chondrocytes. 
Conclusions 
The mechanical integrity of cartilage is extremely important to its normal 
function in the body. Due to its lack of reparative potential, damage to this tissue 
is usually permanent and can lead to further musculoskeletal complications. 
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Therefore, a functional cartilage replacement is a valuable prospect, and tissue 
engineering continues to develop new and exciting answers to this problem. 
Achieving functionality in tissue engineered constructs, however, requires 
knowledge of the intrinsic biomechanics of cartilage and its cells. By first 
characterizing the biomechanics of individual chondrocytes, informed decisions 
can be made regarding the most effective biochemical and mechanical 
stimulation methods to use in more complex arrangements of these cells. 
Healthy cartilage experiences many different types of loads on a daily 
basis, including compression, shear, and tension. How these forces are 
transmitted to individual chondrocytes and their effect on the cell's genotype, 
however, is not well understood. To study this, a number of mechanical testing 
and stimulation systems have been developed which are able to characterize not 
only cellular mechanics, but the effect mechanical loading has on gene 
expression. Additionally, these devices have been able to resolve the effects of 
growth factors on individual cell biomechanics, showing that chondrocytes 
become stiffer in the presence of certain biomolecules. 
As chondrocyte mechanical properties obtained from different systems do 
not always agree with one another, it is important to understand each individual 
system and the type of test it performs. Small differences in load application and 
the type of model used to fit the data can magnify the discrepancies between 
mechanical testing systems. Bulk properties of individual chondrocytes are best 
tested using the Cytocompressor and Cytoshear devices because non-
homogeneities are diminished by the probe being much larger than the cell. In 
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devices where the probe is smaller than the cell, namely the Cytoindenter, AFM, 
and Micropipette Aspiration systems, these non-homogeneities may be 
measured, and can provide information about cytoskeletal arrangement and local 
cell properties. With an understanding of these differences, the mechanical 
properties of single chondrocytes can be determined and this information can be 
used to inform tissue engineering strategies. As more information is available 
about cellular responses to mechanical and biochemical factors, more directed 
efforts can be made to combine cells with various stimuli to create functional 
engineered cartilage. Cellular biomechanics testing and stimulation systems like 
the ones described here are beginning to make this possible. 
Future Directions 
With the recent advances in chondrocyte biomechanics testing and 
evaluation, some interesting questions have emerged which deserve further 
investigation. First, understanding the mechanosensitivity of subcellular 
components can elucidate the major players in the mechanosensitivity of the cell 
as a whole. As it is known that the actin cytoskeleton is an important component 
of cellular stiffness, it may be important in transducing mechanical signals from 
the cell membrane to the nucleus. Moreover, nuclear mechanical properties are 
known to differ from the rest of cell, but the importance of this difference in signal 
mechanotransduction is unknown. These same principles can be applied to any 
number of chondrocyte subcellular components, and may lead to a more 
complete understanding of the machinery of chondrocyte mechanotransduction. 
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These types of experiments can be facilitated by the use of targeted fluorescent 
molecules to track subcellular components throughout a loading regimen, 
providing graphic evidence of their response to mechanical stresses. 
Another area that should be expanded is the application of these cellular 
mechanical testing devices to other cell types. At present, aside from the AFM, 
many of these devices have only been used with a few cell types. Mechanical 
characterization of cells from other mechanically functional tissues such as 
tendon, ligament, bone, meniscus, and muscle can provide the same benefits as 
chondrocyte characterization. As most of these systems are highly adaptable, it 
would be a natural extension of the technology and would provide interesting 
comparative values for use in reconstructive therapies. 
These future applications can add utility to cellular mechanical testing 
systems, and allow for a more complete understanding of mechanotransduction 
pathways of single chondrocytes. 
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Tables 
Table 1: Reported mechanical properties of articular chondrocytes using 
v . t f d . ar1ous es mg ev1ces 
Mechanical Modulus* Viscosity Time Testing Constant Ref. 
Device ( kPa) (Jl, kPa·s) jT, sJ 
Cytocompressor 1.6 ± 1.3 80 1.63 ± 0.31 (E) - (recovery) 
Cytoindenter 8.0 ± 4.41 (Eo) 1.5±0.92 1.32 ± 0.65 84 1.09±0.54 (E.,) 
AFM 0.29 ± 0.14 (Eo) 0.61 ± 0.69 9 ± 6.2 86 0.17 ± 0.9 (E.,) 
4.1 ± 1.3 (/ow) 
93 Cytoshear 2.6 ± 1.1 (med) - -
1.7 ± 0.8 (high) 
0.41 ± 0.17 (Eo) 3 ± 0.18 33 ± 20 103 
Micropipette 0.24 ± 0.11 (E,) 
0.45 ± 0.14 (Eo) Aspiration 0.14 ± 0.05 (E..,) 2.57 ± 1.83 37 ± 26 86 
0.2 ± 0.07 (Ey) 
* Modulus abbreviations: Instantaneous (E0), Relaxed (E..,), Compressive (E), Young's 
(Ey), Shear (low, med, high probe positions) 
79 
Figures 
Figure 1: Schematic diagram of the Cytocompressor. To test single cells 
under unconfined compression, the Cytocompressor uses a cantilever beam with 
a wide probe attached to its end. A piezoelectric actuator precisely moves the 
cantilever probe assembly toward the cell surface, and compresses the cell a set 
amount. Compression events are recorded via a CCD camera, and cell height 
(he) and width (we) are determined from extracted frames. 
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Figure 2: Schematic diagram of the Cytoindenter. The Cytoindenter tests 
cells under creep indentation, using a thin probe of radius R attached to a 
cantilever beam. Like the Cytocompressor, the cantilever-probe assembly is 
controlled by a piezoelectric actuator. The probe placement on the cantilever 
(described by lengths Lt and L2), material properties of the cantilever, and data 
from the laser micrometer allow for the application of constant force to the cell 
surface. Probe displacement data over time are recorded and used to extract 
viscoelastic material properties of the cell. 
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Figure 3: Schematic diagram of Atomic Force Microscopy. In this setup, 
stress relaxation experiments on single chondrocytes are performed by using a 
spherical probe attached to a cantilever beam. The probe displacement 
throughout the experiment is monitored by reflecting a laser off the cantilever and 
monitoring the angle of reflection over time. This information is then fed back into 
the actuator system that moves the cantilever to apply a constant strain on the 
cell . The resultant force versus time graph is then used to determine cellular 
mechanical properties. 
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Figure 4: Schematic diagrams of the Cytodetacher and Cytoshear devices. 
Both the Cytodetacher (a) and Cytoshear (b) systems rely on a piezoelectric 
actuator to move the probe toward the cell and cause deformation. The 
Cytodetacher system uses a glass probe with an attached carbon filament 
positioned at the base of the cell, and monitors the carbon filament displacement 
via a dual photodiode. Attachment force is then calculated using cantilever beam 
theory. The Cytoshear device records each event using a CCD camera, and 
positions its probe some distance above the base of the cell. Shear properties of 
the cell are then determined using the cell width (we) and height (he) over time 
combined with the knowledge of the probe height (hp) and probe displacement 
(Llx). 
:, 
~ p 
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Figure 5: Schematic diagram of Micropipette Aspiration. In this setup, the 
cell is suspended in fluid of pressure p 1 and a micropipette of radius rp is placed 
on the cell membrane. The pressure inside of the pipette is then lowered to Po 
and the resulting deformation of the cell membrane, lp, into the pipette is 
measured. This information, along with the radius of the cell outside of the pipette 
(rc), can be used to determine the cell's tensile modulus and viscosity. 
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Chapter 3: The knee meniscus: A complex tissue of 
diverse cells 
Abstract 
This review describes the knee meniscus and its diverse cell populations. 
Situated between the femur and tibia, the meniscus acts to transmit loads within 
the knee while maintaining joint stability. Not only does this tissue display 
complex geometry and anatomy, its cellular profile ranges from fibroblast-like to 
chondrocyte-like. When the tissue first begins to develop in the body, its cells are 
similar in shape and morphology, but as it matures, these cells take on distinct 
characteristics. The spindle-shaped cells of the outer meniscus are well-suited to 
maintaining a fibrous extracellular matrix rich in collagen type I. The round, inner 
meniscus cells produce both collagen types I and II, and glycosaminoglycans, 
giving rise to a hyaline-like inner portion of the tissue. Cells intermediately 
located display characteristics of both cell types. Fibrochondrocytes are also 
known to be highly dependent on mechanical stimulation to maintain healthy 
tissue, and display regional variation in response to different biomolecular cues. 
Investigating this cell population under a variety of conditions can lead to a better 
understanding of the pathophysiology and regenerative processes of the 
meniscus. 
Chapter published as: Sanchez-Adams, J., and Athanasiou, K. A. "The knee 
meniscus: A complex tissue of diverse cells." Cellular and Molecular 
Bioengineering. 2(3): 332-340, 2009. DOl: 10.1007/s12195-009-0066-6. 
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Introduction to meniscus functions and anatomy 
The knee meniscus is a fibrocartilaginous tissue comprised of two 
semilunar pieces that rest on the medial and lateral sides of the tibial plateau 
(see Figure 1 ). Its main functions are to aid in joint stability, bear and transmit 
loads within the knee, and absorb shock. The ability to carry out these 
specialized functions is imparted by its unique shape and anatomy. 
In addition to being semilunar, the medial and lateral menisci are concave 
on their superior surfaces to increase congruence with the femoral condyles, and 
flat on their inferior surfaces, to match the tibial plateau. Coupled with this 
specialized shape, the meniscus is well suited to aid in joint articulation as its 
surface is smooth both macroscopically and microscopically. 1 With these 
characteristics the meniscus not only acts as a cushion between the femur and 
tibia, but also as a nearly frictionless surface during joint movement. 
The cushioning function of the meniscus is made possible by a network of 
ligaments in the knee (see Figure 2). Ligamentous attachments called horn 
attachments anchor both medial and lateral menisci to the midline of the tibial 
plateau, keeping them in place while bearing joint loads. Though they look similar 
overall, the lateral meniscus can be distinguished from the medial meniscus in 
that its horn attachments are closer together. The medial meniscus is also held in 
place by the medial collateral ligament (MCL), which connects the medial side of 
the femoral condyle to the medial side of the tibia. Two other ligaments, those of 
Humphrey and Wrisberg, connect the posterior horn of the lateral meniscus to 
the lateral side of the medial femoral condyle. According to cadaveric studies, 
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both of these ligaments are present in only about 22% of the population, while 
50% present only the ligament of Humphrey, and 28% have only the Wrisberg 
ligament.104 The coronary ligament is present along the tissue's periphery and 
provides yet another anchor for the meniscus to the tibia. 3 Medial and lateral 
menisci are connected via their anterior horns by the transverse ligament. 
Though not involved in directly anchoring the meniscus, the posterior and 
anterior cruciate ligaments (PCL and ACL) connect the tibia to the femur keeping 
the bones in line with each other, thereby guarding against meniscal injury. All of 
these ligaments work in concert to resist meniscal displacement during normal 
activity, and are essential to normal meniscus functionality. 
Meniscus tissue not only has a complicated shape and anchoring network, 
but also displays great regional variation in its extracellular matrix components. 
The periphery of the meniscus is highly fibrous, abundant in cells and collagen 
type I, while the inner portion of the tissue resembles hyaline cartilage with fewer 
cells, a higher proteoglycan content, and presence of collagen type II. The outer 
portion of the tissue is highly vascularized, while the inner meniscus is devoid of 
blood vessels. Given this range of properties, it is not surprising that a diverse set 
of cells occupies the tissue, and that classifying them is a difficult task. Through 
their differing synthetic and gene profiles, and their various sensitivities to 
mechanical and biochemical cues, the cells of the meniscus work together from 
gestation to adulthood to develop and maintain a tissue containing a 
fibrocartilage spectrum. An understanding of these cells, therefore, could aid 
87 
significantly in engineering attempts to recreate tissues within this spectrum, 
which can potentially lead to the development of new cartilage therapies. 
Development of the meniscus 
Compared to its neighboring hyaline cartilage in the knee, the meniscus is 
fibrous and highly cellular. In their earliest stages of development, however, both 
cartilage types begin as masses of condensed cells. Meniscal cartilage then 
follows a unique developmental path to arrive at its specialized shape and 
anchoring network. A 1983 study on the developing human meniscus observed 
various changes in vascularity, cellularity, and matrix molecule architecture which 
combine over time to form this highly specialized tissue.5 
The distribution of vasculature and cells in meniscal cartilage changes 
over time as the tissue develops (see Figure 3). When first formed in the body, 
the meniscus is completely vascularized and is made up of mostly rounded cells 
with a high nuclear to cytoplasmic ratio. These cells are compacted together, and 
somewhat flattened near the surface of the tissue. The high degree of vascularity 
observed at this stage persists through the development of the tissue in the 
womb and only begins to diminish at around three months after birth, indicating 
that an abundant blood supply is important for the early growth and maturation of 
the meniscus. Nuclear to cytoplasmic ratio also diminishes with time, dropping 
noticeably by seven and a half months' gestation, when the cells appear more 
mature and differentiated, and the surface cells are even more distinctly 
flattened. Approaching nine months' gestation, both the medial and lateral 
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menisci grow to maintain relatively constant contact area with the tibial plateau. 
This growth is accomplished by cell synthesis of extracellular matrix molecules 
rich in collagen, which is organized circumferentially at this stage.5 
After birth, the meniscus continues to grow and refine its collagen 
architecture as a whole, and the cells start to vary in their protein synthetic 
profiles regionally. One of the most visible examples of this change, is the 
decrease in vascularity of the inner meniscus. This is achieved when the cells in 
the outer portion of the tissue stop producing endostatin, allowing blood vessels 
to remain in the periphery.6· 7 Endostatin is a 20 kDa portion on the C-terminal 
region of collagen type XVIII which inactivates vascular endothelial growth factor, 
and is initially present throughout the meniscus at low levels, but accumulates in 
the inner portion with time as the cells continue to produce it.6 This change in 
endostatin abundance results in 10-25% vascularity of the lateral meniscus, and 
10-30% vascularity of the medial meniscus in adulthood.4 Synthesis of other 
proteins, such as proteoglycans, also changes with tissue maturation. 
Proteoglycans are highly sulfated, and their rate of synthesis can therefore be 
detected in vitro by measuring levels of sulfate in the culture medium produced 
by the cells. Using this method it has been determined that meniscus cells from 
tissue less than 20 years of age display a 1-5 mM sulfate per milligram of DNA 
per hour synthetic rate. As the tissue gets older, however, this sulfate synthetic 
rate diminishes to between 0.5 and 1 mM sulfate per milligram of DNA per hour 
in culture.8 Additionally, it has been shown that some of the major proteoglycans 
present are big Iycan and decorin, both of which help organize the collagen matrix 
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and regulate collagen fiber diameter.8 The higher synthetic rate of proteoglycans 
in young meniscus tissue and the abundance of biglycan and decorin indicate 
that early in tissue development, proteoglycans may play an instrumental role in 
organizing the collagen matrix such that the meniscus can withstand various 
forces. 
Meniscus cell diversity 
As discussed previously, when meniscus cells first begin to condense in 
the embryo, they are similar in size and shape. Following tissue maturation, 
however, the cells of the meniscus show a great deal of regional variation in 
morphology and synthetic profiles, making them especially difficult to classify 
(see Figure 4 and Table 1). 
In the superficial layer of the meniscus, the cells are oval or fusiform in 
shape, which is similar to fibroblast morphology.3840 Deeper in the meniscus, 
cells tend to be more rounded (similar to chondrocytes). 1• 3840 Because of this 
morphological variation within the tissue, researchers have classified these cells 
using terms such as fibroblasts, fibrocytes, chondrocytes, fibrochondrocytes, and 
meniscus cells. 1• 38· 39· 4143 The difficulty in describing meniscus cells with one 
term stems not only from the various morphologies present, but also the various 
synthetic profiles of the cells. As the outer portion of the meniscus contains 
predominantly collagen type I, it is not surprising that fibroblast-like cells populate 
it, helping to create and renew the fibrocartilaginous matrix there. The inner 
meniscus is more hyaline in nature, being predominantly collagen type II, with 
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lesser amounts of collagen type I, and necessarily contains cells that are 
chondrocyte-like. The name fibrochondrocytes, therefore, seems a fitting label, 
and has been used previously to refer to meniscus cells.40 Acknowledging both 
the fibrous and cartilaginous characteristics that embody the meniscus, the terms 
fibrochondrocytes and meniscus cells will be used interchangeably in this article 
to describe them as a whole. 
Types of meniscus cells 
A study on the rabbit meniscus has identified as many as four distinct cell 
types in different regions in the tissue, which are separated from each other 
based on their shapes and presence of gap junctions. 38 The outer portion of the 
meniscus was found to contain two different cell types that display many cell 
processes. 38 These cells tend to be closer together than those in the inner 
meniscus and contain gap junctions, allowing them to exchange chemical signals 
efficiently.38 Cellularity in the tissue is greatest at the outer periphery, decreasing 
radially inward. The inner portion of the meniscus contains cells that have a 
rounded morphology, and do not present gap junctions.38 Yet another type of 
cell is present in the superficial zone. These cells are spindle-shaped, and like 
the inner meniscus cells, do not present gap junctions on their cell membranes. 38 
Aside from fibrochondrocytes, there are also endothelial cells that reside in the 
meniscus, which compose the lumen of blood vessels that permeate the outer 
portion of the tissue.44 Therefore, a variety of different cell types can be found in 
the meniscus, which allow for the tissue's complex architecture to be realized. 
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Cell synthetic properties 
Due to the distribution of its different cells and proteins, the meniscus can 
be considered in two parts: the outer one third, and the inner two thirds. The cells 
from these two regions differ in the proteins and enzymes they produce (see 
Table 1). Though it has been shown that fibrochondrocytes from all regions in the 
meniscus produce about the same amount of collagen, it is the type of collagen 
synthesized that sets an outer meniscus cell apart from an inner meniscus cell. 18• 
45 While both inner and outer meniscus cells do produce collagen types Ill, IV, V, 
and VI at low levels, the predominant collagen types are I and 11. 18• 45 Being more 
fibroblastic in nature, outer meniscus cells almost exclusively produce collagen 
type I, while inner meniscus cells are more chondrocyte-like in that they produce 
slightly more collagen type II than type 1. 14 Outer meniscus cells also differ from 
inner meniscus cells as they express CD34, a cell surface marker that functions 
in cell to cell adhesion, as well as proteases MMP-2 and MMP-3, which are 
important for matrix remodeling.38• 45· 51 · 53 Inner and outer meniscus cells are 
again similar in that the types of glycosaminoglycans (GAGs) they produce are 
largely chondroitin sulfate, with lesser amounts of keratin sulfate.46 Inner 
meniscus cells, however, produce more GAGs than outer meniscus cells. 18· 45 
They also stain positively for a-smooth muscle actin, which imparts contractile 
behavior, and highly express nitric oxide synthase (NOS2), which is important for 
meniscus cell biosynthesis.42· 47-49· 53· 54 Based on these observations of gene 
expression and protein synthesis, a clear distinction can be made between the 
92 
cells of the avascular inner portion and highly vascular outer portion of the 
meniscus. 
Like the neighboring hyaline cartilage on the ends of the femur and tibia, 
the meniscus functions in a load-bearing capacity made possible by a matrix rich 
in collagen and proteoglycans. Given the similarities between meniscal and 
hyaline cartilages, it is natural to assume that the gene expression profiles of the 
cells from these tissues would have some commonality. Indeed, a study 
comparing the gene expression of both cartilages to that of a common precursor 
cell, the human mesenchymal stem cell, has identified some common genes. 47 
As well, specific sets of genes are shown to be expressed highly in only one 
cartilage type.47 Using mesenchymal stem cells as a baseline for comparison, 
both meniscal and hyaline cartilages highly express the COL2A 1 gene, specific 
for collagen type II production, but hyaline cartilage expresses this gene around 
six-fold higher than meniscal cartilage on the whole.47 While sharing some 
commonality in gene expression, there are also certain genes that are only highly 
expressed in one cartilage type. Most notable of these differences is that 
meniscal cartilage expresses genes specific for collagen type I, while hyaline 
cartilage does not. 55 A list of genes that are common and specific to hyaline and 
meniscal cartilages can be found in Table 2. 
Using these genes, it may be possible to better characterize tissue 
engineered meniscus constructs. A major hurtle in engineering meniscus tissue 
is determining the similarity between native tissue and engineered neotissue, 
especially early in the culture process. The identification of genes highly 
93 
expressed in the meniscus as compared to hyaline cartilage can facilitate this 
characterization by providing markers to indicate whether fibrocartilaginous 
tissue is being formed. As genetic changes precede changes in protein 
synthesis, and proteins take time to accumulate in a construct, this genetic 
information can be used to determine what type of tissue is likely to form early in 
construct development. Additionally, it may be possible to use these genetic 
markers to track the developmental process of the engineered tissue as well as 
determine appropriate intervention windows for mechanical or biochemical 
stimulation. More research must also be done to determine the specific roles of 
each of these genes in meniscus cells, which will provide a better understanding 
of meniscus cell functions and inform further engineering efforts. 
Mechanosensitivity of meniscus cells 
Because of the geometry of the meniscus, and its anchors to the tibial 
plateau, the tissue undergoes a variety of different mechanical stresses during 
loading. As shown in Figure 5, as the femur presses down on the tibial plateau, 
forces are generated in the anterior and posterior horns of the meniscus, which 
oppose the radial displacement of the tissue from the joint. This results in a 
circumferential hoop stress along the tissue from horn to horn. The tissue also 
experiences compression as the tibial plateau resists the downward force from 
the femur. These mechanical forces generated during the normal functioning of 
the knee provide mechanical signals to meniscus cells within their extracellular 
matrix. 
---------~~~~~~~~~------------~~-
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Loading patterns can alter gene expression profiles of fibrochondrocytes, 
and are known to be necessary for developing and maintaining healthy meniscus 
tissue (see Table 3). Highlighting this fact, a study in chick embryos has shown 
that immobilization of an immature knee joint results in fusion of the knee 
cartilage. 105 Alternatively, if the knee joint of an adult rabbit is immobilized for 
eight weeks, degeneration and decreased permeability of the tissue is 
observed.106· 107 A two- to five-fold decrease in GAG gene expression has also 
been observed in dog menisci following knee joint immobilization at 90° flexion. 
From these examples, it is evident that mechanical stimulation of meniscus cells 
is a constant necessity for proper tissue development and maintenance of 
function. 
Mechanical stimulation in the form of 5% biaxial strain on 
fibrochondrocytes in vitro increases total protein synthesis and nitric oxide levels, 
while NOS2 expression remains constant. 56 These effects are realized in cells 
from all regions of the meniscus.56 Cells from the inner and outer meniscus, 
however, are affected differently by mechanical loading, as evidenced by 
theoretical modeling of the tissue as well as experimental results. Under normal 
loading conditions, finite element models have estimated that outer, more 
elongated, meniscus cells experience between 2% and 4% tensile strain, while 
round inner meniscus cells experience slightly higher (-7%) strains.55 This 
suggests that in situ, meniscal fibrochondrocytes will experience different 
magnitudes of a mechanical cue based on their position within the tissue, which, 
in turn, can affect their synthetic profiles. 
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In addition to the degree of stimulation under tension, meniscus cells are 
known to respond differently to other types of mechanical load, such as 
compression. Gene expression levels of fibrochondrocytes in response to 0.1 
MPa static compressive loading increase three- to four-fold for decorin and 
collagen types I and II, while this stimulation also causes a two- to three-fold 
decrease in mRNA levels for MMP-1.57 In contrast, a dynamic stimulation 
regimen of 1 MPa at 0.5 Hz causes fibrochondrocytes to increase nitric oxide 
levels, but decrease expression of collagen type II (four-fold), and decorin (two-
fold). Changing the type of mechanical stimulation can therefore have a profound 
effect on the gene expression and protein synthetic profiles of meniscal 
fibrochondrocytes. 
Therefore, it has been determined that tensile forces on meniscus tissue 
signal the cells to increase total protein synthesis, while static compressive 
loading can cause up-regulation of collagens and decorin, and dynamic 
compression can down-regulate these genes. Understanding the effect of 
mechanical forces on meniscus cells not only allows for a better understanding of 
normal meniscus functionality, but also informs tissue engineering efforts. Using 
this information, researchers can develop strategies to improve or maintain 
construct properties over time. 
Fibrochondrocytes and growth factors 
Meniscus cells are not only sensitive to mechanical cues, but also 
biochemical ones. Studies in vitro and in vivo have identified a number of 
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biomolecules that can alter cell behavior toward protein synthesis, migration, and 
proliferation (see Table 4). When added to in vitro monolayer cultures of 
meniscus cells from sheep, humans, and rabbits, transforming growth factor beta 
1 (TGF-(31) has the ability to increase proliferation rates as well as proteoglycan 
synthesis. 18• 43· 108 Fibroblast growth factor (FGF), hepatocyte growth factor 
(HGF), platelet-derived growth factor (PDGF-AB), bone morphogenetic protein 2 
(BMP-2), and human platelet lysate (Human PL) can also be used to increase 
cell proliferation in vitro.40• 109· 110 Additionally, rabbit fibrochondrocytes in 
monolayer culture exposed to TGF-(31 increase their collagen production.111 
Aside from causing proliferative and protein synthetic changes, some 
growth factors have been shown to cause meniscus cells to migrate. Cells from 
the inner (avascular), middle (slightly vascular), or outer (highly vascular) 
portions of the meniscus, however, respond differently to different growth factors. 
lnterleukin 1 (IL-1) specifically targets outer meniscus cells to migrate, while 
BMP-2 and insulin-like growth factor I (IGF-1) causes some middle meniscus cells 
to migrate.11° Furthermore, all outer meniscus cells, but only half of inner 
meniscus cells, migrate when exposed to epithelial growth factors (EGF). 110 The 
cells in the meniscus, therefore, vary regionally in how they are affected by 
different biochemical factors, highlighting their different roles in the tissue. 
From this information, it is apparent that some growth factors can affect 
the entire meniscus, but others affect certain regions specifically. While all 
meniscus cells seem to have the capacity to increase proliferative rates in 
response to certain biomolecules, outer meniscus cells have been shown to 
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migrate when exposed to both IL-1 and EGF, while only some inner and middle 
meniscus cells can be induced to migrate. This may point to the outer meniscus 
cells' role in matrix remodeling following injury. Protein synthesis of 
fibrochondrocytes as a whole is also affected by biomolecular cues, indicating 
that meniscus cells, even those of the inner (avascular) portion of the tissue, are 
active and may be stimulated to replace damaged matrix if presented with 
appropriate molecular conditioning. 
Tissue engineering the meniscus 
Given the regional variation in meniscus anatomy, matrix molecules, and 
cells, it is a complex tissue to engineer. Harnessing information about meniscus 
cell morphology, mechanosensitivity, and response to growth factors, 
researchers have made several key advances toward engineering the spectrum 
of fibrocartilage present in the meniscus. Bioreactors have shown great promise 
in encouraging the formation of bi-zonal tissue, scaffoldless construct formation 
has produced tissue with appropriate matrix composition and imparted some 
mechanical integrity, and growth factors have been used in many efforts to 
increase matrix production of cells. 
Engineering approaches using fluid shear bioreactors have capitalized on 
meniscus cell mechanosensitivity to create bi-zonal meniscus tissue. Seeding 
bovine or human chondrocytes on hyaluronic acid scaffolds, and culturing them 
in a rotating flask has resulted in the formation of a construct with a fibrous outer 
capsule of tissue with meniscus-like collagen organization. 112 Other studies have 
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achieved similar results using wavy-walled or flow perfusion bioreactors to 
culture poly(glycolic acid) (PGA) scaffolds seeded with chondrocytes from bovine 
hyaline cartilage. 113· 114 The constructs resulting from these experiments also 
exhibited a bi-zonal structure of fibroblastic outer cells and chondrocytic inner 
cells, and showed that the culture process had a positive effect on meniscus-
specific matrix deposition and cell proliferation.113• 114 The application of fluid 
shear during construct culture has made progress in meniscus engineering by 
producing tissue containing cells that range from fibroblast-like to chondrocyte-
like. Informed by meniscus cell mechanosensitivity research and meniscus 
development and anatomy, researchers have determined that a dynamic culture 
process incorporating shear is beneficial for the creation of bi-zonal tissue. 
However, this process alone has yet to produce tissue that has near-native 
mechanical and geometrical properties. 
A scaffoldless approach to tissue engineering the meniscus has 
addressed the issue of creating geometrically relevant meniscus tissue. Using 
the anatomic knowledge that the meniscus is comprised of two basic cell-types, 
fibroblast-like and chondrocyte-like cells, a high-density co-culture of bovine 
fibrochondrocytes and chondrocytes has been added to agarose molds to form 
meniscus-shaped constructs. 115 Following an eight week culture period, these 
constructs displayed meniscus-like geometry and anisotropic mechanical 
behavior, with a circumferential modulus of around 226 kPa, and a radial 
modulus of around 67 kPa. 115 These constructs also contained meniscus-like 
matrix proteins such as collagen types I and II, as well as GAGs, and presented 
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circumferential collagen orientation.115 By employing a scaffold-less approach to 
tissue engineering it is therefore possible to achieve meniscus-like geometry and 
matrix deposition. The mechanical behavior of these constructs also mimics the 
anisotropy of native tissue, but their mechanical integrity is still much lower than 
native values. 
Biochemical stimulation of engineered meniscus constructs is a promising 
avenue toward achieving higher mechanical properties. As it is known that 
certain biomolecules can induce fibrochondrocytes toward proliferation, 
migration, and protein synthesis, they can be added to the culture medium of 
engineered constructs to increase the production of collagens and proteoglycans, 
which are integral in imparting mechanical integrity to the neotissue. TGF-~1 is 
known to have a profound effect on the collagen and GAG production of 
meniscus cells in monolayer, and has also been instrumental in increasing matrix 
deposition and mechanical properties of various engineered constructs. In 
particular, the addition of TGF-~1 to the culture medium of scaffoldless 
constructs formed from a 50:50 co-culture of bovine fibrochondrocytes and 
chondroctyes allowed for the construct tensile modulus to reach 3 MPa. 116 
Furthermore, TGF-~1 added to constructs created by seeding fibrochondrocytes 
on poly-L-Iactide (PLLA) has been shown to increase matrix deposition.117 
Studies such as these indicate that the regenerative capacity of 
fibrochondrocytes is highly dependent upon culture conditions, and that the 
addition of biomolecules can compliment various engineering processes. By 
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optimizing these conditions it may be possible to create tissue in vitro that mimics 
the native meniscus mechanically and biochemically. 
Conclusions 
Knee meniscus tissue is complex geometrically, with an accompanying 
diversity of cells. These cells vary regionally within the tissue and display unique 
characteristics in terms of their morphologies, protein synthetic properties, and 
response to mechanical and biochemical stimulation. These differences give rise 
to a tissue with regions that are either vascular or avascular, fibrous or 
cartilaginous. An understanding of this diverse population of cells and their 
interaction with their biomolecular milieu can illuminate normal function, 
pathophysiology, and regenerative processes of the meniscus. 
Tissue engineering experiments using fibrochondrocytes have already 
begun to provide information about some of the regenerative capacities of these 
cells. Advances in bioreactor technology, scaffold-free construct formation, and 
the application of growth factors indicate that creating a geometrically, 
biomechanically, and biochemically relevant meniscus-like tissue from cartilage 
cells is feasible. More research should be done to determine if a combination of 
these approaches may help to achieve a complete set of properties. 
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Tables 
Table 1: Regional variation of meniscus molecules, cell morphology, and 
mechanical forces 
Region Molecules present 
Throughout Collagen type 139· 45· 50· 53 
Collagen type 11 39· 45· 50· 53 
Inner Aggrecan53 
NOS253, 54 
CD3451 
Outer MMP253 
MMP353 
Dominant Cell morphology force type 
Round, 
chondrocyte-like 
Fusiform, 
fibroblast-like 
Compression, 
tension, shear 
Compression 
Tension 
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Table 2: Selected senes related to hlaline and meniscal cartilases 
Gene Gene name Cartilage in which 
slmbol hi&hll expressed47 
/GF2 insulin-like growth factor 2 Hyaline (somatomedin A) 
IGL@ immunoglobulin lambda locus Hyaline 
RTN4R reticulon 4 receptor (Nogo receptor) Hyaline 
EPHX2 epoxide hydrolase 2, cytoplasmic Hyaline 
GREG cellular repressor of E1A-stimulated Hyaline genes 
FLJ13840 Homo sapiens eDNA FLJ 13840 fis, Hyaline 
clone THYR01 000783 
BCL7A 8-cell CLL/Iymphoma 7 A Hyaline 
PLA2G2A phospholipase A2, group IIA Hyaline (platelets, synovial fluid) 
CTSC cathepsin C Hyaline 
RBP4 Retinol-binding protein 4, interstitial Hyaline 
COL2A1 collagen, type II, alpha 1 Hyaline and Meniscus 
HPCAL1 hippocalcin-like 1 Meniscus 
FLJ20831 hypothetical protein FLJ20831 Meniscus 
PDLIM1 PDZ and LIM domain 1 (elfin) Meniscus 
C1QR complement component C 1 q Meniscus 
receptor 
COL1A1 collagen, type I, alpha 1 Meniscus 
COL1A2 collagen, type I, alpha 2 Meniscus 
CA12 carbonic anhydrase XII Meniscus 
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Table 3: Effects of mechanical loading on meniscus cells 
Stimulus Details Effect 
Normalloadingss 
Biaxial cellular strain, in 
vitros6 
Static tissue 
compressions7 
Dynamic tissue 
compressions7 
Dynamic tissue 
compressions8 
Joint immobilizations9 
Finite element 
model 
Cyclic, 5°/o, 
0.5 Hz, 24 hrs 
0.1 MPa, 
24 hrs 
0.08-0.16 MPa, 
0.5 Hz, 24 hrs 
0-0.1 MPa, 
0.5 Hz square 
wave, 24 hrs 
In vivo 
Inner cell -7% strain, outer cell 
-2-4% 
Increased protein synthesis 
(higher for outer cells than 
inner cells) ; NO levels 
increase 
Decrease in decorin and 
collagen types I and II 
expression (3- to 4-fold); 
Increase in MMP-1 expression 
(2- to 3-fold) 
Decrease in decorin 
expression (2-fold) , 
Decrease collagen type II 
expression ( 4-fold) 
NO levels increase 
Decrease in aggrecan 
expression (2- to 5-fold) 
Table 4: Effects of growth factors on meniscus cells 
Effect Growth Factor Cell Source (Details) 
Proteoglycan 
synthesis 
Collagen 
synthesis 
Migration 
Proliferation 
Sheep TGF-J31 18. 43, 1o8, 
Human 111 
TGF-J3 1 1o8, 111 
BMP-2 110 
IL-1110 
PDGF-AB 110 
IGF-1 110 
EGF 110 
HGF 11o 
Human PL 40 
HGF 110 
FGF 40 
Rabbit (increased [35S]-sulfate uptake) 
Rabbit (8-fold increase) 
Rabbit (increased [3H]-proline uptake) 
Rabbit ( 15-fold increase) 
Cow (middle cells) 
Cow (outer cells) 
Cow 
Cow (middle cells) 
Cow (half inner cells, all outer cells) 
Cow 
Rabbit 
Cow 
Rabbit 
PDGF-AB 11° Cow 
BMP-2 11° Cow 
105 
106 
Figures 
Figure 1: Anterior view of the meniscus within the knee joint. The meniscus 
rests between the femoral condyles and tibial plateau within the knee joint. Its 
two semicircular, wedge-shaped parts, the medial and lateral meniscus, are 
situated on the medial and lateral sides of the knee, respectively. They are held 
in place by a network of ligaments. 
Ligament 
ofWrisberg 
Tibial 
plateau Horn attachments 
Transverse 
ligament 
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Medial 
Figure 2: Medial and lateral menisci, superior view. Various ligaments allow 
for meniscus stabilization and restrict movement of the femur relative to the tibia . 
Among these are the transverse ligament, which connects the anterior horns of 
the menisci together, and the horn attachments, which provide anchoring to the 
tibial plateau. The ligaments of Humphrey and Wrisberg provide the posterior 
lateral meniscus a connection to the medial femoral condyle, and the ACL and 
PCL connect the tibia to the femur, stabilizing the joint. 
3.5 mo. 3 mo. 
gestation after birth 
9 mo. 
after birth 
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-11 years 
Figure 3: Meniscus vascularity over time. Initially, the meniscus is completely 
vascularized, but over time, this vascularity recedes to the outer periphery of the 
tissue. Blood vessels begin to disappear in the inner meniscus around three 
months after birth, coinciding with the accumulation of endostatin produced by 
the cells. By 11 years of age, this inner portion is completely avascular. 
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(d) 
Figure 4: Four different cell types in the meniscus. Cells in the outer layer of 
the meniscus appear flattened and close together (a) , while cells in the outer 
periphery contain many cell processes like fibroblasts (b). Moving toward the 
inner portion of the meniscus, the cells contain fewer cell processes (c) and cells 
from the inner portion are rounded and chondrocyte-like (d). 
':' 
• 
• 
• 
Ftibia 
110 
Figure 5: Forces generated during normal meniscus loading. The meniscus 
experiences various types of forces as the femur transmits vertical loads through 
the knee joint. Because the tissue is concave on its superior surface, the force 
from the femur results in a vertical (Fv) and horizontal (Fh) force generated in the 
tissue. The vertical force is opposed by the tibial reaction force, resulting in 
compression of the tissue, while the horizontal force is balanced by the anterior 
and posterior horn attachments of the meniscus(Fant and Fpost) - These horn 
attachments anchor the meniscus, and generate circumferential (Fcir) and rad ial 
reaction forces in the tissue (F rad) . 
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Chapter 4: Biomechanics of Meniscus Cells: Regional 
Variation and Comparison to Articular Chondrocytes 
and Ligament Cells 
Abstract 
Central to understanding mechanotransduction in the knee meniscus is 
the characterization of meniscus cell mechanics. In addition to biochemical and 
geometric differences, the inner and outer regions of the meniscus contain cells 
that are distinct in morphology and phenotype. This study investigated the 
regional variation in meniscus cell mechanics in comparison to articular 
chondrocytes and ligament cells. It was found that the meniscus contains two 
biomechanically distinct cell populations, with outer meniscus cells being stiffer 
(1.59 ± 0.19 kPa) than inner meniscus cells (1.07 ± 0.14 kPa). Additionally, it was 
found that both outer and inner meniscus cell stiffnesses were similar to ligament 
cells (1.32 ± 0.20 kPa), and articular chondrocytes showed the highest stiffness 
overall (2.51 ± 0.20 kPa). Comparison of compressibility characteristics of the 
cells showed similarities between articular chondrocytes and inner meniscus 
cells, as well as between outer meniscus cells and ligament cells. These results 
show that cellular biomechanics vary regionally in the knee meniscus, and that 
meniscus cells are biomechanically similar to ligament cells. The mechanical 
Chapter submitted as: Sanchez-Adams, J., and Athanasiou, K.A. "Biomechanics 
of Meniscus Cells: Regional Variation and Comparison to Articular Chondrocytes 
and Ligament Cells." Biophysical Journal. 
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properties of musculoskeletal cells determined in this study may be useful for the 
development of mathematical models or the design of experiments studying 
mechanotransduction in a variety of soft tissues. 
Introduction 
Understanding mechanotransduction in the knee meniscus can help 
elucidate the mechanisms by which meniscus cells maintain healthy tissue or 
mount a healing response following injury. Located between the femoral 
condyles and the tibial plateau in the knee joint, the menisci are semi-lunar, 
wedge-shaped fibrocartilaginous tissues. 19 Each meniscus functions to increase 
congruence between articulating surfaces, distribute load, and absorb shock 
during normal movements such as walking or running?3• 24 Because of its unique 
shape, meniscus tissue is exposed to a variety of load types including 
compression, tension, and shear.30• 32• 37• 118 These forces are also borne by the 
resident cells in the tissue, which affect their gene expression and synthetic 
properties. 56• 119 As the regional mechanical properties of meniscus cells are 
unknown, however, it is difficult to predict how forces at the tissue level are 
translated to the cells and what effect these forces have on tissue homeostasis 
or remodeling. 
As biochemically distinct regions exist in the inner and outer portions of 
the meniscus, the mechanical properties of meniscus cells may also vary 
regionally. Different cell types are known to reside in the inner and outer 
meniscus regions; the inner region contains rounded, articular chondrocyte-like 
113 
cells that produce collagen type II and aggrecan, whereas outer meniscus cells 
display many cellular processes and are the main producers of collagen type 1. 9· 
29
-
31
· 
52 Regional variations in cellular mechanics have been documented 
previously in different zones of articular cartilage86 and in different regions of the 
intervertebral disc, 120 which also correspond with known differences in cellular 
morphology and synthetic profiles. If, in addition to phenotypic differences, outer 
and inner meniscus cells show distinct mechanical properties, these cells may 
deform differently in response to the same mechanical load, causing varying 
phenotypic and synthetic changes. 
It is also important to understand meniscus cell mechanics in the context 
of other musculoskeletal cells. As articular cartilage and ligament represent 
opposite ends of the musculoskeletal soft tissue spectrum, it is likely that cells 
from the meniscus may have similar properties to cells from these tissues. 
Identifying key similarities and differences in the mechanical properties of these 
cells can aid in the development of theoretical models of the meniscus, and 
inform further studies on the effects of mechanical stimulation on meniscus cells. 
Typically, single cells are mechanically tested using one of three 
techniques: micropipette aspiration,94· 96· 99 atomic force microscopy (AFM),85-87· 
90
· 
121 cytoindentation,82· 84 or unconfined compression.80· 97• 100· 101 Because of the 
size of the pipette or probe used in micropipette aspiration and atomic force 
microscopy, these techniques are most useful for measuring the mechanical 
properties of subcellular components such as portions of the cellular membrane. 
Cytoindentation offers some advantages over these techniques as the probe is 
114 
larger than that used in AFM, and the cylindrical probe geometry allows for 
simpler modeling of the viscoelastic mechanical behavior of the cell. Unconfined 
compression, however, uses a probe that is much larger than the cell, giving it 
the unique ability to measure bulk cellular properties. This is advantageous 
because bulk cellular deformation likely occurs during physiologic loading 
experienced by meniscus cells in situ. Bulk cytomechanics have been measured 
previously using a cytocompression device, which has been used to successfully 
detect differences in the mechanical properties of a variety of cell types. For 
example, previous studies found that certain growth factors have a bulk stiffening 
effect on adult articular chondrocytes, and that the actin cytoskeleton provides 
the greatest contribution to chondrocyte stiffness?8• 80 This device has also been 
used to detect stiffening of myeloma cells compared to normal bone marrow 
stroma cells, and track the stiffening of human embryonic stem cells as they 
differentiate along a chondrogenic lineage?9· 122 Thus, application of this 
technique is able to detect differences in cellular mechanics in a variety of 
situations, and presents a useful method of measuring the bulk mechanical 
properties of meniscus cells. 
In light of the lack of information on meniscus cell mechanics, the overall 
objective of this study is to characterize the biomechanical properties of 
meniscus cells and compare them to those of articular chondrocytes and 
ligament cells. To determine if regional variations in meniscus cellular mechanics 
exist, mechanical properties of inner meniscus cells as well as outer meniscus 
cells are also measured and compared. Unconfined compression stress-
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relaxation tests are performed using a cytocompression device to measure bulk 
cell stiffness, Poisson's ratio, and recovery characteristics of each cell type. It is 
hypothesized that inner and outer meniscus cells have distinct mechanical 
properties, and that inner cells are more similar to articular chondrocytes while 
outer cells have properties more similar to ligament cells. By characterizing the 
mechanical properties of inner and outer meniscus cells, this study provides a 
basis for further understanding of mechanotransduction in the meniscus. 
Comparing the mechanical properties of meniscus cells to other musculoskeletal 
cells may also help put this information into context and provide a more complete 
understanding of these cells and how they may function in the knee. 
Materials and Methods 
Cell isolation and seeding 
Five bovine knee joints from two week old animals were obtained 24 hours 
after sacrifice and patellar ligaments, articular cartilage from the femoral head, 
and medial menisci were harvested using aseptic surgical techniques. The outer 
and inner portions of each medial meniscus were dissected from the tissue and 
processed separately. Ligament, cartilage, inner meniscus, and outer meniscus 
tissue was minced to approximately 1 mm2 pieces, and digested in Dulbecco's 
Modified Eagle Medium with Glutamax (DMEM) [Invitrogen, Carlsbad, CA], 1% 
penicillin/streptomycin/fungizone (PIS/F) [Lonza, Basel, Switzerland], 1% non-
essential amino acids (NEAA) [Invitrogen], and 0.2% w/v collagenase type 2 
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[Worthington, Lakewood, NJ]. Digestion was carried out overnight at 37°C with 
gentle shaking, after which cells were counted and frozen in liquid nitrogen in 
DMEM containing 20% fetal bovine serum (FBS) [Atlanta Biologicals, 
Lawrenceville, GA] and 10% dimethyl sulfoxide [Sigma-Aldrich, St. Louis, MO]. 
Prior to each cytocompression experiment, cells were thawed, counted, and 
resuspended in DMEM containing 1% P/S/F, 1% NEAA, 10% FBS, and 50 IJg/mL 
ascorbate-2-phosphate. Cells were then seeded onto cut-glass slides at a 
concentration of 200,000 cells/mL, as described previously.78• 80 After incubation 
at 3rC for 1.5 hours, individual cells were subjected to compression, and videos 
of these compression events were recorded. 
Unconfined compression of single cells 
As previously described, a cytocompression device was used to subject 
single chondrocytes, inner meniscus cells, outer meniscus cells, or ligament cells 
to unconfined compression stress-relaxation tests at 10-50% strain levels.78• 80• 123 
A sample size of n = 30 was used for each group in this study, based on power 
analysis performed for previous studies using this cytocompression method.80 A 
schematic representation of this procedure is shown in Figure 1. Briefly, glass 
slides seeded with cells were placed on an inverted microscope such that the 
objective viewed side profiles of the cells. A tungsten probe, 50.8 IJm in diameter 
and driven by a piezoelectric motor, was brought approximately 5-10 1-1m from the 
top of each cell, and was used to compress the cell at a rate of 4 !Jm/second 
(Figure 1A). Based on the probe's distance from the cell, the cell's stiffness, and 
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the prescribed distance the probe was to travel toward the cell (15 J,Jm), each cell 
was exposed to a different amount of strain. After moving the prescribed 
distance, the probe was held in place for 30 seconds to allow the cell to 
equilibrate, and then retracted at a rate of 4 J,Jm/second (Figure 1 B). Each 
compression event was recorded using a CCD camera, and recovery behavior 
following probe retraction was recorded for 45 seconds. 
Video capture and image analysis 
Recordings of cells compressed and recovering from compression were 
analyzed as previously described.80 Briefly, individual compression events were 
recorded using MetaMorph image analysis software, and cellular dimensions 
were measured throughout each event. Cell height and width was measured 
initially, at equilibrium compression, and during cellular recovery following 
release from compression. Additionally, the distance the probe traveled during 
each compression event was measured. A pixel to micron ratio was determined 
for each session by recording the unimpeded probe as it moved through a 
prescribed distance of 15 J,Jm. 
Biomechanical measurements 
Cantilever beam theory was employed to determine the stress applied to 
each cell based on probe's deflection, stiffness, and moment of inertia, as 
previously described.80• 84 The reaction force, F, on the cell was described as: 
3E/8 
F=-p 
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where the constants E (Young's modulus), I (moment of inertia), and L (length of 
the probe) were 394.5 GPa, 3.27 x 10-19 m4 , and 31.5 em, respectively. The 
deflection of the cantilever (0) was determined by comparing the prescribed and 
actual displacement of the probe for each compression event. The applied stress 
(aa) was determined by dividing F by the approximate contact area of the cell 
with the probe, as in our previous studies?8· 124 Cells were approximated as 
ellipsoids with two identical dimensions, and cellular volume was approximated 
as V = rrhcl/6. Cell volume was calculated initially (V;n;t). at equilibrium 
compression (Veq), and following recovery (Vmc). Cellular height and width 
dimensions initially, at equilibrium compression, and at equilibrium recovery were 
also used to determine lateral (£1) and axial (£a) strains, as well as residual axial 
strain(£,). From these measures, the apparent Poisson's ratio (v) was calculated 
as v = -(£1 I Ea). the recovered volume fraction as VmJV;n;t, and the apparent 
compressibility (/3a) as (V;n;t - Veq)l(aaV;n;t). as previously described.80 The 
characteristic recovery time (r) for each cell was also determined by modeling 
axial strain of the cell over time as an exponential decay function: 
E(t) = Ae -t;-r: + Er 
where A is the recovery coefficient, and t is the time in seconds. 
Immunocytochemistry 
Cells from each group were fluorescently stained for cell nuclei, actin, 
focal adhesion kinase (FAK), and microtubules. Each cell type was seeded onto 
a glass slide at a concentration of 0.25 x 106 cells/ml, and incubated at 37°C for 
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1.5 hours. Following incubation, seeded cells were washed with warm PBS and 
fixed with 3.7% formaldehyde for 15 minutes. After fixation, cells were washed 
with PBS and made permeable via incubation with 0.1% Triton X-1 00 for 15 
minutes. Cells were then incubated with Image-iT™ FX Enhancer [Invitrogen] for 
30 minutes, and then stained for actin using CF594 Phalloidin [Biotium, Hayward, 
CA] for 20 minutes. For microtubule staining, cells were incubated with an anti-a-
tubulin antibody [Invitrogen] for 1 hour, and for FAK staining, cells were 
incubated with an anti-FAK antibody [Sigma] for 1 hour. Secondary antibodies 
specific to each primary, and conjugated to a 488nm fluorophore, were incubated 
with the cells for 1 hour. Cell nuclei were then stained with 10 IJM Hoechst 33342 
for 7 minutes. Each slide was mounted using Prolong Gold Antifade medium 
[Invitrogen]. Images of cells were taken using a fluorescence microscope, and 
exposure times for each fluorophore were optimized for articular chondrocytes 
and kept constant for capturing images from all groups. 
Data analysis 
Linear regression analysis was performed with the data analysis package 
in Microsoft® Office Excel® 2007, one-way ANOVAs were performed in JMP® 
7.0.1, and exponential fits were carried out in MATLAB® 7.11. Linear regression 
analysis was performed to determine if significant correlations of stress, residual 
strain, and apparent compressibility existed as a function of applied axial strain 
and to test if these correlations varied with cell type. A correlation was 
determined significant if p < 0.05. For significant correlations, differences 
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between slopes were detected by comparing 95% confidence intervals as done 
previously. 78· 80 
Results 
Cell morphology 
Initial cell height and width was measured for each cell prior to 
compression and averaged for each cell type. A comparison of these average 
dimensions is shown in Figure 2. Following 1.5 hours of static seeding, it was 
found that the chondrocytes and inner meniscus cells showed statistically greater 
cell height (1 0. 76 ± 1.08 j.Jm and 11.01 ± 1.44 j.Jm, respectively) than outer 
meniscus cells and ligament cells (9.93 ± 1.32 IJm and 9.55 ± 1.13 IJm, 
respectively). Additionally, inner meniscus cells also displayed statistically 
greater cell width (12.93 ± 1.47 IJm) than all the other cell types (chondrocytes: 
11.01 ± 1.05 IJm, outer meniscus cells: 10.8 ± 1.03 IJm, and ligament cells: 10.57 
± 0.93 IJm). 
Compressive behavior 
Cell stiffness and Poisson's ratio were calculated from measurements of 
the cell and probe during each compression event. These biomechanical 
properties are listed in Table 1, and stress-strain plots for each cell type are 
shown in Figure 3. All linear regression models applied to the stress-strain curves 
for each cell type had significance values less than 0.001. Comparisons of the 
95% confidence intervals from the linear regression analysis of each cell type 
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showed that the articular chondrocytes were the stiffest of the four cell types, 
followed by the outer meniscus cells and inner meniscus cells, respectively. The 
stiffness of the ligament cells was not statistically different from either the inner or 
the outer meniscus cells, and was significantly lower than the articular 
chondrocytes. Average apparent Poisson's ratios of the four cell types were not 
statistically different from each other. 
Recovery behavior 
Cell morphological changes following compression were recorded, and 
recovered volume, characteristic recovery time, residual strain, and apparent 
compressibility were calculated for each cell. The average percent recovered 
volume was highest for the articular chondrocytes, and lowest for the outer 
meniscus cells (Table 1). Percent recovered volume for inner meniscus cells and 
ligament cells was intermediate but was not statistically different from articular 
chondrocytes or outer meniscus cells. The average characteristic time to 
recovery was not statistically different between cell types, and was on the order 
of 7 to 10 seconds for all cell types. 
Linear regression analysis of residual strain versus applied strain and 
apparent compressibility versus applied strain revealed significant linear 
correlations for all cell types (Figures 4 and 5, respectively). Regression analysis 
of residual strain versus applied strain showed positive linear correlations for all 
cell types (Figure 4). The slope of the fitted line for articular chondrocyte residual 
versus applied strain was found to be significantly lower than the slope for outer 
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meniscus cells, as determined by comparing 95% confidence intervals. Slopes 
for inner meniscus cells and ligament cells were similar to each other and not 
statistically different from either the chondrocytes or outer meniscus cells (Figure 
4). 
Regression analysis of apparent compressibility versus applied strain 
showed positive linear correlations for articular chondrocytes and inner meniscus 
cells, and negative correlations for outer meniscus cells and ligament cells 
(Figure 5). Chondrocyte and inner meniscus cell slopes were not statistically 
different from each other but were statistically different from outer meniscus cell 
and ligament cell slopes. Outer meniscus cell and ligament cell slopes were also 
not statistically different from each other. 
Immunocytochemistry 
Representative cells stained for actin and FAK or microtubules are shown 
in figures 6 and 7, respectively. All cells stained positively for actin, FAK, and 
microtubules. Articular chondrocytes showed distinct, cortical actin staining, while 
inner and outer meniscus cells and ligament cells showed more diffuse and less 
intense staining for actin (Figure 6). FAK staining (Figure 6) and microtubule 
staining (Figure 7) appeared to be similar for all cell groups. 
Discussion 
This study compared the biomechanical properties of cells from different 
meniscus regions to articular chondrocytes and patellar ligament cells. Overall, it 
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was found that meniscus cells were similar in biomechanical properties and 
cytoskeletal staining to ligament cells, although outer meniscus cells proved to be 
stiffer than inner meniscus cells. Additionally, articular chondrocytes were found 
to be significantly stiffer and show more distinct actin staining than all other cell 
types studied, suggesting that biomechanical properties of cells may correlate to 
the primary loading patterns or biochemical makeup of their tissues of origin. To 
our knowledge, this study is the first to identify two mechanically distinct 
subpopulations of cells in the meniscus which correspond to known regional 
biochemical variations. These results may aid in further characterization of 
musculoskeletal cells, providing key information for mathematical models or 
mechanical stimulation experiments that seek to understand tissue mechanics 
and mechanotransduction. 
Unconfined compression of inner and outer meniscus cells showed that 
mechanical properties of meniscus cells are unique to their region of origin. 
Specifically, outer meniscus cells were found to be smaller and stiffer than inner 
meniscus cells, but also showed more compressibility with applied strain 
compared with inner cells. Immunocytochemistry performed on these cells 
showed similar staining intensity for actin, microtubules, and focal adhesions for 
inner and outer meniscus cells, indicating that they have similar cytoskeletal 
makeup and were actively adhered to the glass surface. As the actin 
cytoskeleton has been implicated as the largest contributor to cell stiffness,80 and 
outer meniscus cells did not appear to contain more actin than inner cells, the 
increased stiffness of these cells may be a result of a more organized actin 
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cytoskeleton to resist axial compression. Additionally, as outer meniscus cells are 
known to be fibroblast-like with many cellular processes,38 and these experiments 
were carried out with cells attached to a glass surface, the increased 
compressibility of outer meniscus cells may be due to the propensity of these 
cells to make focal adhesions and spread on the surface during a compression 
event which may result in reduced cellular volume. This characteristic increase in 
compressibility with strain was also shared by ligament cells, which also have 
fibroblastic characteristics. In contrast, inner cells and articular chondrocytes 
shared similar compressibility characteristics. This biomechanical similarity could 
also be related to the preferred spherical morphology of these cells, which would 
cause less cell spreading to occur during compression and less volume change. 
Therefore, the differences observed in inner and outer meniscus cell mechanics 
further illustrate previously identified morphological and phenotypic differences of 
meniscus cells, and show that apparent compressibility may be linked to 
preferred cell morphology. 
Overall, it appeared that meniscus cells as a whole shared more 
biomechanical similarities to ligament cells than to articular chondrocytes. As 
hypothesized, outer meniscus cells and ligament cells showed similarities in 
nearly all biomechanical measures. Additionally, and in contrast to the proposed 
hypothesis, inner meniscus cells were also similar in stiffness and residual strain 
characteristics to ligament cells. These similarities were also detected in 
fluorescent staining of the actin cytoskeleton, showing similar staining intensity 
for meniscus cells and ligament cells, and markedly brighter staining for articular 
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chondrocytes. As the actin cytoskeleton is known to play a major role in imparting 
cell stiffness,80 the observed differences in staining may indicate that actin in 
articular chondrocytes may be either more abundant or more organized than in 
meniscus or ligament cells. Further, meniscus tissue is similar to ligament tissue 
in terms of collagen organization, with collagen primary oriented in the 
circumferential direction in all regions of the meniscus and along the direction of 
loading in ligaments. The loads experienced by these two tissues are also 
similar, as tension is generated in both tissues along the axis of collagen 
orientation. In contrast, primary loading in articular cartilage is compressive. 
Although inner meniscus tissue bears some resemblance to articular cartilage, 
containing collagen type II and more sulfated glycosaminoglycans than the outer 
meniscus, the similarities in inner meniscus cell mechanics to ligament cells may 
indicate that tensile loading experienced by inner cells is important to their overall 
phenotype. Thus, differences in stiffness between articular chondrocytes and 
meniscus or ligament cells seem to be correlated with the actin cytoskeleton and 
the loading patterns experienced by the cells in their native environment. 
Despite differences in cell stiffness, all cell types showed similar 
characteristic recovery times (Table 1 ). Additionally, microtubule staining of all 
cell types showed similar intensity and distribution (Figure 7). Previous research 
investigating the mechanical role of cytoskeletal elements has shown that 
microtubules are essential for cellular recovery following axial compression, as 
disruption of these elements leads to a 100% increase in characteristic recovery 
time.80 Given the importance of microtubules in cellular recovery behavior, the 
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similarities observed in microtubule abundance between cell types supports their 
similar characteristic recovery times. 
The differences in cellular mechanics demonstrated in this study may also 
indicate that tissues with similar properties may contain cells with similar 
biomechanical properties. This is in agreement with previous work using AFM to 
compare the mechanics of different cell types, which reported a correlation 
between cell stiffness and tissue properties.125 The higher stiffness of articular 
chondrocytes compared with meniscus and ligament cells also closely matches 
the regional mechanical differences observed in intervertebral disc (IVD) cells 120 
which reside in different biochemical environments. In the IVD, nucleus pulposus 
cells have been found to be approximately 3-fold stiffer than annulus fibrosus 
cells. In the present study, articular chondrocytes were found to be approximately 
2-fold stiffer than the other cell types tested. As the nucleus pulposus contains 
similar biochemical components to articular cartilage, namely high sulfated GAG 
and collagen type II content, and the annulus fibrosus is made up of fibrous 
tissue like the meniscus or patellar ligament, the present results agree with the 
correlation of cell stiffness and tissue properties. These correlations may help 
predict the biomechanical properties of cells from other musculoskeletal tissues 
such as tendon, allowing for more accurate biomechanical models to be 
constructed. 
Mathematical models of the mechanical deformation of single cells have 
already been developed for articular cartilage 126 and the intervertebral disc, 127 
and the knee meniscus under axial compression, 55 giving new insights into the 
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translation of tissue strains to cell strains and indicating potential stimulation 
parameters for tissue engineering. With respect to the knee meniscus, previous 
research has used information from modeling to demonstrate that 
mechanotransduction exists in meniscus cells, showing that inner and outer 
meniscus cells respond to cyclic tensile loading with increased nitric oxide 
production and total protein synthesis.56 Meniscus explants have also been 
shown to respond to 2% cyclic compressive strain with increased aggrecan gene 
expression, 128 but other research has shown decreased collagen and increased 
proteinase gene expression levels following a 0.08-0.16 MPa dynamic 
compression regimen.57 These data indicate that there may be optimal levels of 
strain to apply to meniscus cells to achieve protein synthesis, beyond which 
catabolic processes are initiated. Thus, as meniscus cells have demonstrated 
sensitivity to mechanical stimulation, understanding their mechanical properties 
can help to further tailor the stimulation of engineered constructs to initiate 
particular mechanotransductive events for achieving functional tissue properties. 
Characterization of the mechanical properties of single meniscus cells is 
an important step toward understanding mechanotransduction in the meniscus. 
This study demonstrated that meniscus cell mechanics vary regionally in the 
tissue, and that meniscus cells are most biomechanically similar to ligament 
cells. The mechanical properties measured in this study will be useful parameters 
for constructing accurate biomechanical models of various musculoskeletal 
tissues and for designing experiments to deliver precise mechanical stimulation 
to tissue engineered constructs. 
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Tables 
Table 1: Mechanical characteristics of musculoskeletal cells* 
Mechanical Articular Inner Outer Ligament 
Property Chondrocytes Meniscus Cells Meniscus Cells Cells 
Cell Stiffness (kPa) 2.51 ± 0.2 a 1.07±0.14c 1.59±0.19b 1.32 ± 0.2 be 
Poisson's Ratio 0.5 ± 0.27 0.48 ± 0.21 0.54 ± 0.26 0.46 ± 0.17 
Recovered Volume(%) 98.2 ± 6.6 a 94 ± 6.8 ab 92.7 ± 6.8 b 96.2 ± 7 ab 
Recovery Time (sec) 7.15 ±4.96 8.21 ± 3.74 7.34 ± 3.22 10.73 ± 6.09 
*All values are presented as mean± standard deviation, except cell stiffness 
which is presented as slope ± 95% confidence bounds (see Figure 3) 
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Figures 
A B 
(i) 
(ii) 
(iii) 
Figure 1: Schematic of cytocompression experiments. (A) Cells were seeded 
onto a glass slide and compressed at a rate of 4 1-Jm/second by a tungsten probe. 
The height (h) and width (w) of the cell, as well as the probe deflection (o) was 
measured at various stages of each compression event and used to calculate 
cellular biomechanical properties. (B) Representative frames of an inner 
meniscus cell seeded onto a glass slide initially (i) , at equilibrium compression 
(ii), and during the recovery stage (iii) , of a cytocompression event. 
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Figure 2: Comparison of initial cell dimensions. Cell height (A) and width (B) 
were measured for each cell prior to cytocompression. Comparison of average 
height values showed chondrocytes and inner meniscus cells (MCs) to be 
greater than outer MCs and ligament cells. Inner cells also showed greater cell 
width compared with chondrocytes, outer MCs and ligament cells. Data was 
analyzed using a one-way ANOVA with a Tukey's post hoc test. Significance was 
set at p < 0.05. · 
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Figure 3: Stress versus strain correlations for different cell types. Linear 
regression analysis was performed on stress-strain data for chondrocytes, inner 
and outer meniscus cells, and ligament cells. Significant correlations were 
observed for all cell types (p < 0.001 ). For each graph, the equation obtained 
from linear regression is shown with 95°/o confidence bounds for the slope in 
parentheses below. Chondrocytes showed the highest cell stiffness (slope) than 
all other cell types, while ligament cell stiffness was not statistically different from 
either meniscus cell type. Inner meniscus cells, however, were statistically less 
stiff than outer meniscus cells. 
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Figure 4: Correlation of residual vs. applied strain of compressed cells. 
Linear regression analysis was performed on residual strain versus applied strain 
data for chondrocytes, inner and outer meniscus cells, and ligament cells. 
Significant correlations were observed for all cell types (p < 0.001 ). The equation 
obtained from linear regression is shown in each graph with 95°/o confidence 
bounds for the slope in parentheses below. Positive correlations were observed 
for all cell types, but chondrocytes displayed a statistically lower slope than outer 
meniscus cells. 
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Figure 5: Apparent compressibility versus applied strain correlations. 
Linear regression analysis was performed on compressibility versus applied 
strain data for chondrocytes, inner and outer meniscus cells, and ligament cells. 
Significant correlations were observed for all cell types (p < 0.05). The equation 
obtained from linear regression is shown in each graph with 95°/o confidence 
bounds for the slope in parentheses below. Positive correlations were observed 
for outer meniscus cells and ligament cells, while negative correlations were 
observed for chondrocytes and inner meniscus cells. 
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Nucleus Actin FAK 
Figure 6: Actin and FAK immunocytochemistry. Articular chondrocytes, inner 
and outer meniscus cells, and ligament cells were seeded onto glass slides and 
fluorescently stained for cell nuclei, actin, and focal adhesion kinase (FAK). Cells 
from all groups stained positively for actin and FAK, and FAK staining was similar 
in intensity across cell types. Actin staining was most defined in articular 
chondrocytes, and less intense in meniscus and ligament cells. 
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Nucleus a-tubulin 
Figure 7: a-tubulin immunocytochemistry. Single articular chondrocytes, inner 
and outer meniscus cells, and ligament cells were fluorescently stained for 
microtubules using an anti-a-tubulin antibody. All cells stained positively for 
microtubules, with no gross differences in intensity noted. 
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Chapter 5: Regional effects of enzymatic digestion on 
knee meniscus cell yield and phenotype for tissue 
engineering 
Abstract 
An abundant cell source is the cornerstone of most tissue engineering 
strategies, but extracting cells from the knee meniscus is hindered by its dense 
fibrocartilaginous matrix. The identification of a method to efficiently isolate 
meniscus cells is important to the cartilage tissue engineering field, as it can 
reduce the cost and effort required to perform meniscus engineering research. In 
this study, six enzymatic digestion regimens used for cartilaginous cell isolation 
were used to isolate cells from the outer, middle, and inner regions of the bovine 
knee meniscus. Each regimen in each region was assessed in terms of cell yield, 
impact on cell phenotype, and cytotoxicity. All digestion regimens caused an 
overall upregulation of cartilage specific genes Sox9, collagen type I (Col 1 ), 
collagen type II (Col 2), COMP, and aggrecan (AGC) in cells from all meniscus 
regions, but was highest for cells isolated using 1075 U/mL of collagenase for 3 
hrs (HC). In response to isolation, outer meniscus cells showed highest 
upregulation of Sox9 and Col 1 genes, whereas greatest upregulation for middle 
meniscus cells was seen in Col 1 expression, and Col 2 expression for inner 
Chapter under review as: Sanchez-Adams, J., and Athanasiou, K.A. "Regional 
effects of enzymatic digestion on knee meniscus cell yield and phenotype for 
tissue engineering." Tissue Engineering, Part C. 
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cells. Cell yield was highest in all regions when subjected to 45 min of 61 U/ml 
pronase followed by 3 hrs of 1075 U/ml collagenase (PIC) digestion regimen 
(outer: 6.57 ± 0.37, middle: 12.77 ± 1.41, inner: 22.17 ± 1.47 x106 cells/g tissue). 
The second highest cell yield was achieved using 433 U/ml of collagenase for 
18 hrs (outer: 1.95 ± 0.54, middle: 3.3 ± 4.4, inner: 6.06 ± 2.44 x106 cells/g 
tissue). Cytotoxicity analysis showed higher cell death in the LC group compared 
with the P/C group. Self-assembled constructs formed from LC-isolated cells 
were less dense than constructs formed from PIC-isolated cells, and PIC 
constructs showed higher GAG content and compressive moduli than LC 
constructs. All isolation methods tested resulted in similar phenotypic changes in 
meniscus cells from each region. These results indicate that, compared with 
other common isolation protocols, the P/C isolation method is able to more 
efficiently isolate meniscus cells from all regions and produce better tissue 
engineered constructs. 
Introduction 
Successful engineering of meniscus tissue is a valuable goal, as the knee 
meniscus has a limited ability to self-repair despite being prone to a plethora of 
debilitating injuries. However, meniscus tissue engineering strategies often 
require a large number of cells to create tissues with appropriate biochemical and 
biomechanical properties. Primary meniscus cells are often used for this 
purpose, and have shown great promise in creating tissue engineered constructs 
with properties similar to native cartilage.115• 129-135 To obtain meniscus cells for 
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tissue engineering efforts, enzymatic digestion is needed, but little is known 
about the effects of isolation on the phenotype of meniscus cells, or which 
digestion technique is most effective for extracting cells from the meniscus. 
Isolating cells from fibrocartilaginous tissues such as the meniscus is 
difficult due to the abundance of fibrous extracellular matrix. Various techniques 
have been employed to extract cells from cartilaginous tissues including 
collagenase type 2, trypsin, pronase, and hyaluronidase but their efficiency has 
not been compared or reported for meniscus cell isolation. These enzymes differ 
in substrate specificity, and therefore meniscus cell isolation techniques often 
use sequential digestion protocols to break down the tissue. 136-139 Collagenase 
type 2 is comprised of a variety of enzymes produced by the bacterium 
Clostridium histolyticum, and cleaves various sites along the collagen triple 
helix.140-142 Trypsin is a serine peptidase derived from the digestive system which 
breaks down polypeptide chains into shorter fragments. 143-145 Similar to trypsin, 
pronase is made up of a variety of serine proteases produced by the bacterium 
Streptomyces griseus.146-151 Pronase has very broad substrate specificity and is 
able to break down proteins into their constituent amino acids, in contrast to other 
enzymes whose end-products are often poly- or oligopeptides.140• 152• 153 
Hyaluronidase is an enzyme present in bovine testes and produced by certain 
bacteria, which digests the glycosaminoglycan hyaluronan.154• 155 
While a formal comparison of enzymes has not been performed for 
meniscus cell isolation, a similar analysis has been carried out for articular 
chondrocytes. A study on the effects of enzymatic digestion of hyaline cartilage 
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on chondrocytes revealed that digesting the tissue with a high concentration of 
collagenase for a short period of time resulted in the least phenotypic changes in 
the cells. 137 However, other digestion techniques involving a low concentration of 
collagenase for a long period of time, pronase followed by collagenase, or trypsin 
followed by collagenase allowed for a greater cell yield than the high collagenase 
treatment, but also caused more phenotypic changes in the cells overall. 137 
Because of the regional differences in meniscus biochemistry and cell 
phenotype it is possible that different isolation techniques may be necessary for 
optimal cell yield from each region. The inner portion of the meniscus is similar 
to hyaline cartilage in that it contains the majority of sulfated glycosaminoglycans 
(GAGs) and collagen type II, whereas the middle and outer meniscus regions 
contain a higher proportion of collagen type 1.9• 29-31 • 52 The morphology of 
meniscus cells also becomes progressively more fibroblast-like peripherally in 
the meniscus, with the inner region cells more rounded and chondrocyte-like and 
the outer cells containing more cellular processes.38 In addition to morphology, 
regional cell phenotypic differences are observed; cells in the outer meniscus 
show high gene expression for collagen type I, while cells from the inner region 
display high gene expression for collagen type II and aggrecan.18· 53 These 
differences in biochemical content regionally within the meniscus, as well as cell 
morphology and phenotype may dictate the type of digestion technique optimal 
for regional cell yield. The different cell populations resident in each meniscus 
region may also be affected differently in terms of phenotype to different 
digestion enzymes and protocols. 
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Therefore, the objectives of this study were 1) to compare enzymatic 
digestion techniques for each of the three meniscus regions in terms of overall 
cell yield and viability, 2) to determine the effect of these isolation techniques on 
cell phenotype, and 3) to test the cells from the most promising digestion 
techniques in a tissue engineering modality. The self-assembly method was used 
as a model tissue engineering strategy, as it has been used previously with 
meniscus cells yielding constructs with promising biochemical and biomechanical 
properties.115• 130• 131 It was hypothesized that different digestion regimens would 
cause varying phenotypic changes in different regions of the meniscus, and that 
the digestion regimen yielding the highest number of cells could be used in the 
self-assembling process. The identification of a meniscus digestion method with 
high cell yield and minimal detrimental phenotypic changes is of great value to 
the tissue engineering field, allowing for a more efficient and cost-effective 
source of cells for further research. 
Methods 
Tissue dissection 
In phase 1, five medial menisci were harvested from one-week-old bovine 
knee joints. The anterior and posterior horns of the menisci and connective tissue 
from the outer portion were carefully removed. Each meniscus was then 
separated into inner, middle, and outer radial regions. Each region was portioned 
into eight sets of tissue, and the wet weight of each set was measured and 
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recorded. One of the sets was placed in RNA-later and analyzed with RT-PCR, 
and another was digested in papain and assayed for total DNA content using a 
PicoGreen® Assay Kit [Invitrogen, Carlsbad, CA]. 
Cell isolation 
The other six sets of tissue were minced to approximately 1 mm3 , and 
subjected to one of six tissue digestion regimens: 430 U/mL collagenase type II 
[Worthington, Lakewood, NJ] for 18 hrs (Low Collagenase or LC), 1075 U/mL 
collagenase type II for 7 hrs (High Collagenase or HC), 61 U/mL pronase [Sigma-
Aldrich, St. Louis, MO] for 1.5 hrs followed by 1075 U/mL collagenase type II for 
3 hrs (Pronase/Collagenase or PIC), 2.5 mg/mL (0.25%) Trypsin [Invitrogen] for 
45 min followed by 1075 U/mL collagenase for 3 hrs (Trypsin/Collagenase or 
T/C), 433 U/mL hyaluronidase [Sigma] for 45 min followed by 1075 U/mL 
collagenase for 3 hrs (Hyaluronidase/Collagenase or H/C), and 433 U/mL 
hyaluronidase for 30 min followed by 2.5 mg/mL Trypsin for 30 min followed by 
1075 U/mL collagenase for 3.5 hrs (Hyaluronidase/Trypsin/Collagenase or 
HIT/C). Tissues were digested at a concentration 43.73 mg/mL of digestion 
solution, and all digestion steps were carried out at 37°C with gentle shaking. All 
enzymes were reconstituted in DMEM containing 1% P/S/F and 1% non-
essential amino acids, and collagenase solutions contained an additional 10% 
FBS. After each digestion regimen, cell solutions were filtered through a 70~m 
cell strainer, and centrifuged at 700 x g for 5 minutes. Cells were then washed 
once with PBS and resuspended in PBS before being counted with a Z2 Coulter 
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Counter [Beckman-Coulter]. Cells were counted three times and the average and 
standard deviation of cell counts was calculated. Cell count data were analyzed 
using a 2-way ANOVA, with a significance level of p < 0.05. 
Quantitative RT-PCR 
Cells from each digestion regimen and regional tissue controls were also 
analyzed using quantitative RT-PCR for mRNA abundance of cartilage specific 
genes Sox9, collagen type I (Col 1 ), collagen type II (Col 2), cartilage oligomeric 
matrix protein (COMP), and aggrecan (AGC). Total RNA was extracted from 
native tissue using an RNAqueous Kit, and from cells using an RNAqueous-
Micro Kit [Ambion, Austin, TX]. Total RNA was reverse-transcribed using the 
SuperScript™ Ill First-Strand Synthesis System [Invitrogen], and then PCR was 
performed on the resulting eDNA for cartilage-specific genes using SYBR® 
Green PCR Mastermix, 80-100 ng of sample eDNA, and 900 nM of each primer. 
PCR analysis was performed using a RotorGene 3000, and each run used the 
following protocol: 50°C for 2 min, 95°C for 10 min, followed by 40 cycles of 95°C 
for 15 sec and 60°C for 60 sec. Bovine 18s rRNA was used as a housekeeping 
gene for each of the digestion techniques and tissue control. All fold-change 
calculations were determined by normalizing data to native tissue controls from 
each region and were calculated using the formula y = zMct, where llllCt 
represents the difference in takeoff cycle between experimental and control 
groups. Specific primers for each gene are listed in Table 1. Gene expression 
data were analyzed using a 2-way ANOVA, with a significance level of p < 0.05. 
144 
Fluorescent staining of necrosis 
Cells from the highest yielding digestion regimens were also fluorescently 
·stained to visualize cell nuclei and necrotic cells. Hoechst 33342 was used to 
stain cell nuclei, and ethidium homodimer Ill was used to stain cells in a necrotic 
state [Biotium, Hayward, CA]. 
Tissue engineering 
In phase 2, the two digestion techniques with highest cell yield were used 
to extract cells from 3-4 grams of total medial menisci. The cells were counted 
and total cell yield per gram of tissue was determined. An aliquot of cells from 
each digestion technique was stained for live and dead cells using a Live/Dead 
Viability/Cytotoxicity Kit [Invitrogen]. The remaining cells were then seeded into 5 
mm agarose molds at 5.5 x 106 cells per well in 0.5 ml of chondrogenic medium 
containing DMEM with 1% penicillin/streptomycin/fungizone, 1% non-essential 
amino acids, 1 o-7 M dexamethasone, 5mM L-ascorbic acid 2-phosphate, 0.4 mM 
L-proline, and 10 mM sodium pyruvate. Constructs were cultured for 4 weeks in 
an incubator 3JDC with 5% C02 and 0.5 ml of media was changed every day. At 
the end of the culture period, each construct's diameter and thickness was 
measured. Constructs were then either analyzed for total glycosaminoglycan 
content using a dimethyl-methylene blue assay kit [Biocolor, Carrickfergus, UK], 
or total collagen content using a hydroxyproline assay, or were mechanically 
tested using an unconfined compression stress-relaxation test at 10% strain. 
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Compressive testing was initiated with 15 cycles of preconditioning at 0-5% 
strain, and data were fit with a Kelvin solid viscoelastic model to determine the 
modulus of relaxation (Er) and instantaneous modulus (Ei) as previously 
described.156 
Results 
Cell isolation 
Tissue specimens from the inner, middle, and outer meniscus were 
portioned from five medial menisci and minced in preparation for digestion. 
Qualitatively, it was observed that the inner meniscus was the easiest to mince, 
while the outer meniscus was more tough and fibrous, necessitating much more 
time and effort to achieve the desired -1 mm3 fragments. In phase 1, six different 
isolation methods were used to isolate cells from the inner, middle, and outer 
regions of the bovine meniscus. Qualitative differences in the viscosity of 
resultant cell solution were observed among the digestion regimens, with the PIC 
protocol producing the least viscous solution compared with the HC and LC 
protocols, which seemed the most viscous. The number of cells per gram of 
tissue was determined for each isolation regimen (Figure 1 ). Statistical analysis 
showed that the overall cell yield was highest for the inner meniscus compared 
with the outer meniscus. The middle meniscus cell yield trended higher than the 
outer region but was not statistically different from either the inner or outer 
regions. All isolation regimens were able to extract cells from all regions, and the 
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pronase/collagenase (P/C) treatment resulted in the highest overall cell yield 
from all regions (outer: 6.57 ± 0.37, middle: 12.77 ± 1.41, inner: 22.17 ± 1.47 
x106 cells/g tissue). Additionally, the P/C regimen, when applied to the inner 
meniscus region, produced a cell yield closely matching that of native tissue 
(outer: 33.88 ± 0.07, middle: 23.55 ± 1.17, inner: 19 ± 0.16 x106 cells/g tissue). 
Overall cell yields from the other isolation regimens were not statistically different 
from each other, but the low collagenase (LC) treatment trended higher than the 
rest (outer: 1.95 ± 0.54, middle: 3.3 ± 4.4, inner: 6.06 ± 2.44 x1 06 cells/g tissue) . 
Fluorescent staining of necrosis 
Fluorescent staining of cell nuclei and necrotic cells was carried out for the 
highest yielding digestion regimens, P/C and LC (Figure 2). Visual comparison of 
necrotic cells to total cells showed more necrotic cells present in LC digested 
specimens from all regions than in the P/C digested specimens. 
Gene expression 
Gene expression of digested cells from each meniscus region using six 
different isolation protocols were compared to native gene expression from each 
region (Figure 3). In general, isolated cells from all regions showed an increase 
in gene expression for all genes studied compared with native tissue controls. In 
the outer region, Sox9 and Col 1 gene expression displayed the most 
upregulation, whereas Col 2 gene expression was least affected by isolation. 
Amongst the digestion regimens, the outer region cells showed the highest gene 
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upregulation when isolated using the HC protocol, while the gene expression of 
cells resulting from the LC isolation regimen was the only group not statistically 
different from native tissue. In response to isolation, middle meniscus cells 
showed the most upregulation in Col 1, and the least upregulation in Col 2. The 
digestion regimen resulting in the highest overall gene expression levels was the 
HC protocol, and the gene expression of cells from the HfTIC protocol was not 
statistically different from native tissue. Inner meniscus cells showed the highest 
overall upregulation in Col 2, and AGC gene expression was least affected by 
isolation. The HC protocol produced the highest overall gene expression 
upregulation, whereas the gene expression of cells from the LC and PIC 
protocols were not statistically different from native tissue. 
Tissue engineering 
In phase 2, constructs were formed from cells isolated using the LC and 
PIC protocols. Cell yield was similar to results from phase 1, with PIC method 
yielding approximately 50% more cells than the LC method (Figure 4A). Live-
dead staining of the resultant isolated cells showed more dead cells relative to 
live cells in the LC isolated population relative to the PIC isolated cells (Figure 
48). After 4 weeks in culture, constructs from each group were compared in 
terms of gross morphology, GAG content, collagen content, and compressive 
mechanics (Figure 5). Constructs formed from LC-isolated cells displayed 
statistically higher thickness compared to PIC constructs, though construct 
diameters were not different between groups. PIC constructs showed higher 
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GAG content, but no difference was observed in collagen content between 
groups. Stress-relaxation unconfined compression testing of the two groups 
showed higher modulus of relaxation and instantaneous modulus for PIC 
constructs relative to LC constructs. 
Discussion 
This study sought to compare the regional effects of enzymatic digestion 
techniques for meniscus tissue engineering. Six different digestion protocols 
were characterized based on regional meniscus cell yield, viability, and 
phenotype, and the protocols yielding the highest number of cells were tested in 
a tissue engineering modality. In agreement with the proposed hypothesis, 
meniscus cells from different regions showed varying phenotypic changes 
following isolation, and the protocol yielding the highest number of cells (the P/C 
isolation method) was successfully implemented in the self-assembling process. 
In phase 1, isolation of cells from the different regions of the meniscus 
showed wide variation. Specifically, the cell yield from the inner meniscus, 
regardless of digestion regimen, was higher than the yield from the outer region. 
Although the outer meniscus contained the highest concentration of cells (-34 
x106 cells/g tissue), isolation using the PIC protocol was able to extract less than 
20% of these cells. In contrast cell yield from the inner meniscus using the P/C 
protocol was similar to the expected native tissue cellularity. The reason for this 
difference needs further investigation, but could be due to higher GAG content in 
the inner meniscus facilitating digestion solution uptake and enzymatic action, or 
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insufficient release of cells from the outer region matrix increasing the viscosity of 
the isolation solution and impeding cell pelleting during centrifugation. To our 
knowledge, this disparity in cell yield from these two regions has not been 
reported previously. As the meniscus is wedge shaped, however, the relatively 
low cell yield from the outer region is mediated by the abundance of outer tissue 
compared with inner meniscus tissue. Because of this, the relative fractions of 
isolated meniscus cells from the outer and inner regions are likely similar to those 
observed in native tissue. The resulting distribution of cells from enzymatic 
isolation has implications for tissue engineering as meniscus cells from different 
regions show varying synthetic profiles, which affect the biochemical and 
mechanical properties of the engineered constructs they form. 
Interestingly, cell yield was found to be statistically higher using the P/C 
isolation regimen in all regions of the meniscus. This protocol involved 45 
minutes of pronase treatment followed by 3 hours of high collagenase (HC) 
treatment. Since the P/C treatment resulted in higher cell yield than the HC 
treatment, it follows that the introduction of pronase was necessary to achieve 
such a high cell yield. Although both trypsin and pronase are serine peptidases, 
they differ in substrate specificity, with pronase having a wider range of 
proteolytic activity than trypsin. In agreement with the present findings, previous 
reports comparing the efficacy of trypsin and pronase have reported more 
favorable tissue digestion with pronase, with digestion occurring more rapidly and 
the resulting cell solution containing fewer cell clumps.157• 158 As pronase is 
known to act on a wide variety of substrates, breaking proteins down into their 
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individual amino acids, it is likely that pre-treatment of meniscus tissue with this 
enzyme increases tissue permeability and allows the following collagenase 
enzyme better access to collagen molecules throughout the tissue. The high cell 
yield resulting from the P/C isolation protocol represents a vast improvement 
over other common digestion methods, and may be applicable to other 
fibrocartilaginous or fibrous tissues such as the temporomandibular joint disc or 
tendons. More studies are needed, however, to optimize the concentrations and 
application times of pronase and collagenase to minimize cell death and 
maximize efficiency of cell isolation. 
Additionally, no other combinatorial treatment with HC (T/C, H/C, or 
HIT/C) resulted in the same increase in cell yield, indicating that the present 
pronase application acts differently on meniscus tissue than either hyaluronidase 
or trypsin. Compared with trypsin and pronase, hyaluronidase is known to have 
higher substrate specificity, concentrating primarily on the hyaluronan 
molecule.159· 160 It has also been reported that specificity of this enzyme to 
hyaluronan is dependent on molecular weight, with more cleavage occurring on 
high molecular weight molecules.160 While this enzyme may be effective for 
digestion of GAG-rich tissue such as articular cartilage, the meniscus contains 
relatively little GAG, limiting the efficacy of hyaluronan for meniscus cell 
isolation. 52• 136 
As hypothesized, phenotypic changes in isolated meniscus cells were 
observed in all regions. Although a general upregulation of cartilage specific 
genes was noted in all isolated cells compared with native tissue, gene 
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expression was found to be altered differently in isolated outer, middle, and inner 
meniscus cells. This variation in phenotypic response based on meniscus 
regions corresponds to the known differences in native meniscus cell morphology 
and phenotype. 38• 53 Specifically, outer meniscus cells showed the highest 
upregulation in Sox9 and Col 1 expression, middle cells in Col 1 expression, and 
inner cells in Col 2 expression. Outer and middle meniscus cells, therefore, show 
similar phenotypic changes in response to tissue digestion, and the gene most 
affected (Col 1) also corresponds to the most abundant extracellular matrix 
(ECM) protein, collagen type I, in these regions. Similarly, increased inner 
meniscus cell expression of Col 2 also corresponds to the most abundant 
collagen protein found in the inner region.9· 29· 52 These results suggest that, upon 
liberation from their resident ECM, meniscus cells respond by upregulating genes 
commensurate with restoring their native environment. This behavior is different 
than that observed in freshly isolated articular chondrocytes, in which gene 
expression of collagen type II and aggrecan was unaffected or decreased 
following tissue digestion, providing more evidence of the distinction between 
articular chondrocytes and meniscus cells.29 The general upregulation of 
cartilage-specific genes in meniscus cells isolated from native tissue may 
indicate that isolation of these cells stimulates them to produce cartilage matrix 
components during in vitro culture or tissue engineering. 
The PIC protocol proved to be an efficient mode of extracting meniscus 
which had higher viability than LC isolated cells. Cytotoxicity analyses on cells 
isolated using LC and PIC protocols revealed fewer dead cells in the P/C isolated 
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population in both phase 1 and phase 2. As cell viability following isolation of 
meniscus cells is rarely reported in the literature, it is difficult to compare these 
results to published data. While the mechanism by which P/C isolation preserved 
cell viability is unknown, it may be related to the relatively short digestion regimen 
of the PIC protocol relative to the LC protocol. Regardless of the mechanism, 
however, the increased cell viability observed in P/C isolated cells is an attractive 
property for use of these cells in tissue engineering. 
In addition to increased viability, isolated P/C cells also showed more 
promising biochemical and mechanical properties when used in a tissue 
engineering modality. In phase 2, tissue engineering showed increased GAG 
content and compressive properties in constructs formed from PIC isolated cells 
compared with constructs formed from LC cells. However, LC constructs were 
also significantly thicker than their P/C counterparts. This difference in thickness 
may be attributed to the characteristics of the cell solution seeded. The LC 
protocol resulted in a much more viscous cell solution than the PIC protocol, 
perhaps due to the presence of higher molecular weight digestion fragments in 
the LC isolate. In contrast, the PIC isolated cells settled to the bottom of the 
agarose well readily, which may have aided cell-cell contacts and subsequent 
protein synthesis, as has been theorized to be important in self-assembled 
articular chondrocyte constructs. 161 Further, the higher compressive properties of 
P/C constructs relative to LC constructs may be related to the increased GAG 
content of P/C constructs compared to LC constructs as GAGs are known to be 
important for maintaining compressive properties in tissue such as articular 
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cartilage. 162• 163 The P/C cells, therefore, appeared to be more active in the self-
assembling process than LC cells. 
In summary, the P/C isolation regimen resulted in 1) higher cell yield from 
all meniscus regions than other protocols tested, 2) higher cell viability than cells 
isolated using the LC protocol, and 3) cells that produced tissue-engineered 
constructs with higher GAG content and compressive properties than the LC 
regimen. Therefore, the P/C meniscus cell isolation method is an efficient way to 
harvest meniscus cells, regardless of region, with relatively low cytotoxicity. This 
method can be widely applicable to tissue engineering strategies using a variety 
of fibrocartilaginous or fibrous tissues. However, more studies are warranted to 
identify the optimal concentrations and durations of pronase/collagenase tissue 
digestion. 
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T bl 1 Q ftaf RT PCR f\ d d a e . uan 1 1ve - orwar an reverse pr1mers . 
Gene Forward Primer Reverse Primer Target Accession Ref. (5'-3') (5'-3') (bp) Number 
18SrRNA CAAATTACCCACTCCCGACCC AATGGATCCTCGCGGAAGG 114 DQ066896.1 164 
SOX9 ACGCCGAGCTCAGCAAGA CACGAACGGCCGCTTCT 71 AF278708 165 
Coil CATTAGGGGTCACAATGGTC TGGAGTTCCATTTTCACCAG 97 NM_174520 166 
Col2 AACGGTGGCTTCCACTTC GCAGGAAGGTCATCTGGA 69 X02420 166 
COMP TCAGAAGAGCAACGCAGAC TCTTGGTCGCTGTCACAA 72 X74326 102 
AGC GCTACCCTGACCCTTCATC AAGCTTTCTGGGATGTCCAC 76 U76615 166 
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Figure 1: Cell yield from different meniscus regions using six isolation 
methods. The number of cells per gram of tissue was determined for each 
isolation regimen in each radial region of the meniscus. For comparison, native 
tissue average cellularity is depicted for each meniscus region (dashed lines). 
Overall, cell yield from the inner region was highest, followed by the middle and 
outer regions, respectively. Amongst the isolation regimens, the 
pronase/collagenase (PIC) treatment resulted in the highest overall cell yield 
from all regions. Results were analyzed using a 2-way ANOVA, with significance 
set at p < 0.05. Groups not connected by the same letter are statistically different. 
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Figure 2: Total and necrotic cells from different meniscus regions using 
two isolation methods. Fluorescent staining of cell nuclei and indicators of cell 
necrosis for low collagenase (A) and pronase/collagenase (B) isolated cells. 
Cells isolated using the pronase/collagenase method displayed fewer necrotic 
cells than those isolated using the low collagenase protocol. 
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Figure 3: Gene expression of meniscus cells in response to isolation. 
Outer (A), middle (B), and inner (C) meniscus cells were isolated from native 
tissue (NT), or subjected to one of 6 isolation regimens: low collagenase (LC), 
high collagenase (HC), pronase/collagenase (P/C), trypsin/collagenase (T/C), 
hyaluronidase/collagenase (H/C), or hyaluronidase/trypsin/ collagenase (HIT/C). 
Gene expression levels were normalized to native tissue values for Sox9, 
collagen type I, collagen type II, COMP, and aggrecan. Results for each cell type 
were analyzed using a 2-way ANOVA, p < 0.05. Groups not connected by the 
same letter are statistically different. 
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Figure 4: Phase 2 cell yield and live-dead analysis. Cells from whole medial 
menisci were isolated using the low collagenase (LC) and pronase/collagenase 
(PIC) protocols from phase 1. Cell yield was higher for the pronase/collagenase 
method (A). Live-dead staining of the resultant isolated cells showed more dead 
cells relative to live cells in the LC isolated population compared with the P/C 
isolated cells. Quantitative data were analyzed using a Student's t-test, with 
significance set at p < 0.05. Groups not connected by the same letter are 
statistically different. 
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Figure 5: Phase 2 gross morphology, biochemistry, and compressive 
mechanics. Self-assembled constructs were formed using cells isolated by the 
low collagenase or pronase/collagenase methods (A). LC constructs were 
significantly thicker than P/C constructs, however construct diameter was not 
different between groups. Biochemical analysis of GAG and collagen content (B 
and D, respectively) showed increased GAG content per cell in the PIC 
constructs, but no difference in collagen content between groups. P/C constructs 
showed higher modulus of relaxation (Er) and instantaneous modulus (Ei) 
compared to LC constructs when subjected to unconfined compression stress-
relaxation at 20% strain (C). Student's t-tests were performed on each data set, 
with significance set at p < 0.05. Groups not connected by the same letter are 
statistically different. 
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Chapter 6: Pathophysiology of the Knee Meniscus and 
the Need for Tissue Engineering 
Section 6.1: Pathophysiology and injury 
Meniscus pathology 
The normal meniscus, as discussed previously, is composed of medial 
and lateral semilunar, wedge-shaped structures. Various deviations from this 
normal morphology can occur through abnormal development, disease, 
degeneration, or traumatic injury. Most commonly, abnormal development results 
in a discoid meniscus, in which the inner portion of the meniscus extends and the 
tissue is disc-like in shape. This most often afflicts the lateral meniscus and can 
be complete, in which the meniscus covers almost the entire articulating surface, 
or incomplete, covering more surface area than normal (see Figure 1). The 
incidence of discoid abnormality is unclear, but population estimates range from 
0.4-5%.167• 168 Though many cases are thought to be asymptomatic and 
therefore undiagnosed, some discoid menisci can cause locking of the knee and 
general knee pain.168 
The meniscus may also be affected by metabolic disease, degeneration, 
and traumatic injury. Metabolic diseases including calcium pyrophosphate crystal 
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deposition, hemochromatosis, and ochronosis, can cause calcification, gross 
discoloration, and interference with the overall consistency of the tissue.169• 170 
These disorders heavily compromise the functionality of the meniscus, but 
cannot be treated locally as they are due to systemic changes in the body. Other 
types of disorders, such as degeneration and trauma, afflict the meniscus more 
specifically allowing clinicians to focus treatment on the meniscus itself. 
Osteoarthritis and meniscal degeneration 
Little is known about the causes of meniscal degeneration, however with 
degeneration the meniscus becomes more prone to injury.171 • 172 Osteoarthritis 
can cause widespread degenerative changes in the meniscus as well as the 
surrounding hyaline cartilage, and has been implicated in meniscal injury. While 
in the early 1980's meniscus pathology was found to be weakly correlated with 
osteoarthritis, researchers have more recently identified meniscal injury in around 
75% of patients with symptomatic osteoarthritis. 173-175 
Osteoarthritis affects the meniscus in multiple ways, resulting in 
compromised tissue functionality. This disease is known to affect the geometry of 
the meniscus, causing thickening of the medial posterior and lateral anterior 
horns, which may in turn affect the biomechanics of the meniscus making it more 
prone to injury.176 Osteoarthritic changes in the biochemical makeup of the 
meniscus may also play a role, as induced osteoarthritis in dogs causes an 
increase in meniscal water content and changes in GAG content and type over 
time.177 This disease may also be associated with calcification of the meniscus, 
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but causality has yet to be confirmed. 171 It has also been shown that severe 
osteoarthritis causes medial joint space narrowing as the medial meniscus 
displaces radially, which acts to preserve the tissue at the horns slightly, but 
overall functionality of the tissue is lost and widespread meniscal degeneration is 
apparent.178 Therefore, osteoarthritic degeneration can be an important 
contributor to meniscal injuries. 
Tears of the meniscus 
Various types of meniscal tears can occur as a result of degeneration 
and/or trauma. There are four main types of meniscal tears: vertical longitudinal, 
oblique, radial, and horizontal (see Figure 2).4• 179 Additionally, there are 
degenerative (complex) tears which describe an overall fraying of the inner 
meniscal edge consisting of many different types of tears. The vertical 
longitudinal tear occurs when the meniscus is split along a circumferential line. 
These tears can either span the entire thickness of the meniscus vertically (called 
a bucket-handle tear), or only a portion of it.4• 180 When a bucket-handle tear 
occurs, the inner portion of the meniscus is free to intrude into the joint space, 
causing mechanical opposition to joint movement. The length of vertical 
. 
longitudinal tears ranges from less than 1 mm to almost the entire circumference 
of the tissue.4 Oblique tears are also vertical in nature but extend inward from the 
inner meniscus in a slanted fashion.4 These tears are often referred to as parrot 
beak or flap tears because of their shape. The free end of this type of tear can 
catch within the joint, inhibiting joint movement. Radial tears are similar to oblique 
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tears but propagate radially, cleaving the circumferential collagen fibers.4 These 
tears often exist without any symptoms as their free ends are not as prone to 
catching within the joint space as other tear geometries. However, radial tears 
can be especially damaging to the overall function of the tissue if left to 
propagate. Horizontal tears cut the meniscus into superior and inferior parts. 
They begin in the inner portion of the meniscus and extend outward, and are 
often associated with the formation of fluid-filled cysts. 4 These types of tears are 
thought to be a result of shear forces within the joint and are more common in 
older patients.4 
Epidemiology of meniscus tears 
Meniscal tears compromise the overall structural integrity of the joint as 
well as present symptoms such as locking and catching of the knee, a sensation 
of giving way, and joint pain.4• 181 According to one study surveying 1000 patients, 
meniscus tears occurred more often in the right knee (56.5%).182 Of medial 
meniscus lesions, most (75%) were vertical longitudinal tears and 23% were 
horizontal tears. 182 In the lateral meniscus the tears are more diverse, with 54% 
being vertical longitudinal tears and the rest divided amongst oblique and 
complex pathologies.182 Overall, meniscal tears affect men more often than 
women, with 70-80% of meniscus tears occurring in men.4 Afflicted men are 
most often 21-30 years of age, whereas this pathology affects women most often 
between the ages of 11 and 20.4 Traumatic injuries also dominate in younger 
patients, while older patients are more prone to degenerative changes. 
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Meniscal health is heavily reliant on the ligamentous attachments of the 
knee. Joint laxity (instability of the joint) as a result of a ruptured ACL can have a 
profound effect on the meniscus as it has been estimated that the ACL 
contributes 85% to the restraint of anterior displacement of the femur. 183• 184 
Clinically, meniscal injuries are common in patients with torn ACLs, highlighting 
the co-dependence of the meniscus with surrounding ligaments for normal joint 
function.4• 185• 186 Non-linear finite element modeling of knee joints confirms this 
clinical finding, showing that without the ACL, the medial meniscus is subjected 
to higher loads from oo to 30° flexion. 187 Interestingly, though the biomechanics of 
the knee are altered by tearing an ACL, the types of tears that the meniscus 
endure are indistinguishable from those of an ACL-intact knee. 188 This evidence 
suggests that meniscus tears are more frequent when knee stability is 
compromised, and that meniscal tears follow certain patterns regardless of 
ligament health. 
Concepts 
Meniscal abnormalities such as the discoid meniscus may be benign or 
symptomatic, but are rare, estimated to afflict only as much as 5% of the 
population. Systemic diseases can change the pigment and consistency of 
knee meniscus tissue, but cannot be treated locally. Osteoarthritis is an 
important contributor to the overall health of the meniscus and has been 
implicated as a cause of meniscal tears and degeneration. The most common 
injury specific to the knee meniscus is a meniscus tear. Tears can be classified 
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into four different categories based on their geometry: vertical longitudinal, 
oblique, radial, and horizontal. The most common in both the medial and lateral 
menisci is the vertical longitudinal tear. Overall, men are affected by meniscus 
tears 70-80% more often than women, and are usually in their 20's when this 
occurs.4 Meniscus tears can come about through degenerative changes or 
trauma, degeneration being a catalyst in older ages. ACL tears significantly 
compromise knee stability and increase the likelihood of a meniscal tear. 
Section 6.2: The meniscus healing problem 
Introduction 
As the meniscus was originally thought to be a vestigial tissue and 
because surgery on it was difficult, early treatments (prior to the mid-1960s) for 
meniscal damage were limited to total removal of the tissue, called 
meniscectomy.189· 190 As early as 1948 it was shown that meniscectomy causes 
joint space narrowing, and many studies have subsequently shown that 
degenerative changes also occur following this procedure. 191-194 After more 
became known about the importance of the meniscus in load distribution and 
stability within the knee joint, treatments shifted to partial meniscectomy, surgical 
repair, or transplantation, which are still used today.3• 189• 195• 196 
Healing in the meniscus 
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Given that the meniscus is not a homogeneous tissue, it is particularly 
difficult for it to self-repair. While lesions or tears that occur in the outer periphery 
of the tissue can regenerate due to the high degree of vasculature there, damage 
to the inner non-vascularized portion of the tissue is unable to heal on its own.3• 4• 
12
• 
195
• 
197
-
199 Following injury in the vascular portion of the meniscus, the defect 
site is filled with a fibrin clot which uses proinflammatory factors to recruit blood 
vessels from the surrounding areas.199 After this initial response and depending 
on proximity to abundant blood vessels, fibrous scar tissue can take as little as 
10 weeks to form. 199· 200 After a few months, the scar tissue will then mature into 
tissue with inferior mechanical properties to the native meniscus.199 This timeline 
is extended with distance from the peripheral blood supply, and does not occur 
for injuries in the inner meniscus. For inner meniscus injuries, some 
reorganization of the matrix may occur due to the changed mechanical 
environment, but a healing response is absent.201 · 202 Some research has 
focused on creating vascular access channels from the outer to the inner 
meniscus to allow healing factors from the blood to reach the damaged white 
zone, which has helped heal longitudinal tears in the avascular region of dogs 
and goats, and has reduced symptoms in patients.203-206 As a result, proximity to 
blood vessels is the best predictor of a meniscal healing response, but the type 
of healing that takes place does not restore tissue functionality. 
Characteristics of repair tissue 
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Though the outer portion of the meniscus may heal to some degree, the 
new tissue is quite different from native tissue. Repair tissue in the outer portion 
of the meniscus is distinct from normal meniscal tissue in that it may contain 
calcified regions, cysts, unattached collagen fragments, and pools of 
proteoglycans.28 This is in stark contrast to normal tissue in which the collagen 
matrix is highly aligned with proteoglycans throughout and no calcification or void 
spaces. In torn menisci it is twice as common for the tissue to become calcified 
over time, and this is often found in conjunction with osteoarthritis.207 Apoptosis is 
also increased 2-fold in tissue having undergone traumatic injury or degeneration 
as compared to normal tissue.208 
Functionally, meniscal repair tissue is weaker than normal tissue. 
Meniscal repair tissue in rabbits has been measured to require around 75% less 
energy (0.8-0.9 mJ) to fail than normal tissue at 12 weeks post-injury.2°9 The 
strength of this tissue increases only marginally with the use of sutures or fibrin 
glue to hold the torn edges together, and does not reach normal values.209 
Therefore, even in the region of the meniscus that undergoes some repair, the 
tissue is either lacking in quantity or insufficient in strength and there is an 
inhibitory environment for new tissue formation. This evidence points to the need 
for tissue engineering to develop technologies to heal meniscal injuries and 
prevent calcification or apoptosis from taking place. 
Concepts 
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Meniscus tissue was originally thought to be vestigial, but upon further 
investigation it has proved to be an important part of normal knee function and 
maintenance of healthy tissue. Since this realization, preservation of meniscal 
tissue is a main priority for reparative therapies. The meniscus is able to heal on 
its own to a certain degree, but this only occurs when the defect site is in the 
outer periphery of the meniscus, near vasculature. Even after self-repair has 
taken place, the scar tissue formed requires 75% less energy to fail than native 
tissue and may contain calcification, pockets of proteoglycans, and unorganized 
collagen fibrils. This type of matrix therefore compromises the mechanical 
integrity of the meniscus as a whole, highlighting the need for tissue engineering 
to provide an alternative viable solution. 
Section 6.3: Tissue engineering and historical perspectives 
Definition of tissue engineering 
Tissue engineering strives to recreate the complex tissues of the body by 
harnessing biological processes. Using the classic tissue engineering paradigm 
(Figure 3), cells are seeded onto a scaffold and are subjected to biochemical 
and/or mechanical stimuli to create a tissue engineered construct ready for 
implantation. Recently, a new paradigm has emerged which is based on the 
ability of cells to self-assemble without the use of a scaffold, showing promising 
results in the field of cartilage regeneration.115· 210 Tissue from either paradigm 
may be used to repair damaged areas in the body permanently, thereby 
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eradicating the need for synthetic implantable prostheses that have a limited 
lifetime of service. This field is especially relevant to the meniscus, which has a 
limited reparative potential, and its complex biomechanical properties render 
synthetic replacement materials insufficient. 
Historical perspectives 
The first use of the term "tissue engineering" was by Y. C. Fung in 1985 in 
a proposal to the National Science Foundation for the creation of a tissue 
engineering facility.211 He presented the idea of tissue engineering as a field to 
bridge the gap between biology, which studies the single cell, and medicine, 
which is primarily concerned with the functioning of entire organs.211 Though his 
proposal was not accepted, the concept of tissue engineering surfaced again at 
many different symposia and meetings throughout the late 1980s, prompting 
much discussion and debate over the exact definition of the term?11 Beginning in 
the early 1990s, a steady increase in journal articles can be found containing the 
term "tissue engineering" indicating its acceptance and popularity throughout the 
scientific community.211 Also during this time many different centers for tissue 
engineering around the world were established, which continue to conduct 
advanced research in the field?12 Tissue engineering, though a relatively new 
concept, has quickly blossomed into a field with wide application and promise to 
fulfill Y. C. Fung's vision of bridging the gap between science and clinical 
implementation. 
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Functional tissue engineering and the meniscus 
As the field has progressed, so have the standards for success. 
Functional tissue engineering refers to the emerging effort to not only recreate 
the biochemical traits of a tissue, but also match native mechanical properties of 
load bearing tissues.213-217 To do this, researchers rely heavily on tissue 
characterization research, and use this information to hone in on the most 
important biochemical and mechanical properties of the tissues they are working 
to reproduce. For biomechanically active tissues, such as the knee meniscus, it 
is vital that these characteristics be recapitulated in the engineered version in 
order that it perform as native tissue and thus be a useful replacement in the 
body. 
Specifically of importance are the tensile and compressive properties of 
the knee meniscus as well as its geometry, biochemical content, and matrix 
molecule organization. Attempts at functional tissue engineering of the knee 
meniscus are ongoing, but key progress has been made in producing similar 
matrix proteins and geometry to the native tissue. 115· 116• 131 Unfortunately, many 
tissue engineering studies do not evaluate the mechanical properties of the 
constructs produced, making functional assessment and comparison to native 
tissue more difficult. Ideally all functional aspects of a tissue engineered 
construct should be tested, in order to better understand the potential of each 
engineering method. A more detailed discussion of the studies in meniscal tissue 
engineering ensues in chapter 9. 
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Concepts 
Tissue engineering is a multidisciplinary field which aims to recreate 
biological tissues using a combination of cells, scaffolds, and biochemical and 
mechanical stimuli. These tissues may then be used to replace or restore 
function to missing or damaged elements in the body. A relatively new field, 
tissue engineering efforts increased in the 1990s with the establishment of 
research centers around the world. Functional tissue engineering is especially 
important for the meniscus as it emphasizes mimicking not only tissue 
biochemistry, but also mechanical and geometric properties. Functional 
assessment of tissue engineered meniscal constructs is the next step in 
developing useful meniscal replacement tissue. 
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Figures 
Normal Incomplete discoid Complete discoid 
Figure 1: Discoid meniscus morphology. The normal meniscus is semi-lunar 
in shape, but abnormal development may result in a discoid meniscus. When the 
inner portion of the tissue covers more area than normal , it is deemed an 
incomplete discoid meniscus. A complete discoid morphology occurs when the 
inner portion covers nearly the entire articulating surface. 
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Figure 2: Types of meniscus tears. The normal meniscus (a) is smooth , 
wedge-shaped, and semi-circular. Complex (degenerative) tears (b) result in a 
jagged edge and combine many different types of tears. Oblique tears (c) and 
radial tears (d) typically propagate from the inner portion of the meniscus to its 
periphery. Horizontal tears (e) split the tissue into superior and inferior parts and 
also typically propagate outward. Vertical longitudinal tears (f and g) , split the 
meniscus along the direction of collagen orientation. When a vertical longitudinal 
tear passes through the tissue's thickness it is called a bucket-handle tear (g). 
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Figure 3: Tissue engineering paradigm. In the classical tissue engineering 
paradigm, cells combine with a scaffold and are subjected to a regimen of growth 
factors and/or mechanical stimulation . The resulting construct is then implanted 
into an animal model with the expectation that meniscus regeneration will ensue. 
A scaffoldless paradigm has recently emerged in which cells are seeded at a 
high density and are conditioned biochemically and/or biomechanically. 
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Chapter 7: lmmunogenicity of Bovine and Leporine 
Articular Chondrocytes and Meniscus Cells 
Abstract 
Acute immune rejection is a major concern for any allogeneic or 
xenogeneic graft. For in vivo investigations of cartilage tissue engineering 
strategies, small animal models, such as the leporine model, are commonly 
employed. Interestingly, many studies report little to no immune rejection upon 
allogeneic or xenogeneic implantation of native articular and meniscal cartilages. 
This study investigated whether bovine and leporine articular chondrocytes (ACs) 
and meniscus cells (MCs) display immunoprivileged characteristics in terms of 
their ability to stimulate proliferation of leporine peripheral blood mononuclear 
cells (PBMCs) in vitro. After six days of co-culture, none of the cell types caused 
a significant proliferative response in the leporine PBMCs, indicating that these 
cells may not elicit an acute immune rejection in vivo. RT-PCR analysis for MHC 
I, II, and co-stimulation factors CDBO and CD86 revealed that all cell types 
produced mRNA for MHC I and II, but only some were CDBO or CD86 positive, 
and none were positive for both co-stimulation factors. Flow cytometry for major 
histocompatibility complex II (MHC II) was also performed. Bovine MCs and ACs 
displayed MHC II positive populations (MCs: 32.51%, ACs: 14.44%) while only 
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leporine ACs were MHC II positive (7.53%). Despite some presence of MHC 11 
and co-stimulation factors, all of the cell types studied were unable to stimulate T 
cell proliferation. These findings indicate that bovine and leporine MCs and ACs 
share a similar immunoprivileged profile, bolstering their use as allogeneic and 
xenogeneic cell sources for engineered cartilage. 
Introduction 
Due to their lack of vasculature and relative acellularity, articular cartilage 
lining the ends of long bones and the hyaline-like cartilage of the inner meniscus 
have little capacity to self-repair following injury. Though tissue engineering 
strategies are being developed to address this problem, they often require the 
use of large numbers of primary cells. Donor site morbidity and the lack of 
available tissue render autologous techniques for cartilage tissue engineering 
prohibitive, so increasing focus has been on the development of allogeneic and 
xenogeneic approaches. A major concern with any allogeneic or xenogeneic 
implant is immune rejection, resulting in a breakdown of the implanted material 
overtime. 
Typically, an immune response to implanted tissue is triggered by T cell 
sensitization, followed by activation. Sensitization occurs when antigens 
presented on donor cells, specifically major histocompatibility complex classes I 
and II (MHC I & MHC II), are recognized by T-cell receptors (TCRs) CDS and 
CD4, respectively. T cells become activated when co-stimulatory binding of 
donor cell 87 antigens (CD80 or CD86) with T cell receptor CD28 happens 
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simultaneously, causing proliferation of the T cell and initiation of an immune 
response to destroy the foreign material.218-220 Therefore, the MHCs and 87 
antigens present on donor cells are important constituents involved in immune 
rejection of an implanted tissue engineered construct. 
Mounting evidence suggests, however, that cartilaginous tissues are 
immunoprivileged, thus causing little to no immune response when implanted. 
While the precise reasons for the immunoprivileged nature of cartilage tissue are 
not well understood, both cartilage cells and extracellular matrix (ECM) seem to 
play a role in inhibiting an immune reaction. Flow cytometry analysis of human 
and sheep articular chondrocytes has shown that these cells present MHC I 
antigens but not MHC II, CD80, or CD86. In addition to lacking some key 
immunogenic surface markers, these cells are unable to promote allogeneic T 
cell proliferation in vitro. 221 -223 Moreover, studies testing allogeneic (human and 
leporine) and xenogeneic (porcine to leporine and leporine to caprine) 
implantation of articular chondrocytes agree with these in vitro experiments, 
reporting that they produce little to no immune response.224-228 A comparison of 
literature results suggests that the degree of immune reaction to implanted 
cartilage material is inversely related to the amount of ECM it contains. This 
indicates that along with lacking critical surface markers involved with the 
induction of an immune response, cartilage ECM may shield immunogenic 
markers on chondrocytes from host T cells, enhancing the reparative capacity of 
these therapies. 228 
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Though little investigation has been made into the immunogenicity of 
meniscus cells, some evidence suggests that they may share a similar 
immunoprivileged profile to chondrocytes. When used to fill an articular cartilage 
defect in the leporine model, both allogeneic and xenogeneic (bovine) meniscus 
tissue failed to elicit a measureable immune response.227 Given these promising 
results, it is possible that the meniscus may provide an abundant cell source for 
allogeneic and xenogeneic tissue engineering strategies that avoids the concern 
for immune rejection. 
There are a variety of cartilage engineering strategies that could benefit 
from using an abundant allogeneic or xenogeneic cell source. One promising 
strategy used in cartilage and meniscus tissue engineering is the self-assembly 
method, where articular chondrocytes are seeded alone or in co-cultures with 
meniscus cells to produce functional articular cartilage and fibrocartilage 
replacements. 76• 130· 131 • 210• 229 Though these self-assembled constructs show 
great promise biochemically and biomechanically, the potential immunogenicity 
of these highly cellular constructs in an allogeneic or xenogeneic animal model is 
unknown. Therefore, this study investigates the immunogenicity of bovine and 
leporine articular chondrocytes and meniscus cells in a rabbit model. 
lmmunogenicity is determined by the ability of cartilaginous cells to induce 
proliferation of leporine peripheral blood mononuclear cells (PBMCs) in a mixed 
lymphocyte reaction (MLR) test. In addition, the presence of MHC II is assessed 
using flow cytometry, and RT-PCR is performed to detect MHC I, MHC II, CD80, 
and CD86 mRNA. It is hypothesized that both of these cell types have an 
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immunoprivileged profile, lacking the ability to induce PBMC proliferation and not 
expressing key factors for immune response initiation, MHC II, CD80 and CD86. 
Methods 
Isolation of cartilaginous cells 
Both bovine and leporine cells were obtained as previously described. 130• 
230 Briefly, cartilage and meniscus tissue was sterilely dissected from the knee 
joint and minced into small pieces. After an 18 hr digestion in 0.2% collagenase 
(Worthington), cells were isolated with sequential centrifugation and rinses with 
PBS. Cells were then cryopreserved in media containing 20% fetal bovine serum 
(Gemini Bio-Products) and 10% dimethyl sulfoxide (Sigma) until needed. 
Previously, primary bovine ACs and MCs have been used to form self-
assembled constructs, so no further steps were needed to prepare these cells. 
However, when leporine cells are used to generate self-assembled constructs, 
they are expanded in monolayer culture. The leporine cells used for subsequent 
MLR assessment were expanded to test the immunogenicity of the population of 
leporine cells previously employed for self-assembly. This expansion protocol 
has been described in detail elsewhere?30 Briefly, leporine ACs and MCs were 
separately expanded in a cell culture media consisting of DMEM with 4.5 giL-
glucose and GlutaMAX (Invitrogen), 100 nM dexamethasone, 1% fungizone, 1% 
penicillin/streptomycin (BD Biosciences), 1% ITS+ premix (BD), 50 mg/ml 
ascorbate-2-phosphate, 40 mg/ml L-proline, 100 mg/ml sodium pyruvate 
(Fisher Scientific), and 5 ng/ml basic fibroblastic growth factor. Cells were 
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seeded at a density of 2.5 x 104 cells/cm2 and allowed to grow until 4 days 
passed from when confluence was reached. Expansion proceeded until passage 
3 was reached. 
Mixed Lymphocyte Reaction 
The mixed lymphocyte reaction test was based on a protocol described 
previously.231 Bovine and leporine ACs and MCs were treated with 25 J.Jg/ml 
mitomycin-C (Sigma) for 45 minutes and then mitomycin was removed by 3 
media rinses with centrifugation between each. Leporine PBMCs (Rockland 
lmmunochemicals) were mixed with the each of the 4 cartilaginous cell types to 
obtain 2 cell solutions each, that per 100 JJL contained: 1) 103 cartilaginous cells 
+ 105 PBMCs and 2) 104 cartilaginous cells + 105 PBMCs. Into a well on a 96-well 
plate, 100 JJL of the cell solutions were dispensed. In addition, control groups 
(cartilaginous cells at either 103 or 104 cells per well) corresponding to each of 
the MLR groups were seeded. As a positive control, concanavalin A (Sigma) was 
added to 105 PBMCs at a concentration of 12.5 J.Jg/ml and this mixture was 
seeded into wells of a 96-well plate. Negative controls consisted of 105 PBMCs 
seeded with or without mitomycin pre-treatment. In all this generated 8 groups of 
MLR assays, 8 control groups without PBMCs corresponding to the MLR groups, 
a positive PBMC control (with concanavalin), 2 negative PBMC controls (cells 
only and cells with mitomycin pretreatment). For each of the 19 groups, 5 
replicates were employed. 
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Following a 6 day culture, plates were centrifuged to pellet all non-
adherent cells and trypsin-EDTA (Invitrogen) was applied for 15 minutes to 
ensure all adherent cells entered into solution. After removal of trypsin via 
centrifugation and rinsing, plates containing the cell solution were subjected to 3 
freeze-thaw cycles to ensure cell lysis. Aliquots from each well were tested in 
triplicate for DNA content using the PicoGreen® dsDNA reagent (Invitrogen) and 
dsDNA controls. The amount of DNA was converted to cell number using a 
conversion factor of 7.8 pg DNA/cell. 
RT-PCR 
RNA was extracted from bovine ACs and MCs, leporine passage 3 ACs and 
MCs, and bovine and leporine PBMCs {positive controls) using an RNaqueous 
Micro Kit (Ambion, Carlsbad, CA). The extracted RNA was then reverse 
transcribed to eDNA using Superscript Ill First Strand Synthesis System 
(Invitrogen, Carlsbad, CA). PCR was run on the resulting eDNA to determine if 
the following transcripts were present: MHC I, MHC II, COSO, and CD86. 
Additionally, amplification of GAPDH for bovine cells and 13-actin for leporine cells 
served as positive controls. All PCR was performed on a RotorGene 6000 
[Corbette Life Sciences, Valencia, CA], using Platinum PCR Supermix [11306-
016, Invitrogen] and run using the following thermal cycling protocol: 94°C 2 min, 
40x(94°C 15 sec, [annealing temperature] 30 sec, 72°C 60 sec). Reactions were 
visualized by gel electrophoresis with gel green dye (Biotium, Hayward, CA). The 
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specific primers, target lengths, and annealing temperatures were determined 
from the literature166' 232-235 and are outlined in Table 1. 
Flow Cytometry 
Bovine ACs and MCs, leporine passage 3 ACs and MCs, and bovine and 
leporine PBMCs (positive controls) were analyzed using flow cytometry to 
determine the presence of immunogenic antigen MHC II. Cells were first blocked 
with 5% goat serum in PBS for 30 minutes, then incubated with mouse an anti-
MHC II primary antibody (VMRD) or mouse anti-lgG2a isotype control 
(Invitrogen) for 30 minutes and were washed with 1% BSA (Sigma) and 0.1% 
sodium azide (Sigma) in PBS. The cells were then stained with GtxMs lgG 
phycoerythrin-conjugated secondary antibody (Abeam) for 20 minutes, washed, 
and resuspended in 1% paraformaldehyde in PBS (Sigma). Following incubation 
at 4°C for 24 hours, cells were analyzed for presence of MHC II using a 
FACScan flow cytometer (BD Biosciences). Up to 105 cells were recorded for 
each group and forward scatter (FSC), side scatter (SSC), and fluorescence 
channel 2 (FL2) were recorded using CeiiQuest software. Cyflogic software was 
used to analyze the generated flow cytometry files. The cell populations of 
interest were identified by gating FSC versus SSC plots, fluorescence histograms 
of the isotype control and MHC II stained cells were created using the cell 
population of interest. Positive staining for each marker was represented as the 
percentage of the curve exceeding the fluorescence value at 95% of the isotype 
control curve. 
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Statistics 
Following subtraction of control group cellularity from their corresponding 
MLR assay group, the number of PBMCs in each group was compared to the 
number of cells in the PBMC only group with a t-test. Significant differences were 
defined as p<O.OS. 
Results 
Mixed Lymphocyte Reaction 
The results of the cell number analysis of the MLR assay are shown in 
Figure 1. Total cell numbers from the control groups containing only mitomycin-
treated cartilaginous cells were subtracted from their corresponding group in 
which mitomycin-treated cartilaginous cells were co-cultured with PBMCs. No 
statistically significant differences (p < 0.05) were observed between the co-
culture groups and the PBMC-only control. A significant increase in cell number 
was noted when the concanavalin-treated PBMCs were compared to the PBMC-
only controls. A small amount of base-line proliferation was observed when 
comparing mitomycin-treated PBMCs to PBMC-only controls. 
RT-PCR 
RT-PCR analysis of bovine PBMCs, ACs, and MCs revealed positive 
expression of GAPDH, MHC I, and MHC II. Bovine PBMCs also expressed CD80 
and CD86, while bovine ACs did not express either costimulatory molecule, and 
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bovine MCs expressed only CD86 (Figure 2). Analysis of leporine PBMCs, ACs, 
and MCs was similar to that of the bovine cells in that all cell types showed 
positive expression of ~-actin, MHC I, and MHC II, and leporine PBMCs also 
expressed CD80 and CD86. Leporine ACs and MCs both showed positive 
expression of CD80, but not CD86. 
Flow cytometry 
Flow cytometric analysis of MHC II on bovine and leporine MCs and ACs 
revealed that this marker is present on all cells studied except for leporine MCs. 
As seen in Figure 3, both types of bovine cells stained positively for MHC II. 
Bovine articular chondrocytes were 14.44% MHC II positive. Bovine MCs, when 
stained for MHC II, displayed a bimodal distribution of fluorescence. These cells 
displayed slightly higher expression for MHC II (32.51 %), than bovine ACs. For 
leporine cells (Figure 3), ACs showed some positive staining for MHC II (7.53%), 
while leporine MCs showed no positive staining for MHC II. All leporine 
fluorescence histograms were normally distributed, and no bimodal phenomena 
were observed. 
Discussion 
Assessment of the potential for immune response is a critical step in 
selecting a cell source for tissue engineering. While allogeneic sources have 
been commonly applied for in vivo studies of cartilaginous tissue replacement, 
the use of xenogeneic sources is less common.224-228• 236 However, the available 
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data indicate that xenogeneic cell sources may be applied in cartilage and 
meniscal tissue engineering because of the immunoprivileged nature of these 
cells.224-228• 236 The benefits of applying a xenogeneic cell source for cartilage 
engineering are significant. Concerns of donor-site morbidity and difficulties 
associated with obtaining a sufficient number of cells required for tissue 
engineering efforts such as high-density scaffold-free cartilage formation can be 
mediated using a xenogeneic approach. Toward this end, this study sought to 
test in vitro whether allogeneic (leporine) or xenogeneic (bovine) meniscus cells 
and articular chondrocytes show non-immunogenic characteristics when 
introduced to leporine lymphocytes. The major hypothesis of this study that 
neither leporine nor bovine ACs or MCs would induce an in vitro immune 
response by leporine PBMCs was proven. This suggests that the functionality of 
bovine cell-based constructs can be assessed in a leporine in vivo model, without 
the concern for immune rejection. 
In agreement with previous results assessing the immune reaction 
following allogeneic or xenogeneic implantation of articular or meniscal cartilage, 
none of the cartilaginous cells in this study induced proliferation of PBMCs. 227• 228 
Previous studies on the immunogenicity of cartilaginous cells have linked this 
lack of immunogenicity to the absence of cell surface markers required for 
promoting an immune response, including MHC II and co-stimulation factors of 
the 87 family. 221 -223 The present study, however, confirmed the presence of 
MHC II and co-stimulation factors CDBO and CD86 in bovine and leporine ACs 
and MCs using PCR and flow cytometry. All of the cell types studied showed the 
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presence of mRNA for at least some of the immunogenic markers studied. MHC 
II mRNA was found in all cell types, while COSO mRNA was present in leporine 
cells, and CD86 mRNA was only found in bovine MCs. Further, translation of the 
MHC II mRNA was confirmed by flow cytometric analysis, which showed that 
bovine MCs and ACs, and leporine ACs do express this marker to some degree. 
As MHC class II molecules are traditionally associated with professional 
antigen presenting cells (APC) such as macrophages, dendritic cells, and 8 cells, 
the presence of MHC II in the cartilaginous cells examined in this study may 
appear counterintuitive. While cartilage-derived cells are not typically thought of 
as APCs, researchers have discovered that chondrocytes possess the potential 
to obtain properties of APCs.223• 237• 238 In particular, chondrocytes isolated from 
arthritic joints have been shown to possess higher amounts of MHC class II 
molecules and are more immune-reactive when used in an MLR assay than 
chondrocytes from healthy joints?37-240 While the cells employed in this study 
were not isolated from arthritic joints, it is possible that the insult due to 
enzymatic digestion of the cartilage matrix induced the cells to transition to a 
phenotype more amenable to antigen presentation. In support of this claim, other 
researchers have discovered that MHC II is present in isolated chondrocytes 
while absent in intact, healthy cartilage.223• 240-242 Overall, the results of this study 
are in accord with previous studies demonstrating the presence of MHC II on 
chondrocytes isolated from healthy cartilage. 
In contrast to articular chondrocytes, few accounts exist regarding the 
presence of MHC class II molecules on cells isolated from the meniscus. Prior to 
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this investigation the presence of MHC class II had not been analyzed for 
isolated meniscus cells. However, researchers have stained native human and 
ovine meniscus tissue for MHC class II and found that meniscus cells do not 
express MHC class II but synovial and endothelial cells within the meniscus 
do.243-245 In context with native tissue investigations, the results from the present 
study suggest that meniscus tissue may be similar to articular cartilage where 
MHC class II is not present on cells in situ, but upon isolation MHC II expression 
is enhanced. 
Along with expressing MHC I and II, some of these cells also showed 
mRNA expression of 87 family co-stimulation factors, though none of the cell 
types showed expression of both CD80 and CD86. The presence of 87 mRNA 
indicates that some of the cell types studied have the molecular machinery to 
stimulate T-cells, but, when exposed to T-cells, fail to initiate a proliferative 
response. This suggests that either 1) these cells are unable to induce an 
immune response due to a lack of 87 family cofactors required to activate T-cells 
or 2) a factor produced by the cartilage cells is actively quenching immune 
response. Co-stimulatory molecules CD80 and CD86 are known to be necessary 
for the effective priming and activation ofT-cells, and seem to act on the T-cells 
through distinct mechanisms.246-252 Regarding cartilaginous cells, Adkisson et 
al. 221 showed absence of co-stimulatory molecules on juvenile human articular 
chondrocytes, which is in agreement with the present results for bovine ACs. The 
absence of co-stimulatory molecule transcripts in bovine ACs may explain their 
inability to stimulate xenogeneic T -cells. Bovine MCs and leporine ACs and MCs, 
189 
however, showed gene expression for either CD80 or CD86, yet still failed to 
elicit T-cell activation. One possible explanation for this phenomenon is that 
though mRNA for these proteins is present, there may be some regulatory 
mechanism inside the cell inhibiting translation of these mRNAs into functional 
co-stimulatory proteins. 
It is also possible that these cells are actively producing factors that 
suppress an immune response. There are a number of molecules known to 
inhibit T-cell activation such as negative co-stimulators in the 87 family, and 
Chondromodulin-1, an immunosuppressive factor, that juvenile and adult articular 
chondrocytes have been shown to produce.236• 253 Another factor produced by 
chondrocytes is transforming growth factor~ (TGF- ~).which has been shown to 
be a potent inhibitor of T-cell activation in studies using chondrocytes and 
mesenchymal stem cells. 223• 254-256 Thus, it is possible that the lack of P8MC 
proliferation in co-culture with leporine and bovine ACs and MCs can be 
explained by an absence of 87 cofactors due to lack of transcription or 
translation in the cell, or by the production of an immune response inhibitor by 
the cells. 
Given that some of these cell types express co-stimulation factors, future 
studies are needed to investigate the soluble factors produced by cartilaginous 
cells that could inhibit an immune response. However, since the present results 
indicate that neither bovine nor leporine MCs or ACs stimulate leporine P8MC 
proliferation, it is likely that engineered cartilage constructs using these cells may 
be implanted into a leporine model without concern for immune rejection. 
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Conclusions 
Overall, this study shows that it is unlikely that the use of tissue 
engineered cartilaginous constructs formed from either leporine or bovine ACs or 
MCs will elicit an immune response when implanted into the leporine knee. This 
opens the door for a plethora of cell types to be evaluated for in vivo 
assessments in animal models. Further, it suggests that xenogeneic 
transplantation into humans could be a possibility if the presence of alpha-
galactosyl of tissues generated from animal cells can be eliminated. 
191 
Tables 
T bl 1 8 a e . ovme an eporme 
-
r1mers . dl RT PCR P. 
Target Accession Species Gene 5'-3' Forward Primer 5'-3' Reverse Primer Length Number (bp) 
GAPOH ACCCTCAAGATTGTCAGCAA ACGATGCCAAAGTGGTCA S6 US5042 
MHCI GGCTCCCACTCCCTGAGGTATTTC TCTCCAGGTATCTGCGGAGCC 534 XS2672 & XS2673 
Bovine MHCII GGAAGAAGGAGACGGTGT CAGGAAGACCGTCTGTGA 305 X7S30S 
coso TGTGGCCTGAATACAAGAACC CAGGTGCTGATTAGCAGAAGG 4SS Y09950 
COS6 GACCTTGAGACTCCACAACG GTAGAGCTGCAATCCAGAGG 534 AJ291475 
a-actin CGTGCGGGACATCAAGGA AGGAAGGAGGGCTGGAACA 177 AF309S19.1 
MHCI CGACTACATCGCCCTGAACG CCCAGAAGGCACCACCACA 394 K02441.1 
Leporine MHCII GGAGCACTGGGGCCTGGAGA GCACCACCTGAGCGCAGTCC 421 M15557.1 
coso TGCGCATATACTGGCAGAAG TTCTCCATCTTCCATCCAGG 356 NM 0010S2663.1 
COS6 TGACCAGGAAAGTTGGAACC ACACACAACGATCAGGGTGA 517 NM 0010S220S.1 
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Figure 1. Results of mixed lymphocyte reaction assay. Following subtraction 
of the control cartilaginous cell-only group, the average number of PBMCs 
present in each group is compared to the PBMC-only group. Significant 
differences are defined as p<0.05 and denoted with an asterisk (*) . 
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Figure 2. RT-PCR analysis of bovine and leporine PBMCs, ACs, and MCs. 
RT-PCR of bovine (a) and leporine (b) PBMCs (positive control) , MCs, and ACs. 
All bovine and leporine cell types express MHC I and MHC II mRNA, while CD80 
is only expressed in bovine PBMCs and leporine PBMCs, ACs, and MCs. CD86 
is expressed in both bovine and leporine PBMCs, but only in one other cell type, 
bovine MCs. 
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Figure 3. Flow cytometry for MHC II. Histograms of relative cell count versus 
fluorescence for isotype control and anti-MHC II staining for leporine and bovine 
ACs, and MCs. Percentages indicate the number of cells with fluorescence 
values greater than 95%> of the isotype control. 
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Chapter 8: Regional variation in the mechanical role of 
knee meniscus glycosaminoglycans 
Abstract 
High compressive properties of cartilaginous tissues are commonly 
attributed to the sulfated glycosaminoglycan (GAG) fraction of the extracellular 
matrix (ECM), but this relationship has not been directly measured in the knee 
meniscus, which shows regional variation in GAG content. In this study, biopsies 
from each meniscus region (outer, middle, and inner) were either subjected to 
chondroitinase ABC (CABC) to remove all sulfated GAGs or not. Compressive 
testing revealed that GAG-depletion in the inner and middle meniscus regions 
caused a significant decrease in modulus of relaxation (58% and 41% 
decreases, respectively, at 20% strain), and all regions exhibited a significant 
decrease in viscosity (outer: 29%, middle: 58%, inner: 62% decrease). Tensile 
properties following CABC treatment were unaffected for outer and middle 
meniscus specimens, but the inner meniscus displayed significant increases in 
Young's modulus (41% increase) and ultimate tensile stress (40% increase) 
following GAG depletion. These findings suggest that in the outer meniscus 
GAGs contribute to increasing tissue viscosity, while in the middle and inner 
meniscus, where GAGs are most abundant, these molecules also enhance the 
tissue's ability to withstand compressive loads. GAGs in the inner meniscus also 
Chapter under review as: Sanchez-Adams, J., Willard, V.P., and Athanasiou, 
K.A. "Regional variation in the mechanical role of knee meniscus 
glycosaminoglycans." Journal of Applied Physiology. 
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contribute to reducing the circumferential tensile properties of the tissue, perhaps 
due to the pre-stress on the collagen network from increased hydration of the 
ECM. Understanding the mechanical role of GAGs in each region of the knee 
meniscus is important for understanding meniscus structure-function 
relationships and creating design criteria for functional meniscus tissue 
engineering efforts. 
Introduction 
Functioning under shear, compression, and tension, the knee meniscus 
relies on the complex organization of its biochemical constituents to distribute 
load and absorb shock in the joint. The meniscus bears between 45% and 75% 
of knee joint loads which are estimated to be 2.7-4.9 times body weight while 
walking.21 · 22 Unfortunately, the knee meniscus is prone to tears and 
degeneration which are unable to heal effectively in the outer and middle portions 
of the tissue. These injuries are especially devastating in the inner, non-
vascularized portion, where a healing response is absent.3· 4· 12· 195· 197-199 Tissue 
engineering efforts seek to address this problem by creating functional meniscus 
tissue for replacement. A complete understanding of the structure-function 
relationships that exist in the knee meniscus can help advance these tissue 
engineering efforts by identifying essential design criteria that can enhance the 
functionality of engineered tissues. 
As a biphasic tissue, the knee meniscus relies on the interplay of solid and 
fluid components to achieve its viscoelastic characteristics.26• 27• 34• 63• 201 
-------------------
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Composed of approximately 30% organic matter and 70% water, the meniscus is 
highly hydrated.3 The flow of the water fraction in and out of the tissue during 
loading plays a role in the tissue's viscoelastic behavior and allows for the 
exchange of nutrients between the synovial fluid and meniscus. 32 The solid 
fraction, dominated by collagenous proteins and, to a lesser degree, sulfated 
glycosaminoglycans (GAGs), provides structure to the tissue. Collagen, the most 
abundant biochemical component in the meniscus, has been well-characterized 
in terms of its distribution, organization, and mechanical contribution to meniscus 
mechanics. Microscopic and mechanical analyses of meniscal collagens have 
revealed that these proteins are organized mainly in the circumferential direction 
of the tissue, with some radially oriented fibers throughout.29-31 Tensile tests in 
the circumferential and radial directions indicate that tensile properties are 3- to 
1 0-fold higher in the circumferential direction than in the radial direction.30• 32 
The mechanical contribution of sulfated GAGs in the meniscus, however, 
is not as well understood. While collagen is abundant throughout the meniscus, 
sulfated GAG content is scarce in the outer region of the meniscus and increases 
in abundance moving radially inward. In tissues with high sulfated GAG content, 
such as articular cartilage, GAGs mainly contribute to tissue compressive 
properties; containing many GAG side chains, the negatively charged aggrecan 
molecule attracts water molecules and therefore helps to resist the flow of water 
out of the tissue while under compression.62-s5 In articular cartilage, however, 
sulfated GAGs are, on average, 8-fold more abundant than in the knee 
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meniscus, which may indicate a difference in the mechanical role of GAGs in 
these two tissues. 11 · 12· 16· 257· 258 
The mechanical role of sulfated GAGs in musculoskeletal tissues has 
been investigated through selective digestion of sulfated GAGs and subsequent 
mechanical testing. A common method of depleting GAGs from native tissues is 
to use the catabolic enzyme chondroitinase ABC (CABC), which depolymerizes 
chondroitin sulfate, dermatan sulfate, and, to a lesser degree, hyaluronan.259 
CABC has been used previously to investigate the contribution of GAGs to the 
mechanical properties of various musculoskeletal tissues. GAG-depletion of 
articular cartilage has been shown to reduce the tissue's compressive modulus 
and increase tissue permeability.163 In the tendon, a tissue similar to the knee 
meniscus in terms of GAG content, results suggest that sulfated GAGs impart 
higher tissue viscosity in the transverse direction (perpendicular to collagen 
alignment).260 A study investigating the human medial collateral ligament, 
however, showed that dynamic viscoelastic properties of the tissue were largely 
unchanged by sulfated GAG removal. 261 These results show that GAGs in 
different tissues play varying roles in the tissue's mechanical properties, 
indicating that they may affect regional meniscus mechanics as well. 
This study, therefore, investigates the regional contribution of sulfated 
GAGs to meniscus compressive and tensile mechanics. CABC is used to deplete 
GAGs from each meniscus region, and compressive and tensile material 
properties are compared between depleted and control specimens. It is 
hypothesized that GAG-depletion will have varying effects on material properties 
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regionally in the meniscus. The results from this study will inform further tissue 
engineering efforts to recapitulate the meniscus, and allow for a better 
understanding of regional variations in meniscus mechanics. 
Materials and Methods 
Medial menisci from two-week-old bovine knees [Research 87, Boston, 
MA] were surgically removed, and frozen in saline solution with protease 
inhibitors until treatment and mechanical testing were performed. In phase 1 of 
the study, the minimum treatment time required to remove all of the sulfated 
GAGs from each region was determined. Samples from each region (inner, 
middle, and outer meniscus) were dissected from the tissue and either treated 
with chondroitinase ABC (CABC) in an activation solution, or placed in the 
activation solution without CABC (untreated control). Treated samples were 
placed in a 1 U/ml CABC [Sigma-Aldrich, St. Louis, MO] solution containing 50 
mM Tris, 60 mM sodium acetate, and 0.02% bovine serum albumin and 
incubated with gentle shaking at 37°C. Following treatment or incubation in 
buffer, samples were placed in an inactivation solution (1 mM Zn2+ with 50 mM 
Tris) for 15 minutes with gentle shaking at 37°C. Three samples from each region 
were treated for either 1, 3, 6, 12, and 24 hours. Biochemical analysis was 
performed on each sample to determine sulfated glycosaminoglycan (GAG) and 
collagen content per dry weight of tissue. Sulfated GAG content versus time data 
were fit with an exponential decay model and the half-life for GAG depletion for 
----------~------
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each region was determined. A one-way ANOVA was performed on the data for 
each region with significance level p < 0.05. 
The appropriate treatment time determined in phase 1 was then carried 
forward to phase 2, where compressive and tensile mechanical testing was 
performed on each GAG-depleted region and untreated control. For compressive 
samples, three millimeter dermal punches were used to obtain inner, middle, and 
outer meniscus samples, which were cut to around 1 mm thickness with 
razorblades. Unconfined compression stress-relaxation testing was performed in 
the axial direction on each tissue sample. The diameter and sample thickness 
was determined just prior to testing. Samples were preconditioned with 15 cycles 
of 0-5% compressive strain, and then stress-relaxation tests were carried out at 
10% and 20% strain. As described previously, a Kelvin solid viscoelastic model 
was fit to the data to yield the following compressive material properties at each 
strain level: instantaneous modulus (Ei), modulus of relaxation (Er), and viscosity 
(IJ) 156. For tensile samples, circumferential strips of the inner, middle, and outer 
portions of the meniscus were cut into dog bone shapes with an average 
thickness of 1 mm. Sample thickness and gauge length was determined just prior 
to mechanical testing. Tensile strain-to-failure testing was carried out in the 
circumferential direction of the tissue, with preconditioning of 15 cycles of 0-2% 
strain, followed by tensile testing at 1% strain/second. The linear portion of each 
stress-strain curve was used to determine the Young's modulus (Ey) of each 
sample, and the ultimate tensile stress (UTS) was determined from each curve. 
An integration of the stress-strain curve was used to determine the toughness, or 
201 
energy to failure, of each sample. GAG depletion was verified for each region 
histologically using Safranin-0 staining as well as biochemically. Collagen 
content of the regional samples was also determined biochemically. 
Four to six samples were used for each region and treatment group, and 
Student's t-tests were performed between treated and untreated groups. 
Statistical significance was set at p < 0.05. 
Results 
Results from phase 1 of the study are shown in Figure 1. Inner, middle, 
and outer meniscus samples were treated with CABC for 0, 1, 3, 6, 12, or 24 
hours. In the untreated state, the inner meniscus contained the most sulfated 
GAG per dry weight (3.88% ± 1.5%) compared to the outer (0.91% ± 0.33%) and 
middle (1.2% ± 0.42%) regions. When treated with CABC, it was found that the 
outer and middle meniscus displayed similar GAG depletion profiles, with half-
lives of 0.325 hours and 0.456 hours, respectively. In contrast, the inner 
meniscus GAG depletion profile displayed the longest time to full depletion, with 
a half-life of 0.899 hours. Collagen content for each region was unaffected by 
CABC treatment, and it was found that the inner meniscus had statistically less 
collagen then the outer and middle meniscus. The outer and middle meniscus 
contained 89.01% ± 4.8% and 87.07% ± 4.62% total collagen, respectively, while 
the inner meniscus contained 82.04% ± 3.75%. Based on these results, it was 
determined that the middle and outer meniscus specimens would be treated with 
--------- ------~--- -----
202 
CABC for three hours, and the inner meniscus specimens would be treated for 
24 hours to ensure full GAG depletion in Phase 2. 
In Phase 2, outer, middle, and inner meniscus explants were treated with 
CABC for the duration determined in Phase 1 and tested under compression and 
tension and compared to untreated controls. Histological and biochemical 
assessment of untreated and treated explants verified that GAG depletion was 
achieved for all three regions (Figure 2). Additionally, biochemical analysis of 
collagen content for treated and untreated samples confirmed that no change in 
collagen content was observed in any of the regions (Figure 2). 
Compressive testing results are shown in Figure 3. Unconfined 
compression stress-relaxation testing on CABC treated samples showed that 
GAG depletion reduced the coefficient of viscosity for all regions compared to 
untreated controls. For the inner and middle regions, GAG depletion also 
significantly reduced the tissue's modulus of relaxation and caused a trend lower 
in the tissue's instantaneous modulus. These statistical differences were seen 
both at the 1 0% and 20% strain levels. 
Tensile material properties of control and GAG-depleted meniscus 
specimens are shown in Figure 4. The tensile properties of the middle and outer 
meniscus were not significantly affected by CABC treatment either for ultimate 
tensile stress or Young's modulus. However, CABC treatment did significantly 
increase inner meniscus Young's modulus (40.75% over untreated control) and 
ultimate tensile stress (40.55% over untreated control). Additionally, inner energy 
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to failure increased significantly with CABC treatment compared to the untreated 
control. 
Discussion 
This study investigated the effects of sulfated GAG-depletion on the 
material properties of the inner, middle, and outer meniscus in order to elucidate 
structure-function relationships in the knee meniscus. Viscoelastic compressive 
testing showed that GAG depletion causes decreased tissue viscosity in all 
regions of the meniscus, as well as decreased modulus of relaxation in the inner 
and middle regions. Statistically significant decreases in compressive properties 
for all regions were observed at both 10% and 20% strain levels, indicating that 
GAGs are mechanically important at even low tissue strains. Tensile properties 
of the inner region were also found to be increased following GAG depletion, 
suggesting that sulfated GAGs play a role in the meniscus tensile characteristics. 
Understanding these contributions of sulfated GAGs to the mechanical properties 
of the meniscus can help explain the complex structure-function relationships 
that exist in the tissue. As the meniscus undergoes both static and dynamic 
compression, tension, and shear under normal loading conditions, it is vital to 
elucidate the major contributors to this mechanically important tissue. Many 
investigations have shown that the presence of the meniscus in the knee protects 
the articulating cartilage from the progression of osteoarthritis.173-175 
Unfortunately, the meniscus is prone to injury, has little self-regenerative 
capacity, and repair techniques are often insufficient to restore full functionality. 
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Tissue engineering efforts aim to create functional replacement tissues, and 
depend on detailed design criteria to achieve this goal. While many studies exist 
bearing out the types, organization, and mechanics of collagens in the meniscus, 
much less is known about the mechanical contribution of GAGs regionally in the 
tissue. To our knowledge, this study is the first to assess the regional 
contributions of sulfated GAGs to viscoelastic meniscus mechanics. 
The success of this study depended on an efficient GAG-removal 
technique, and CABC proved to be an effective mode of depleting sulfated GAGs 
from the bovine meniscus (see Figure 2). In the present study, all regions of the 
meniscus subjected to CABC treatment showed greater than 95% decreases in 
sulfated GAG content. As CABC is known to act mainly on chondroitin and 
dermatan sulfate molecules,259 it follows that these comprise the vast majority of 
GAGs in the bovine meniscus. This is in agreement with previous 
characterization of the human meniscus, in which the GAG distribution was found 
to be 40% chondroitin-6-sulfate, 10-20% chondroitin-4-sulfate, and 20-30% 
dermatan sulfate.16 These similarities between bovine and human menisci could 
indicate that the structure-function relationships borne out in this study may have 
broader clinical relevance. 
GAG depletion affected biochemical content differently in the inner region 
compared with the outer and middle regions. Following GAG-depletion of the 
inner region, an increase in percent collagen per dry weight was observed (see 
Figure 2). This is likely because the inner region contains around 4% GAG per 
dry weight and when this fraction is removed, there is a concomitant increase in 
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collagen fraction. The same result is not observed in the outer and middle 
regions. This is likely because GAGs in these regions do not comprise such a 
large fraction of the dry weight, and therefore minute increases in collagen 
content between control and GAG-depleted groups could not be detected. These 
differences in the effect of GAG-depletion on biochemical content, however, were 
not predictive of the effect of GAG-depletion on compressive properties. 
As hypothesized, the viscoelastic compressive properties of the meniscus 
were affected by sulfated GAG depletion, and these effects varied regionally. The 
present data establish that in compression, all regions of the tissue rely on 
sulfated GAG to impart viscosity, even the outer region where these proteins are 
most scarce. In the middle and inner regions, where sulfated GAGs are more 
abundant, both the viscosity and modulus of relaxation of the tissue are reliant on 
sulfated GAG, indicating that the molecule is also important in supporting 
compressive loads. This overall change in viscosity is in agreement with the 
literature on compressive mechanical properties of GAG-depleted ligaments, and 
cartilages.163• 260 GAG removal in porcine medial collateral ligament (MCL) 
causes overall increases in tissue permeability. As ligament tissue is similar in 
biochemical content and organization to the outer meniscus in the circumferential 
direction, the observed changes in viscosity in the present study for the outer 
meniscus were found to closely match the change in permeability for GAG-
depleted ligaments. Thus, it appears that the coefficient of permeability reported 
in these studies is inversely proportional to viscosity. Increased permeability has 
also been observed in GAG-depleted articular cartilage explants, along with a 
-------- -~~~~~~~~~~~-
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decrease in lubrication of the tissue.163 Though not measured in the current 
study, it is possible that GAG depletion of the meniscus also has an effect on the 
lubrication properties of the tissue. Therefore, these results show that changes in 
compressive properties resulting from GAG-depletion are commensurate with the 
native GAG content in each region. 
Tensile testing on GAG-depleted meniscus regions showed a significant 
increase in inner region properties, but had no statistically significant effect in the 
outer and middle regions. As the inner region contains the most sulfated GAG of 
all the meniscus regions, it is possible that the GAG content imparts a pre-stress 
on the resident collagen molecules, a phenomenon that has been modeled in 
GAG-rich tissues such as articular cartilage.262 If the same principles are applied 
to the inner meniscus, in its normal state, sulfated GAGs attract water molecules 
which increases hydrostatic pressure and imparts a pre-stress to the collagen 
network. Once the GAG is depleted and the pre-stress is removed, the apparent 
tensile properties of the tissue increase. This increase could be a result of minute 
decreases in tissue volume as the GAGs are removed. As tissue volume 
decreases, the same force would be applied to a smaller cross-sectional area, 
resulting in a higher calculated stress and higher tensile properties. Although not 
directly measured in this study, decreased tissue volume and increased tensile 
properties have been noted in CABC-treated articular cartilage, as well as tissue 
engineered articular cartilage constructs, which are both rich in sulfated GAG?63• 
264 In the other two regions, where GAGs are not as abundant, the pre-stress and 
volume changes may not be significant enough to make a difference in the 
-----~~--~~---~---- --------
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tensile properties measured. These results show, therefore, that sulfated GAGs 
play a role in inner meniscus tensile properties. 
In conclusion, this study showed that GAGs in the knee meniscus 
contribute significantly to the viscoelastic properties of the meniscus, especially 
in the inner and middle regions where GAGs are most abundant. These regional 
variations in the contribution of GAGs to meniscus mechanics illustrate the 
importance of these molecules to the overall function of this tissue. Therefore, 
when engineering the meniscus, constructs should use, produce, or mimic the 
regional distribution of GAGs to attain native viscoelastic mechanics. 
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Figure 1: Temporal effects of CABC treatment in different meniscus 
regions. Percent sulfated GAG content (A) , and total collagen content (B) per 
dry weight was measured for outer, middle, and inner meniscus specimens 
treated with CABC for 0, 1, 3, 6, 12, and 24 hours. Inner meniscus specimens 
contained more sulfated GAG per dry weight than the outer and middle 
specimens prior to CABC treatment, and required longer treatment time to reach 
full GAG depletion. Collagen content remained unchanged in all groups in 
response to CABC treatment, and the inner meniscus was found to contain 
statistically less collagen than the outer and middle meniscus. Each data point 
represents the average measurement and standard deviation. Significant results 
from the one-way AN OVA performed on the data are shown in the legend , where 
groups not connected by the same letter are statistically different from each 
other. 
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Figure 2: Histology and biochemistry of control and CABC treated 
specimens. Safranin-0 staining (A) , and biochemical analyses for sulfated GAG 
content (B), and total collagen content (C) were performed on control and CABC 
treated specimens from the outer, middle, and inner regions of the meniscus. 
Positive staining for sulfated GAGs could be detected readily in the inner region, 
and , to a lesser degree in the middle and outer regions; all regions were negative 
for sulfated GAGs following CABC treatment (A). Biochemical analysis confirmed 
histological results, with all regions showing >95°/o decreases in GAG content 
following CABC treatment (B). Percent collagen content per dry weight in the 
outer and middle regions remained unchanged following GAG-depletion, and 
increased in the inner region (C). Scale bar: 100 !Jm. Student's t-tests performed 
in (B) and (C), with significance set at p < 0.05 and indicated by an asterisk. 
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Figure 3: Compressive properties of control and GAG-depleted regional 
meniscus specimens. Unconfined compression stress-relaxation tests at 1 0°/o 
and 20o/o strain levels were performed on outer, middle, and inner meniscus 
specimens either treated with CABC or not (Control). Similar results were 
observed at both 1 Oo/o and 20% strain levels. All regions displayed a decrease in 
tissue viscosity in response to GAG depletion. The modulus of relaxation 
remained unchanged in outer meniscus specimens following CABC treatment, 
but decreased in middle and inner regions. No region showed differences in 
instantaneous modulus following GAG depletion. Student's t-tests were 
performed at each strain level with significance set at p < 0.05 indicated by an 
asterisk. 
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Figure 4: Tensile material properties of GAG-depleted meniscus regions. 
Young's modulus (A), ultimate tensile stress (B), and toughness (C) were 
measured for outer, middle, and inner meniscus regions subjected to GAG 
depletion (CABC) or not (Control). Outer and middle meniscus regions did not 
show any significant difference in either Young's modulus or UTS following GAG 
depletion. Inner meniscus specimens, however, showed a statistically significant 
increase in both parameters after CABC treatment. Student's t-tests were 
performed on these data with significance set at p < 0.05 indicated by an 
asterisk. 
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Chapter 9: Tissue Engineering of the Knee Meniscus 
Section 9.1: Bioreactors 
Introduction 
The meniscus is a mechanically-sensitive tissue that can respond 
favorably or unfavorably to biomechanical stimuli.265 It is known that during 
development, the meniscus experiences a myriad of mechanical stresses that 
are important for normal maturation. Studies have shown that immobilizing chick 
embryos results in the complete absence of the meniscus and fusion of the 
cartilaginous parts in the joint.105 Additionally, the mature meniscus is also 
heavily reliant on mechanical stimulation to maintain its health. Joint 
immobilization of rabbit knees for 8 weeks results in degeneration of the deep 
zone of the meniscus and reduced tissue permeability.106· 107 Given the 
importance of mechanical cues for normal meniscal development and function, it 
is natural to expect that mechanical stimulation of tissue engineered meniscal 
replacements would be beneficial. To impart mechanical forces to tissue 
engineered constructs many different bioreactors have been developed which 
can apply compression, shear, hydrostatic pressure, vibration, or combinations of 
these forces in a controlled environment. As the exact type and pattern of optimal 
Chapter published as: Athanasiou, K. A., and Sanchez-Adams, J. "Part 3: Tissue 
Engineering of the Knee Meniscus." Engineering the Knee Meniscus. Morgan 
and Claypool Publishers. 2009. 
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mechanical stimulation of the meniscus is not known, various stimulation 
regimens should be investigated. 
There are only a few bioreactors that are specifically designed for 
stimulation of meniscal tissue, and they comprise a subset of bioreactors 
designed for stimulation of cartilage constructs. As cartilages in the knee 
experience similar types of forces, bioreactors generally designed for cartilage 
stimulation can also be considered applicable to engineering the meniscus. 
Cartilage bioreactors fall into five different categories: direct compression, 
hydrostatic pressure, high shear systems, low shear systems, and ultrasound. 
Other bioreactors use combinations of these in an effort to achieve more tailored 
results. 
Direct compression 
Direct compression bioreactors, sometimes called cyclic strain 
bioreactors, impart a compressive load to cartilage constructs to simulate normal 
loading patterns (see Figure 1). Typically strains of 1-10% have been used with 
frequencies of 0.1-1 Hz. Varying degrees of success have been achieved using 
this type of stimulation including increases in hydroxyproline content, indicating 
collagen increases, and [358] sulfate incorporation, indicating an increase in 
glycosaminoglycans following the loading regimen (see Table 1 )_266-270 This type 
of bioreactor has been used to stimulate meniscal explants, showing an increase 
in aggrecan gene expression by 108% with dynamic stimulation (2% oscillatory 
strain, 1 Hz). 128 Direct compression bioreactors may also be used to simulate 
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loading patterns of the meniscus following partial meniscectomy, showing that 
removing part of the meniscus results in loading patterns that detrimentally affect 
proteoglycan retention in the tissue. 271 
Hydrostatic pressure 
Static and dynamic hydrostatic pressure bioreactors have also been used 
to simulate the pressurization of the interstitial fluid or the joint capsule (see 
Table 2). Using this type of loading, constructs or explants are placed in a 
chamber which is pressurized via a piston to physiologic levels (Figure 2). 
Magnitudes of 0.1-15 MPa either applied statically or dynamically at 0.01-1 Hz 
have been used to stimulate cartilage constructs and have been shown to be 
effective at increasing mRNA levels responsible for collagen types I and II and 
aggrecan, and also to reduce tissue breakdown of meniscal explants.107· 111 · 272-
278 Hydrostatic pressure can be applied to constructs intermittently, in which a 
period of static culture is interrupted with hydrostatic pressure stimulation, or 
continuously, in which constructs are cultured within a pressurized chamber. 
Continuous culture provides the added advantage of minimal construct 
manipulation, minimizing user variables. 
Shear 
Bioreactors that impart shear forces to constructs can be considered in 
two classes: high shear systems and low shear systems (see Table 3 ). Both use 
fluid flow to impart mechanical forces. Two types of high shear systems are 
currently in use: flow perfusion chambers and spinner flasks. In flow perfusion 
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chambers medium flows through the construct, creating shear forces as the fluid 
makes its way through the pores of the construct. 114• 279-281 Another type of high 
shear environment can be achieved using a spinner flask in which medium is 
stirred around the constructs, creating high shear as it flows around the boundary 
of the construct. The main difference between these two approaches is that the 
perfusion chamber creates shear within the construct and the spinner flask 
creates shear at the construct's surface. Flow in the perfusion chamber imparts 
higher shear at the first contact with the construct, and lower shear as the 
medium exits the construct, which can cause differences in cellular response 
based on the construct thickness.282 Spinner flasks, however, only impart shear 
on the outside of the construct which affects cells at the surface differently than in 
the center. Despite their differences, both of these bioreactors have been shown 
to increase collagen and GAG production, while the spinner flask has been 
especially effective at creating bi-zonal tissues with an outer fibrous capsule.283 
For meniscal tissue engineering, high shear systems such as spinner flasks may 
be beneficial to create the fibrocartilaginous outer portion while maintaining a 
more hyaline-like core. 
Low shear systems such as parallel plate flow bioreactors and rotating 
wall bioreactors also impart fluid forces to the constructs, but the forces felt are 
much lower than those in the high shear systems. A laminar flow bioreactor has 
been shown to increase collagen type II production and increase tensile 
properties of cultured chondrocytes, indicating that low shear can be a beneficial 
way to stimulate cartilage formation in vitro. 113 Much work has been done using 
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rotating wall bioreactors in which small amounts of fluid shear are imparted to 
constructs as they are cultured in a medium-filled chamber that slowly rotates. 
This environment simulates microgravity by maintaining constructs in a mostly 
free-floating state. The mechanical environment has shown mixed results in 
tissue engineering cartilage, in some cases increasing matrix production and in 
other cases not appreciably improving construct properties.129• 284• 285 An 
intermediate form of the rotating wall bioreactor is the wavy-walled bioreactor in 
which constructs are subjected to a more complicated set of fluid stresses due to 
the irregular shape of the bioreactor walls.286"288 In this type of bioreactor, ECM 
synthesis is stimulated to varying degrees based on the position of the construct 
in the chamber. 289 
Ultrasound 
Another type of stimulation that may be used for tissue engineered 
cartilage is low-intensity ultrasound (Table 4). The impetus for using ultrasound 
stimulation came from research done in the late 1990s which showed that 
ultrasound increased the gene expression for aggrecan in cultured 
chondrocytes?90"292 This type of stimulation has shown a similar, but less 
persistent enhancement of ECM formation when compared to the rotating wall 
bioreactor.293 Pulsed ultrasound stimulation of cartilage constructs at 1 MHz and 
67 mW/cm2 for 10 minutes per day was shown to be beneficial for cell 
proliferation and matrix production in a cell-seeded construct for up to 4 weeks, 
beyond which decay of the construct was observed.293 The effect of low-intensity 
------------ ~--~~---
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ultrasound also has a minimal effect on cartilage construct maturation.294 
Ultrasound therefore may be effective during the cell culture stages of tissue 
engineering, but has not shown great promise for stimulating cartilage construct 
maturation. 
Combinations 
Limited studies have been performed on combinations of mechanical 
stimulation (Table 5). Direct compression has been combined with shear in two 
different bioreactor systems, emulating physiologic loading patterns and 
increasing cartilage matrix production.75• 295 Both bioreactors use a round piece 
that rotates and imparts a shear force while pressing down on the construct to 
impart compression. Using an oscillating pin and ball mechanism simulates 
physiologic compression and shear within a joint and has been shown to 
increase cartilage oligomeric protein synthesis, which helps to organize cartilage 
matrix?95 Another type of combination bioreactor uses fluid shear with cyclic 
compression and shows higher GAG retention with varying matrix compositions 
on the surface of the construct versus the core?81 Combinations of mechanical 
stimulation can therefore be beneficial to enhancing construct properties beyond 
that which can be reached using one type of stimulation. 
Application to meniscus engineering 
Based on the research that has been done using these various systems to 
tissue engineer hyaline cartilage, some projections for their potential use in 
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meniscal tissue engineering can be made. High shear systems may be especially 
useful for meniscal tissue engineering as they can create bi-zonal tissue, an 
important attribute of the meniscus. Hydrostatic pressure bioreactors have 
achieved marked success in increasing mechanical properties of tissue 
engineered cartilage constructs, a central concern for engineering 
biomechanically important tissues like the meniscus. Direct compression may be 
beneficial for meniscal constructs during the later stages of maturation, when 
mechanical stimulation is known to be important for normal tissue function. Low 
shear systems could provide stimulation for overall ECM production, but due to 
the mixed review of this stimulation in articular cartilage engineering it is unclear 
how beneficial it might be. Ultrasound stimulation is fairly new to cartilage tissue 
engineering and may be beneficial for stimulating GAG synthesis of cultured 
cells, but has not shown beneficial effects on construct maturation. Rather than 
choosing one type of bioreactor, it is likely that some combination of these stimuli 
will provide the best environment for meniscus tissue regeneration, given the 
vast number of events that occur during meniscal development. 
Concepts 
Tissue engineering the knee meniscus has garnered much attention in the 
scientific community due to the prevalence of meniscus degeneration and 
defects and the tissue's limited ability to self-repair. As the meniscus is 
dependent on mechanical stimulation for normal function, bioreactors that 
simulate physiologic stresses have been developed and may provide the 
------------------- ----~-------
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appropriate conditions for meniscal regeneration in vitro. Though there are few 
bioreactors specifically designed for meniscus tissue engineering, a basic 
understanding of cartilage bioreactors as a whole provides the necessary 
background for the progression of this field. Five different categories of cartilage 
bioreactors exist: direct compression, hydrostatic pressure, high shear systems, 
low shear systems, and ultrasound. Amongst these, direct compression, 
hydrostatic pressure, and high shear systems seem the most promising for 
developing tissue mechanically and biochemically similar to the native meniscus. 
Combination bioreactors incorporate two or more types of these stimuli, and 
could allow for more directed formation of the meniscus. 
Section 9.2: In vitro tissue engineering 
Introduction 
According to the classic tissue engineering paradigm, the basis of any 
meniscus tissue engineering attempt are cells and scaffolds. Currently in the 
meniscus tissue engineering field, the focus has been mostly on characterization 
of meniscal fibrochondrocytes and their sensitivity to various biochemical stimuli. 
This information has been used to create various methods for tissue engineering 
the meniscus that maximize matrix synthesis and increase the biochemical and 
mechanical relevance of engineered constructs. 
Cell Source 
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Success of tissue engineering strategies relies heavily on the type of cells 
used and their potential to create enough of the appropriate extracellular matrix 
molecules. Fibrochondrocytes are well characterized and have been used in 
many meniscus engineering attempts. 18• 40• 42• 43• 46• 110• 117 While the presence of 
these cells is optimal for understanding the culture environments and stimuli 
appropriate for engineering a meniscus-like tissue, they are relatively scarce in 
the body and would likely be an impractical source for large-scale engineering 
attempts. This has prompted research into other sources of cells that may 
present an abundant, autologous or allogenic source. 
Other cell types that have been used in tissue engineering the meniscus 
include chondrocytes, mesenchymal stem cells, and embryonic stem cells. 
Chondrocytes are nicely suited to meniscal engineering as they can be induced 
to produce collagen type I through passaging. Their synthetic capacity for 
collagen and GAGs in tissue engineering is also higher than 
fibrochondrocytes. 131 Chondrocytes are, however, also relatively scarce in the 
body and therefore would prove difficult to procure for tissue engineering. 
Mesenchymal and embryonic stem cells, on the other hand, present a potentially 
limitless cell source. The difficulty in using these cells lies in understanding the 
necessary stimuli for directing their differentiation to a fibrochondrocytic lineage. 
Encouraging results have been obtained using various growth factors including 
IGF-1, TGF-~1, TGF-~3, BMP2, and BMP6, for directing MSCs from the bone to 
produce collagen types I and 11.296-298 Human embryonic stem cells have also 
shown promise toward producing fibrocartilaginous tissue when conditioned with 
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transforming growth factors, bone morphogenetic proteins, and when co-cultured 
with native fibrochondrocytes?99 These embryonic stem cells, when differentiated 
and formed into scaffoldless constructs, can produce matrix molecules important 
for meniscus tissue including collagen types I and II, as well as GAGs.131 • 300 
More work needs to be done to solidify the differentiation regimen for both of 
these cell types, and also to identify MSCs that are sensitive to fibrochondrocytic 
differentiation. 
There are also some cell types that are promising for use in this field, but 
have yet to be fully investigated for meniscal tissue engineering. These include 
auricular chondrocytes, dermal fibroblasts, adipocytes, and synovial tissue cells. 
All of these cell types are advantageous for tissue engineering in that they are 
easily procured, and have minimal donor site morbidity. Auricular chondrocytes, 
from the elastic cartilages of the nose and ear, have high proliferative and 
synthetic capacities and can produce a matrix of collagens I and II that is similar 
in makeup to meniscal tissue.301 Recently a subpopulation of dermal fibroblasts 
has been identified that has the capacity to be chondroinduced through various 
means including gene transfection and culture on or with various proteins. 302-304 
This conditioning produces cells that synthesize collagens I, II, and GAGs, which 
are all important components of the normal meniscus. Like dermal fibroblasts, a 
subset of adipocytes has also been identified as a cell source for cartilage tissue 
engineering. Using culture medium containing BMP6 has proved effective for 
differentiating these cells towards a chondrocytic pathway.305-307 Synovial tissue 
cells may also prove beneficial for meniscal engineering as they have shown 
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chondrogenic capacity, and an ability to vary production of collagen types I and II 
in response to the culture environment. 165 All four of these cell sources may 
provide autologous cell sources for meniscal tissue engineering but more 
research must be completed to illuminate their potential. 
Growth factors 
Though a different cell source may ultimately be used for meniscal 
engineering, an understanding of the behavior of fibrochondrocytes to growth 
factors is advantageous as it provides the framework for culturing meniscus-like 
cells. Meniscal fibrochondrocytes respond in different ways to different growth 
factors, as outlined in Table 6. It has been shown in multiple studies that 
monolayer cultures of fibrochondrocytes exposed to transforming growth factor 
beta 1 (TGF-~1) exhibit enhanced proteoglycan synthesis and cell proliferation. 18• 
43
• 
108 Fibroblast growth factor (FGF), hepatocyte growth factor (HGF), platelet-
derived growth factor (PDGF-AB), bone morphogenetic protein 2 (BMP-2), and 
human platelet lysate (Human PL) also increase cell proliferation, but at a high 
enough concentration FGF decreases GAG synthesis.40• 109• 11° Cell migration of 
all fibrochondrocytes is stimulated by PDGF-AB and HGF, and slightly by 
epidermal growth factor (EGF), but only outer meniscus cells migrate when 
exposed to interleukin-1 (IL-1). 110 All of these growth factors have some effect on 
meniscal cells and therefore can be used along with scaffolds to enhance matrix 
synthesis, cell proliferation, and cell penetration into tissue engineered 
constructs. 
----------- -----~---~ ---
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Several of these growth factors have already been incorporated into the 
culture medium for engineered constructs, and their effects investigated. One 
growth factor, TGF-J31, has proved especially effective for enhancing construct 
properties in various engineering modalities. Using a scaffoldless approach in 
which cells are cultured in a non-adherent well, application of TGF-J31 has been 
shown to increase tensile properties of engineered fibrochondrocytic constructs 
up to 3 MPa. 116 TGF-J31 has also been shown to increase matrix production of 
fibrochondrocytes seeded on poly-L-Iactide (PLLA) constructs, outperforming 
PDGF-AB, FGF, and insulin-like growth factor 1 (IGF-1).117 Bone marrow 
mesenchymal stem cells seeded on collagen matrices are also stimulated by 
TGF-J31 to make collagen type II and glycosaminoglycans, important proteins for 
reconstruction of the inner one-third of the meniscus.308 
Synthetic scaffolds 
In scaffold-based approaches, scaffold material can have similar effects on cell 
synthetic profiles as growth factors. Scaffolds that have been used for meniscal 
engineering are either synthetic, such as PLLA, or natural, such as decellularized 
tissue or scaffolds made from various matrix proteins (see Table 7). Synthetic 
scaffold materials must be biocompatible, but have the innate advantage over 
natural scaffolds of low batch variability, which is important for reproducibility. For 
meniscus engineering polyglycolic acid (PGA) and PLLA have been used 
previously. These two scaffold materials are biocompatible and degradable, and 
their degradation products are non-toxic, though acidic. Seeding 
----- ------- -----
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fibrochondrocytes on PGA scaffolds has the effect of increasing cell proliferation, 
sulfated GAG production, and collagen synthesis over an agarose scaffold 
control. 129 PLLA has also been proven biocompatible with fibrochondrocytes, 
though the effect of PLLA alone on fibrochondrocyte processes has not been 
investigated. 117 
Natural scaffolds 
Natural scaffolds have also garnered success in meniscal engineering 
(see Table 9). Collagen meshes have been shown to allow cell proliferation and 
collagen and GAG production, and to allow for growth factors to enhance these 
properties.46• 308 The type of collagen used for the scaffold also has an effect on 
cell behavior. Collagen type II-GAG meshes fared better than type I-GAG 
meshes when seeded with fibrochondrocytes, reducing contraction of the 
constructs and increasing collagen and GAG production.42 Matrices made of 
hyaluronic acid (HA) are also biocompatible, as they are made of a major 
component of cartilage, and when cultured in a mixed flask can create bi-zonal 
tissue reminiscent of the non-uniform properties of the meniscus.309• 310 Agarose 
is another type of natural scaffold that has been used extensively in cartilage 
tissue engineering. This scaffold material can encapsulate fibrochondrocytes as it 
crosslinks and can be made into any shape. This material has not been shown to 
be as effective at stimulating matrix production or imparting mechanical integrity 
as other scaffold materials, however, and therefore is not as popular for meniscal 
engineering.129 The last type of natural scaffold material used in meniscal 
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engineering is decellularized meniscal tissue. This material is advantageous 
because it contains matrix that is already organized and can best simulate the 
natural microenvironment for meniscal cells. While decellularization of meniscal 
tissue has been achieved, mechanical integrity of the matrix has been 
maintained, and cytocompatibility has been demonstrated, work has yet to be 
done to demonstrate its use in tissue engineering.244 
Scaffold-free approaches 
An emerging technique in meniscal tissue engineering is to use a scaffold-
free method to grow meniscal tissue. Eliminating scaffold material from the tissue 
engineering approach eliminates variables such as the degradation profile, acidic 
degradation products from polymers such as polylactides/polyglycolides, and 
biocompatibility of the scaffold. Recently, a self-assembling method has been 
devised for scaffoldless tissue engineering in which cells are seeded into an 
agarose mold which inhibits cell attachment.210 Using the self-assembling 
method, a 50:50 co-culture of bovine fibrochondrocytes and chondrocytes were 
formed into constructs which were cultured for 4 weeks and were found to 
contain both collagen types I and II as well as proteoglycans. 131 
This method has also been employed to create meniscus-shaped 
constructs using this same co-culture of bovine meniscal fibrochondrocytes and 
chondrocytes, showing that these constructs were 200--400% stiffer after 4 
weeks than cell-seeded PGA scaffolds (Figure 3). 115 This scaffold-free method 
therefore seems promising for recreating meniscus biochemistry and geometry 
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as well as improving upon mechanical properties of constructs formed using 
synthetic scaffolds (see Table 7). 
Concepts 
In vitro tissue engineering of the knee meniscus has yet to produce 
constructs that match native meniscal properties. A variety of cell types are under 
investigation for meniscal engineering, prompted by the overall scarcity of 
fibrochondrocytes. Progenitor cells, either adult or embryonic, hold much promise 
as they have shown chondrogenic capacity when exposed to various growth 
factor treatments. Much work has been done to identify biochemical factors and 
scaffold materials to which fibrochondrocytes are sensitive, and various studies 
have used them in combination to maximize construct biochemistry and 
biomechanics. Much is still unknown as to the effect of other combinations of 
cells and scaffold materials as well as the addition of mechanical stimulation to 
many of the current approaches. Some promising results have been obtained 
using co-cultures of chondrocytes and fibrochondrocytes in a scaffold-free 
approach (self-assembly process), which mimic the native meniscus in terms of 
biochemical makeup and geometrical properties as well as improve upon the 
mechanical properties when compared to constructs that use synthetic scaffolds. 
Section 9.3: In vivo tissue engineering 
Introduction 
228 
As a next step to in vitro studies or to demonstrate feasibility of a tissue 
engineering technology, in vivo work with the knee meniscus provides practical 
measures of construct properties. There have been many different attempts to 
repair damaged meniscal tissue by implanting scaffolds with or without cells into 
the body, using the joint itself as a bioreactor to stimulate tissue formation. 
Animal models 
An ideal model for testing engineered meniscus products would replicate 
the environment found in the human knee joint. Though this has not yet been 
achieved, various animal models are used as approximations, providing a first 
understanding of how engineered meniscus tissue will fare when placed inside 
an organism. The most popular animal model for testing engineered meniscus 
technologies is the New Zealand white rabbit. 133• 311 -316 Well-characterized and 
relatively inexpensive, the rabbit model is large enough for surgical procedures 
and small enough to raise easily. Though it has been shown that the mechanical 
properties of the rabbit meniscus are not as similar to the human meniscus as 
those of baboons, dogs, and pigs, the rabbit still remains the model of choice for 
most studies.37 Larger animal models such as dogs, sheep, pigs, and goats have 
also been used to show the biocompatibility and feasibility of tissue engineered 
meniscus constructs.317-323 Showing good performance in these models may 
more closely approach expected outcomes in a human, as they are more 
comparable in size and the meniscus in these animals has similar biomechanical 
properties to human tissue. Additionally, testing in these types of animals is often 
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required by the Food and Drug Administration (FDA) prior to embarking on 
clinical trials. 
Table 8 lists the advantages and disadvantages of the various animal 
models used in meniscus tissue engineering. It is important to note that in 
addition to the type of animal used, the age of the animal has a large influence 
on tissue plasticity. Researchers must take the age of the animal model into 
account when evaluating in vivo success rates. 
Fibrin 
The earliest attempts to tissue engineer cartilage in vivo involved using 
fibrin or fibrin clots as a scaffold. Fibrin, a natural material formed in the body 
following injury, can be processed into a gel and in combination with endothelial 
cell growth factor was shown to increase healing of defects created in the dog 
meniscus.322 Following this success, fibrochondrocytes were encapsulated in 
fibrin gels and implanted into rabbit meniscal defects. After two months, the 
scaffolds showed signs of cell proliferation and sulfated GAG production.316 
Fibrin gel has shown better success than fibrin clots even with the incorporation 
of mesenchymal stem cells. Fibrin clots that were implanted into defect sites did 
not induce much healing when implanted into avascular defect sites of the 
meniscus.318 Although some success has been observed with these fibrin 
scaffolds, full defect healing was not observed and no mechanical testing was 
performed on the repair tissue. 
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Synthetic scaffolds 
In the mid-1990's, cell-seeded synthetic scaffolds were investigated in vivo 
as possible replacement therapies for meniscal defects (see Table 9). PGA 
scaffolds were seeded with meniscal fibrochondrocytes and implanted 
subcutaneously in nude mice for 16 weeks, showing organization with time of a 
fibrous matrix containing sulfated GAGs. 324 These scaffolds were also seeded 
with fibrochondrocytes transfected with a gene to encourage vascularization, and 
implanted subcutaneously. In this experiment the gene transfection successfully 
encouraged vascularization of the construct.325 Recently, a PGA scaffold was 
seeded with fibrochondrocytes and implanted into a rabbit knee that had 
undergone total meniscectomy. Following 10 weeks in vivo, fibrocartilaginous 
tissue had formed, although the biochemical and mechanical characteristics of 
the neotissue were still a fraction of native tissue. 133 Another synthetic scaffold 
type comprised of a PLLA and poly(p-dioxanone) PPD blend was also used 
recently as a meniscal prosthesis to stimulate meniscal regeneration. 312 After 14 
weeks there was some ingrowth of tissue and extensive degradation of the 
scaffold.312 Additionally the cartilage underlying the scaffold was intact, while in 
control specimens the cartilage had signs of damage.312 Therefore, the 
PLLAIPPD scaffold was shown effective as a meniscal prosthetic but was not 
able to stimulate complete tissue repair prior to degradation of the material. 
Natural scaffolds 
Currently, focus has turned to the potential of natural scaffolds to repair 
the meniscus (see Table 9). Studies using decellularized tissue such as the 
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meniscus and small intestine submucosa have been able to achieve partial 
regeneration of meniscal tears, but their in vivo success has been limited.317· 323 
More success has been achieved using collagen scaffolds from bovine Achilles 
tendon called collagen meniscus implants (CMI). These implants aim to act as 
prostheses and to stimulate tissue ingrowth. Longitudinal studies in patients have 
shown that 6 months post-implantation, the underlying cartilage was intact, the 
scaffold was infiltrated with fibrochondrocytes and that the implant contained 
fibrous tissue after 5 years. 326• 327 Another study in sheep used CMI in a tissue 
engineering strategy in which fibrochondrocytes were seeded into the scaffold 
and then implanted in an inner-meniscus defect.319 The results after 3 months 
suggested that cell-seeded CMI performed better than non-seeded controls, 
although the matrix produced was more fibrous than that found in the inner 
meniscus, and the constructs tended to contract significantly.319 CMI is therefore 
a promising technology for meniscal replacement, although more research must 
be done to induce inner-meniscus like tissue to form. 
Another natural scaffold used currently in meniscal tissue engineering 
research in vivo is hyaluronan. This scaffold has been used to encapsulate 
chondro-differentiated mesenchymal stem cells and was implanted in a rabbit 
meniscal defect for 12 weeks.311 The repair tissue formed by this method was 
more similar to native meniscus tissue than non-treated controls and good 
integration was observed between the scaffold and native meniscus.311 
Concepts 
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In vivo testing of engineered materials is important for ensuring the 
biocompatibility of the technology as well as its feasibility to repair damaged 
tissue. The most popular animal model for in vivo testing of meniscus constructs 
is the New Zealand white rabbit. Other animals that have been used include 
sheep, dogs, pigs, and goats. Many different types of cells and scaffold materials 
have been investigated in vivo for use as meniscal replacements. Fibrin has 
demonstrated a limited capacity to induce sufficient repair of meniscal tissue. The 
addition of cells to scaffolds tends to increase overall reparative potential of a 
construct, but complete healing of a meniscus defect has yet to be achieved. A 
number of scaffold materials have been used for meniscus tissue engineering 
including synthetic types (PGA, PPD, PLLA) and natural types (collagen, 
hyaluronan). Recent focus has been on using natural scaffolds rather than 
synthetic ones to better achieve meniscus-like repair tissue. There are a few 
promising approaches currently being investigated using both types of scaffolds, 
but more research must be done to understand their long-term behavior in the 
body. 
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Tables 
Table 1: Summary of direct compression bioreactors 
Stimulation Specimen Effect Ref. 
20x1 06 bovine 15-25°/o increase [
35S]-3% cyclic strain, 
sulfate incorporation, 10- 266 0.1-1 Hz, 6 chondrocytes/ml 35%, increase [3H]-proline 
wks agarose gel incorporation 
10% cyclic 
60x 1 06 bovine strain, 1.74o/o GAG/wet weight 267 1Hz, 5 chond rocytes/m I 2.64% collagen/wet weight dayslwk, 3 agarose gel 
hrslday, 4 wks 
10% cyclic 
Aggregate modulus: 53 kPa , strain, 20x1 06 bovine Young's modulus: 66 kPa, 268 1Hz, 5 chondrocytes/ml 1.43%, GAG/wet weight dayslwk, 3 agarose gel 1.23% collagen/wet weight 
hrs/day, 4 wks 
10% cyclic 
No increase in mechanical strain, 60x1 06 bovine 1Hz, 5 properties or GAG/wet weight 268 chondrocytes/ml (-1.6%); collagen/wet weight days/wk, 
3 hrslday, 4 agarose gel significantly higher (1.86o/o) 
wks 
20-40°/o increase in [35S]-1-5% cyclic Bovine hyaline 
sulfate and [3H]-proline 269 
strain, 1Hz explant incorporation 
Bovine meniscus 1 08o/o increase aggrecan 
128 2% cyclic strain, expants (medial and gene expression, no effe~t on 1Hz, 4 hours lateral) collagen type II express1on 
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Table 2: Summary of hydrostatic pressure bioreactors 
Stimulation Specimen Effect Ref. 
2a-fold increase 
10 MPa, 1Hz, 1 as cow wrist cells/cm2 aggrecan mRNA, 9- 272 
4 hrs/day, 4 days monolayer fold increase collagen 
type II mRNA 
Prevents up-regulation 
1 MPa, 0.5 Hz, Rabbit meniscus of catabolic agents 1114 min (on/off) , (MMPs, TIMPs) that 107 
4 hrs explant occurs in unstimulated 
controls 
6. 87 MPa, 5115 s 5-7.5x1 a
6 juvenile 2a-fold increase in 
(on/off) , for 20 min horse GAG, 2.4-fold increase 273 
chondrocytes/cm3 PGA 
every 4 hrs, 5 wks scaffold in collagen 
3.45 MPa, 5115 s 2x1 a6 juvenile horse 2-fold increase GAG 
(on/off) , for 20 min chondrocytes/cm3 PGA concentration , no 274 
every 4 hrs, 5 wks scaffold increase in collagen 
10 MPa, static, Aggregate modulus 
1 hrlday, 5.5x1a6 cow 273 kPa, Young 's 
days 10-14 in chondrocytes, scaffold- modulus 1.6 MPa, 27S 6.1 °/o GAG/wet weight 
culture, less construct 1 a.6°/o collagen/wet 
4 wks weight 
10 MPa, static, 4-fold increase in 
1 hrlday, 113 days 1 x1 a
6 rabbit meniscus collagen production, 3- 111 
cells/ml PLLA scaffold fold increase in GAG (onloff) ,4 wks production 
10 MPa, 1Hz, 
5.5x1a6 cow Prevents decrease in 4 hrslday, 
chondrocytes, scaffold- GAG content observed 277 5 dayslwk, less construct in static culture Bwks 
10 MPa, static, 1 as temporomandibular Increased collagen 
4 hrslday, 211 days joint disc (cow) type I gene expression 278 and collagen (on/off) , 1 wk cells/ml , PGA scaffold production 
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Table 3: Summary of shear bioreactors 
Stimulation Specimen Effect Ref. 
Spinner flask, 25x1 0
6 bovine 60°/o increase in GAG, 
chondrocytes /cm 3 PGA 125°/o increase in collagen, 283 Bwks scaffold fibrous capsule formation 
12x1 06 ovine Outer layer of fibroblast-
Flow perfusion chondrocytes/cm3 PET like cells, inner core of 114 
scaffold meniscus-like cells 
113°/o increase in total 
Parallel plate, 1. 7x1 06 bovine collagen, 230°/o increase in 
1 dynelcm2, 3 chondrocytes/cm2 , collagen type II, Young's 113 
days scaffold-less modulus 2.28 MPa, 
ultimate strength 0.81 MPa 
127x106 bovine GAG levels 68o/o of native, Rotating wall, 6 
chondrocytes/cm3 , PGA collagen levels 33%, of 285 
wks native, collagen type II scaffold 
crosslinked 
Rotating wall, 7 5x1 0
7 rabbit No significant effects over fibrochondrocytes/cm 3 , 129 
wks PGA scaffold or agarose static control 
30%, increase in cell 
number and 60°/o increase 
Wavy-wall, 5x1 0
6 bovine in ECM deposition over 
chondrocytes PGA controls, fibrous outer 287 4 wks scaffold capsule with type I 
collagen , inner core with 
type II collagen and GAG 
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Table 4: Summary of ultrasound bioreactors 
Stimulation Specimen Effect Ref. 
1 MHz pulsed, 
Increase in aggrecan 50 or 120 
mW/cm2, Rat chondrocytes, gene expression and 291 
monolayer [358]-sulfate 10 min/day, incorporation 
3 or 5 days 
Increased cell 
1 MHz pulsed, pro I iteration, 
67 mW/cm2, 4x106 human beneficial effects last 293 
10 min/day, chondrocytes/cm 3 scaffold around 28 days 
6days (shorter than rotating 
wall bioreactor) 
1.5 MHz, No effect on 
30mW/cm2, 30x1 0
6 bovine accelerating 
20 min/day, chondrocytes/cm
2
, PLGA chondrogenesis or 294 
scaffold, implanted into maturation of 7 dayslwk, nude mice engineered 
12 wks constructs in vivo 
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Table 5: Summary of combination bioreactors 
Stimulation Specimen Effect Ref. 
260°/o increase in 
Bovine aggrecan gene 
chondrocytes, expression, 31 0°/o increase in Compression and shear, scaffold less, 
collagen gene 75 0.5N immature 
cartilage-like expression at 2 hrs, 
return to normal after 4 
construct hrs; 4 days increases 
GAG content 
Oscillating pin Slight increase in (5% strain, 0. 1 Hz), Bovine nasal COMP gene 295 
and ball( 0.6 Hz, ±60°), carti lage explant expression 
1 hrlday, 3 days 
Perfusion and 
compression, Bovine Flat top and bottom, 
static (10% strain), or chondrocytes increased GAG 281 seeded in PGA dynamic (5% strain, 0.3 scaffold retention in construct 
Hz), 37 days 
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Table 6: Effects of growth factors on meniscus cells 
Type Source Effect References 
Increases proteoglycan synthesis 
Sheep Increases proteoglycan synthesis 
Human Increases [35S]-sulfate [3H]-proline 
TGF-{31 Rabbit uptake 18, 43, 108, 111 
Rabbit 15-fold increase in collagen production 
and 
8-fold increase in GAG production 
Stimulates some cell migration in red-
BMP-2 Cow white region, 110 
also stimulates proliferation 
/L-1 Cow Stimulates migration of outer meniscus 110 
cells 
PDGF-AB Cow Stimulates cell migration, proliferation 110 
/GF-1 Cow Stimulates some cell migration in red- 110 
white region 
EGF Cow Stimulates half of inner and outer cells to 110 
migrate 
HGF Cow Stimulates cell migration, proliferation 110 
FGF Rabbit Increases proliferation 40 
Human PL Rabbit Increases proliferation 40 
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Table 7: Scaffolds and scaffold-free methods for in vitro meniscus 
engineering 
Type 
Synthetic 
PLLA 
PGA 
PGA 
Natural 
Collagen 
type II-GAG 
Collagen 
type I-GAG 
Hyaluronic 
acid 
Agarose 
Decellularized 
meniscus 
Scaffold-free 
Details 
2.5x1 07 rabbit 
fibrochondrocytes/cm 3 , 
9 days, addition of 
growth factors 
23x1 06 50:50 bovine 
fibrochondrocytes and 
chondrocytes, meniscus-
shaped, 8 wks 
5x1 07 rabbit 
fibrochondrocytes/cm 3 , 
7wks 
18x1 06 calf or dog 
fibrochondrocytes/cm 3 , 
3wks 
18x1 06 calf or dog 
fibrochondrocytes/cm3 , 
3wks 
3.9x1 07 bovine or human 
fibrochondrocytes/cm 3 , 
4 wks, mixed or rotating 
flask 
5x1 07 rabbit 
fibrochondrocytes/cm 3 , 
7 wks 
105 sheep 
fibrochondrocytes/ml , 
4wks 
Result 
Supports cell survival, 
attachment 
Irregularly shaped, 
presence of GAGs and 
collagen , random 
orientation of collagen, 
stiffness 16 ± 5 kPa , 
fibers degraded by 8 
wks 
Increases sulfated 
GAGs, cellularity 
<1 Oo/o contraction, 2-fold 
increase in DNA 
content, GAG and type I 
collagen synthesis 
50%> contraction , cells 
confined to margins of 
scaffold, produced GAG 
and collagen 
Bi-zonal tissue created 
with meniscus-like 
collagen organization , 
matrix deposition, and 
mechanical behavior 
Some initial cell death, 
rounded cell 
morphology, some GAG 
and collagen production 
Scaffold nontoxic, 
higher stiffness (17°/o) 
and compression (26%) 
than native 
Ref. 
117 
115 
129 
42 
42 
309, 
310 
129 
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Type Details Result Ref. 
Stiffness anisotropic, 
50:50 co-culture of circumferential modulus 
bovine fibrochondrocytes 226 ± 76 kPa, radial 
Self-assembly and chondrocytes, modulus 67 ± 32 kPa, 115 
meniscus-like collagen 
meniscus-shaped 
orientation, presence of 
agarose well , 8 wks GAGs and collagen 
types I and II 
50:50 co-culture of Collagen I and II 
Self-assembly bovine fibrochondrocytes present, GAGs, 131 
and chondrocytes, constructs largely 
agarose well , 4 wks uncontracted 
Bovine Collagen I and GAGs 
Self-assembly fibrochondrocytes, present, constructs 131 
agarose well , 4 wks contracted significantly 
Table 8: Animal models used in meniscus tissue engineering 
Animal model Advantages Disadvantages 
Commonly used for meniscus Small, meniscal 
Rabbit studies, cost, feasibility, relatively properties differ from 
Dog 
Sheep 
Pig 
Goat 
Human 
easily operable, small humans 
Large, meniscus Poisson's ratio and 
permeability similar to humans, 
easily operable 
Large, easily operable 
Large, meniscus Poisson's ratio 
similar to humans, easily operable 
Large, easily operable 
Most clinically relevant 
Cost, feasibility 
Cost, feasibility 
Cost, feasibility 
Cost, feasibility 
Regulatory approval 
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Ref. 
133, 
311-
316 
321 , 
322 
319, 
320 
323 
317, 
318 
326, 
327 
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Table 9: Scaffolds for in vivo meniscus engineering 
Type Details Result Ref. 
Synthetic 
2.5x1 07 bovine Fibrous matrix fibrochondrocytes/m L formation, presence PGA alginate, subcutaneous nude 324 of GAGs and 
mouse, 
collagen 16wks 
2x1 07 bovine Fibrous matrix 
PGA fibrochondrocytes/cm
3
, formation , firm 325 
subcutaneous nude mouse, consistency, collagen 
8wks and GAG presence 
Fibrous tissue 
2x1 06 rabbit formation, up to 40o/o 
fibrochondrocytes/scaffold, collagen/dry weight, 
PGA meniscus-shaped scaffold, GAG and collagen 133 type II found in inner 
replaced meniscus in rabbit portion of scaffold, knee, 10 wks type I collagen in 
outer portion 
Fibrous matrix 
formation, some 
PLLAIPPD acellular, filled rabbit partial c.ollagen alignment, 312 
meniscectomy defect, 14 wks some preservation of 
underlying hyaline 
cartilage 
Natural 
Rabbit fibrochondrocytes, 8 Cells able to produce Fibrin sulfated GAGs, 316 
wks proliferate 
Fibrous tissue 
Small formation, no 
intestine Filled goat meniscal defect, organization, partially 317 
submuco 12 wks filled defect, hyaline 
sa cartilage 
degeneration 
Pig chondrocytes on surface Some healing of tear Acellular of scaffold, filled longitudinal 
observed, matrix 323 
meniscus tear in avascular region of pig contained GAGs 
meniscus, 9 wks 
Rabbit bone-marrow Some repair tissue 
Hyaluronan mesenchymal stem cells, formed, contained 311 
rabbit meniscal defect, 12 
wks collagen type II 
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T e Details Result Ref. 
Collagen Acellular, human meniscal Pain scores improved 
meniscus significantly, implant 326 
implant defect, 5 years maintained structure 
Collagen Sheep fibrochondrocytes, Scaffold contraction , 
meniscus sheep meniscal defect, 21 some fibrous repair 319 
implant wks tissue formed 
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Figures 
Figure 1: Direct compression bioreactor. The main component of a direct 
compression bioreactor is the loading chamber (a), inside of which constructs are 
placed for stimulation . A stepper motor (b) induces axial deformation to 
constructs in the load chamber and receives spatial feedback from the LVDTs (c) 
and force feedback from the load cell (d) . 
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Figure 2: Hydrostatic pressure bioreactor. An lnstron machine (a) drives a 
hydraulic piston (b) which pressurizes a sealed chamber (c) . For stimulation, 
constructs are sealed in media-filled bags and placed in the water-filled chamber. 
The chamber is submerged in a water bath and pressurized via the hydraulic 
piston. 
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Figure 3: Self-assembled meniscus-shaped construct. The length (a) and 
height (b) in millimeters of a self-assembled construct after 4 weeks in culture is 
shown. The construct correctly mimics the wedge-shaped, semi-circular 
geometry of the native meniscus. 
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Chapter 10: Current Therapies for Meniscus Injuries 
Section 10.1: Products and current therapies 
Products involving biological materials 
Currently, the only clinical product available for meniscus repair that uses 
biological materials is the Menaflex™ collagen meniscus implant, which has 
been approved for use in Europe and, more recently, in the United States. 
Developed in the United States by ReGen Biologics (Hackensack, New Jersey), 
the implant is approved for use in both the medial and lateral menisci in Europe, 
but in the U.S. it is currently only FDA approved for use in the medial meniscus. 
Menaflex™ is made of a collagen type I scaffold which can be sutured to the 
remaining meniscus following partial meniscectomy and degrades almost 
completely after one year. It has gone through several clinical trials and has 
shown an ability to allow cell infiltration and increase activity levels of patients 
who had a history of meniscus surgeries.328 For patients with acute injuries who 
had not undergone previous surgeries on the meniscus, activity level increased 
the same amount with or without treatment with Menaflex ™. 328 While activity 
levels do increase for patients with chronic meniscus problems, arthroscopic 
evaluation has revealed that this treatment will only partially fill a meniscus defect 
Chapter published as: Athanasiou, K. A., and Sanchez-Adams, J. "Part 4: 
Current Therapies and Future Directions." Engineering the Knee Meniscus. 
Morgan and Claypool Publishers. 2009. 
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site (around 50-60% on average).328 Additionally, the repair tissue resulting from 
Menaflex™ treatment is not extensively characterized, leaving the biomechanical 
benefits of the implant unknown. Therefore, though there exists a product on the 
market to address the need for replacement meniscus tissue, it may not be 
optimal in all cases and there is still a need for more alternatives. 
Other current therapies 
Clinical therapies for meniscus repair are varied. Meniscus surgery is most 
often performed arthroscopically, as this method is the least invasive and leaves 
the smallest scars. Depending on the type of meniscus injury, surgical 
techniques may involve arthroscopic suturing, other fixation devices, or 
meniscectomy. Abrasion may also be used to smooth the remaining meniscus 
tissue following meniscectomy. The success of sutures or other fixation devices 
to encourage healing of meniscus tears depends on the location of the tear. 
Tears in the outer portion of the meniscus are more likely to bond when held 
together due to the proximity of blood vessels, whereas tears in the inner region 
are unlikely to repair. 
Suturing is a popular repair mode for bucket-handle tears as it can hold a 
tear closed to encourage bonding. Suture materials in use today are usually 
biodegradable, eliminating the need for subsequent procedures for removal. 
Suturing techniques can be inside-out, outside-in, or all-inside depending on 
where the suture material first enters the meniscus (see Figure 1).329• 330 Suturing 
meniscus tears can take around 20 minutes using the inside-out technique, and 
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around 40 minutes using the outside-in technique. 331 Both of these suturing 
methods have around 1 00% success rates for healing a peripheral tear. 331 All-
inside suturing techniques are less common, but can provide the benefit of 
reducing arthroscopic incision size compared to the other methods. 330• 332-334 
Recently, all-inside repair techniques that do not use sutures have gained 
popularity. These include meniscus arrows, screws, and anchors. These all-
inside fixation devices take less time to place than normal sutures, though there 
is debate as to whether these methods work as well as suturing.331 • 335-342 
Amongst the all-inside repair options, the most popular is the meniscus arrow. 
The meniscus arrow is quick and easy to implement, uses fewer incisions than 
suturing techniques, and has a higher success rate than either screws or 
anchors. Success rates for meniscus arrow treatments typically range from 70-
95%. 338• 339· 343 In contrast, success rates for meniscus screws and anchors are 
reported to be around 27% and 65%, respectively.331 • 342 Though there are many 
benefits to using meniscus arrows, they also involve some risks including 
migration out of the tissue, inflammation of the surrounding tissue, and/or 
damage to the hyaline cartilage surfaces.337• 340 
In some cases, the meniscus is so damaged that total meniscectomy is 
necessary. In this case the knee is either left without a meniscus or a meniscus 
allograft is implanted. Allografts, though scarce, can improve the stability of the 
knee and increase the success rate of ACL repair.344 In arthritic joints, a 
meniscus allograft has an estimated lifetime of around 4.4 years and can 
decrease joint pain significantly.345 Challenges to using meniscus allografts on a 
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large scale include difficulty in preserving, sterilizing, and attaching the tissue, as 
well as the limited lifetime of the material. 346 
Partial meniscectomy and abrasion are used to remove torn inner 
meniscus tissue that causes pain or impedes joint movement. In arthroscopic 
partial meniscectomy, a scalpel or other tool is used to cut away the torn tissue, 
leaving the rest of the meniscus intact. Following partial meniscectomy, abrasion 
may be performed to smooth out the remaining meniscal surface, thereby 
discouraging tear propagation or new tear formation. This mode of therapy was 
shown especially effective for tears of the posterior horn of the lateral meniscus, 
or radial tears that appear stable.347 
Concepts 
Presently, the only product available for meniscus repair that uses 
biological materials is the Menaflex™ collagen meniscus implant by ReGen 
Biologics. This product is a collagen type I sponge that can be sutured to the 
remaining meniscus after a partial meniscectomy. Menaflex™ is biocompatible, 
providing a scaffold for cell infiltration and new tissue formation, and has 
increased activity levels in some patients. Use of this product, however, has not 
demonstrated full defect healing. Other current therapies that do not involve 
engineered biological materials include sutures and other fixation devices 
(arrows, screws, anchors), meniscectomy, abrasion, and allografting. Suturing is 
most successful for vertical-longitudinal (bucket-handle) tears in the outer region 
of the meniscus and can be done three ways: outside-in, inside-out, or all-inside. 
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The all-inside technique has become popular with the introduction of meniscus 
arrows, which are easy and quick to implant as compared to suturing techniques. 
There is still controversy as to whether arrows work as well as sutures, and 
indeed the reported success rates for arrows are lower than for sutures. For inner 
region tears that are symptomatic, partial meniscectomy is often performed. 
Following partial meniscectomy abrasion of the remaining tissue can be 
performed to smooth out the tissue surface and discourage new tear formation. If 
the meniscus is thoroughly damaged, total meniscectomy may be performed and 
a meniscus allograft can be implanted. Allografts tend to work well for most 
patients, but they are generally scarce and conditioning them for implantation 
may compromise tissue integrity. 
Section 10.2: Design standards for tissue engineering the meniscus 
Determining design standards 
Meniscus tissue engineering has made great advances in recent years, 
but has yet to produce a therapy that can fully restore function to a damaged 
meniscus. In the normal meniscus, a complex set of characteristics work together 
to form a tissue that is able to bear load, transfer stresses, absorb shock, and 
stabilize the knee joint. Ideally, a meniscal replacement would have the same 
properties as the native meniscus, but in practice it is difficult to get all of them to 
coexist using current tissue engineering modalities. Therefore, tissue engineers 
must carefully consider which meniscus properties they will reproduce such that 
252 
the resulting tissue is able to perform well in the body. Based on what is known 
about the role of the meniscus, there are certain characteristics that a meniscal 
replacement must have in order to restore function. Primarily, a meniscus 
replacement must be biocompatible and have specific geometrical and 
biomechanical attributes to operate well in the knee joint. Of secondary concern 
are the biochemical characteristics, vascularization, enervation, and cellularity of 
the replacement. Prioritizing meniscal attributes as such is advantageous to the 
tissue engineer as it allows for the design of a tissue that is maximally functional, 
a main concern for meniscus replacement options. 
Primary standards 
The main design standards important for tissue engineering a functional 
meniscus are proper geometry, biomechanics, and biocompatibility. The 
geometry of the meniscus has a central role in allowing for smooth joint 
movement and stabilization. Being wedge-shaped and semi-circular, the 
meniscus increases the congruence of the femur and tibia. The shape and size 
of tissue engineered constructs should therefore match that of the native 
meniscus to best restore meniscal function. 
Biomechanical properties of the meniscus are also primary contributors to 
normal meniscus function. The anisotropic material behavior of the meniscus in 
tension, compression, and shear allows for dynamic load bearing and distribution 
and is imparted to the tissue through the organization of matrix molecules. 
Engineered meniscus tissue must also withstand these loading patterns, either 
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by organized matrix deposition or other means. Specifically, circumferential 
tensile properties for the engineered tissue must be higher than radial properties, 
and compressive properties must be higher in the inner portion than in the outer 
portion. Having mechanical properties regionally similar to native values will 
ensure that the construct is not destroyed upon implantation. This is especially 
important if the engineered tissue is used to fill a defect site, in which case 
mechanical similarity will ensure a normal distribution of load. Creating a 
biomechanically robust tissue is also advantageous for surgical implantation. 
Fixation methods involving screws and sutures place great amounts of local 
stress on the tissue. As it is known that the meniscus relies heavily on tibial horn 
attachments for anchoring within the joint, it is imperative that a replacement 
tissue is able to withstand these fixation stresses in addition to loading stresses. 
The safety of an implantable meniscal replacement is not only linked to its 
function within the joint, but also to its immune response. Biocompatibility is, of 
course, a primary concern for tissue engineering the meniscus as this attribute 
can increase safety, which is highly important for eventual clinical approval. 
Increasing the biocompatibility of the engineered tissue by using natural scaffolds 
or scaffolds with non-toxic degradation products, or using autologous cells can 
reduce the likelihood of an immune reaction in the body. 
Secondary standards 
Creating a tissue that mimics the geometrical, biomechanical, and 
biocompatibility of the native meniscus may be sufficient to restore function, but 
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there are some secondary characteristics that could increase its longevity and 
overall compatibility within the body. These include biochemical makeup, 
vascularization, and cellularity. Once the primary functional characteristics are 
achieved in a meniscal replacement, these secondary characteristics should be 
examined. 
There are many different chemical components that make up meniscus 
tissue, yet all of their functions are not known. Given their relative abundance in 
the tissue, however, collagens and proteoglycans seem to be the main 
biochemical contributors. Their distributions and orientations within the meniscus 
contribute greatly to the regional variation in mechanical properties, highlighting 
the need for tissue with complex regional makeup for replacement. Specifically, 
collagen is primarily oriented circumferentially, and proteoglycans are most 
abundant in the inner portion of the meniscus. Collagen type I is the primary type 
of collagen in the outer portion, while collagen type II is more abundant in the 
inner portion. Mimicking the regionally varying relative abundance of these two 
components of the meniscus, as well as their structural organization, may lead to 
appropriate mechanical properties. It should be noted, however, that other 
molecules such as those used for adhesion may be important for tissue 
organization and overall function. The functions of many of these minor 
biochemical components of the meniscus are not well understood, but they could 
play an important role in creating a functional construct. 
Because not all of the functions of a meniscal blood supply are known, the 
importance of vascularization for a tissue engineered meniscus is difficult to 
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determine. In the normal adult meniscus, the blood supply is confined to the 
peripheral two-thirds and helps in tissue remodeling following injury. It is likely 
also responsible for proper delivery of nutrients and removal of waste products. 
Depending on the cellularity and permeability of the engineered tissue, 
vascularization could play an important role in allowing the tissue to thrive 
indefinitely. 
The cellular aspects of an engineered meniscus are also of secondary 
concern. As many as four different types of cells have been identified in the 
meniscus, though their functions are not well understood. The morphologies of 
these cells range from rounded in the inner portion of the meniscus to having 
many cell processes in the outer portion. While in general cells are important for 
the creation or remodeling of tissue, little is known about the extent of remodeling 
that takes place in the adult meniscus. For engineered tissue, cells are important 
for creating specific types of matrix molecules that can aid in developing a 
mechanically robust construct. It is unclear, however, whether having the exact 
types and morphologies of cells found in the native meniscus is necessary for 
maintaining the overall function of an engineered meniscus. 
Concepts 
In designing an engineered meniscal replacement, much thought must be 
put into which characteristics are most important to the overall function of the 
construct. For the meniscus, a biomechanically active tissue, primary design 
standards focus on recreating functional aspects. These include mimicking 
----------------------------- --------
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meniscus geometry, biomechanics, and biocompatibility. Of secondary concern 
are the specific biochemical makeup of the construct, its vascularity, and the 
types of cells that it contains. By focusing primarily on the functional aspects, a 
robust and clinically suitable tissue may be achieved. As more is discovered 
about the specific functions of meniscus matrix molecules, vascular supply, and 
cells, these secondary criteria may become useful to extend construct longevity 
and compatibility in the body. 
Section 10.3: Assessments for tissue engineered constructs 
Need for functional assessment 
Whether or not engineered meniscus tissue will perform well in vivo may 
depend on many different factors, including biochemical and biomechanical 
properties of the engineered neotissue. Not only do laboratories engaged in 
tissue engineering need standards to evaluate the functionality of their work, but 
regulatory agencies must likewise determine the type of assessments required 
for approval of such products. 
Functionality index 
Common methods to functionally evaluate engineered meniscus tissue 
are tensile tests, compression tests, shear tests, and biochemical assays. Ideally, 
all of these measurements would be taken, and the collective set of properties 
would be compared to native tissue. Typically, however, only one measurement 
---------------------------
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is compared to the gold standard at a time, giving a limited view of the overall 
functionality of the engineered construct. Determining this overall functionality is 
not trivial, as some construct properties will inevitably be closer to native values 
than others. Using a functionality index (FI) is one way to assess the overall 
similarity of an engineered tissue to known native values. This method uses a 
weighted average taken of the similarity fractions of the engineered tissue's 
properties compared to native values. The Fl has been used previously to 
compare engineered hyaline cartilage to native hyaline cartilage.348 
(I (a~ -GeJJ+(I-(c~ -c.JJ+~[I ( E:;E~)]+ 
1 nat nat nat 
FI = 4 [ (EC EC )] [ (sT 8 T )] [ (sC sC )] 
_!_ 1 _ nat - ec + _!_ 1 _ nat - ec + _!_ 1 _ nat - ec 
2 Ec 2 8r 2 8c 
nat nat nat 
(Equation 1) 
In the functionality index above (Equation 1 ), G and C represent the total 
GAG and total collagen per wet weight, E represents stiffness and S represents 
strength. Superscripts ofT and C indicate tensile and compressive properties, 
respectively, and the subscripts 'nat' and 'ec' indicate natural or engineered 
construct properties, respectively. According to this equation, equal weight is 
given to biochemical and mechanical properties. This could be adjusted, 
however, if one property demonstrates a dominant role in the overall functionality 
of the tissue. As the right hand side of the equation approaches a value of 1 , the 
engineered tissue approaches the properties of native tissue. A value close to 
zero indicates that the engineered tissue has much lower properties than native 
tissue, and a value higher than 1 indicates that some or all of the engineered 
- -----------------------~ 
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tissue's properties are higher than native values. The functionality index can 
therefore provide an extra measure of engineered tissue's similarity to native 
tissue by considering all measured properties simultaneously. 
Variable considerations 
There are many different considerations to make when writing a 
functionality index equation. Weights must be assigned to each parameter based 
on its overall importance to tissue functionality. Whether to assign mature or 
immature tissue properties to the native tissue variables in the equation must 
also be determined. Once the equation is formulated, a level must be set to 
determine satisfactory or unsatisfactory similarity to the comparison tissue. 
In the above example, equal weight is applied to biochemical and 
mechanical properties. For the meniscus, as it is known that mechanical integrity 
plays a large functional role, more weight might be shifted toward mechanical 
performance. Other parameters that take into account the circumferential versus 
radial stiffness and strength could also be included in the equation to assess 
appropriate functional behavior. 
As engineered meniscal tissue is likely to be implanted into adult patients, 
using adult tissue properties as a comparison in the Fl equation could provide 
valuable information. During the process of tissue development, however, 
engineered meniscus constructs may exhibit immature properties. Immature 
native tissue properties could therefore be used in the Fl during this process to 
determine if engineered tissue mimics native tissue in early developmental 
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stages. While it is unclear whether native properties should be attained prior to 
implantation or if a construct can mature in vivo, the Fl is a useful tool to 
determine similarity between engineered and native tissues and may eventually 
be used to identify the readiness of a construct for implantation. 
A highly important consideration for the tissue engineer is how similar an 
engineered tissue must be to native tissue in order to be useful in the body. The 
functionality index is suited to quantify this similarity, but it remains to be 
determined what Fl threshold must be reached to indicate acceptable properties. 
More research must be done to determine suitable characteristics for 
implantation, but once this threshold is determined, engineers will have a tangible 
success criterion that takes into account many different aspects of an engineered 
tissue. 
Concepts 
Engineers use various tests to functionally assess their tissue engineered 
constructs. The properties that are measured are usually considered alone, 
allowing for only a limited understanding of tissue functionality. The functionality 
index (FI) can be used to consider all measured properties of an engineered 
construct compared to native tissue. This allows for an overall assessment of 
tissue functionality. The Fl is calculated by taking the average of similarity 
fractions of engineered tissue properties compared to native tissue properties. An 
unlimited number of properties can be included in this equation, and different 
weights can be assigned to each property based on its importance to tissue 
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performance. When writing a functionality index equation for engineered 
meniscus tissue, it may be necessary to weight certain mechanical properties 
higher than biochemical properties, given its highly biomechanical role in the 
body. Also of importance is determining what type of tissue (mature or immature) 
to use for comparison, as well as identifying an Fl value that indicates an 
acceptably functional tissue. 
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Figures 
Outside-in Inside-out All-inside 
Figure 1: Meniscus suturing techniques. There are three main modes of 
suturing the meniscus arthroscopically. The outside-in technique passes the 
suture material from the periphery of the tissue to the inner surface, while the 
inside-out technique passes the suture into the meniscus from within the joint 
space, exiting at the periphery. The all-inside technique does not affect as much 
of the meniscus, as the suture enters and exits only at the inner portion of the 
tissue. Other repair methods such as the meniscus arrow are considered all-
inside techniques as they are implanted into the tissue via the inner surface. 
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Chapter 11: Dermis Isolated Adult Stem Cells for 
Cartilage Tissue Engineering 
Abstract 
Adult stem cells from the dermal layer of skin are an attractive alternative 
to primary cells for meniscus engineering, as they may be easily obtained 
through out-patient biopsy techniques and used autologously. Recently, 
chondroinducible dermis cells from caprine skin have been identified that show 
promising characteristics for cartilage tissue engineering. In this study, their 
multilineage differentiation capacity is determined, and methods of expanding 
and tissue engineering these cells are investigated. It was found that these cells 
could differentiate along adipogenic, osteogenic, and chondrogenic lineages, 
allowing them to be termed dermis isolated adult stem cells (DIAS cells). 
Focusing on cartilage tissue engineering, it was found that passaging these cells 
in chondrogenic medium containing basic fibroblast growth factor and forming 
them into self-assembled tissue engineered constructs caused upregulation of 
collagen type II and COMP gene expression. Further investigation into 
biochemical stimulation of self-assembled DIAS cell constructs showed that 
application of either transforming growth factor J31 (TGF-J31) or bone 
morphogenetic protein 2 (BMP-2) caused increased sulfated glycosaminoglycan 
content. Additionally, TGF-J31 treatment caused significant increases in 
Chapter submitted as: Sanchez-Adams, J., and Athanasiou, K.A. "Dermis 
Isolated Adult Stem Cells for Cartilage Tissue Engineering." Biomaterials. 
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viscoelastic compressive properties: 14-fold, 5.5-fold, and 7-fold increases in 
modulus of relaxation, instantaneous modulus, and coefficient of viscosity, 
respectively, compared with controls, but also resulted in the most contracted 
constructs. In contrast, BMP-2 treatment resulted in the largest and most 
hydrated constructs, but did not increase compressive properties over untreated 
controls. These results show that DIAS cells can be easily manipulated for 
cartilage tissue engineering strategies, and may also be a useful cell source for 
other mesenchymal tissues. 
Introduction 
Injuries to the knee meniscus are common and severely compromise the 
tissue's ability to stabilize, distribute load, and absorb shock in the knee joint.1• 23· 
24
· 
29 Unfortunately, meniscus regenerative capacity is limited and clinical 
therapies are often insufficient to restore full functionality.3· 4• 12• 195· 197-199 
Meniscus tissue engineering efforts seek to address this problem by creating 
functional replacement tissue, often using primary cells from hyaline and 
meniscal cartilages. 111 • 116· 131 · 349· 350 However, these cells are scarce and 
concerns of donor site morbidity hinder their use as autologous cell sources. In 
contrast, stem cells are an abundant alternate cell source for meniscus tissue 
engineering, and can be derived from embryos, umbilical cords, or adult tissues. 
Among these, adult stem cells are especially useful as they may be harvested 
from a patient's own body as needed and used to create autologous tissue, 
avoiding the concern for immune rejection. While adult stem cells have been 
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identified in many tissues in the body,302• 306· 351 "356 skin is an especially attractive 
source since it is the body's largest organ and has high regenerative capacity. 
Stem cells have been identified in all regions of the skin: epidermis,356-358 
dermis, 302• 304• 355· 359-361 and hair follicles,362-365 but dermal stem cells are of 
particular importance as they are of mesodermal origin, and have the potential to 
regenerate mesenchymal tissues such as cartilage. Recently, a chondroinducible 
population of dermis cells from adult caprine skin has been identified,302 which 
could be used to repair meniscal tissue. These cells have many benefits for 
cartilage tissue engineering as they are easily isolated from the dermal 
population through rapid adherence to tissue culture treated plastic, and show 
high chondroinductive potential when plated on an aggrecan-coated surface. 
Engineered cartilage formed from these cells could also be implanted 
autologously into the goat, a mid-sized animal model, which is an important 
benefit for developing strategies that could be translated for eventual clinical 
application. In fact, autologous implantation of cartilage constructs has 
successfully been employed in the goat, indicating that this animal model may 
also be appropriate for in vivo meniscus tissue engineering studies. 366 Although 
these cells can be induced toward a chondrogenic phenotype, their multilineage 
differentiation capacity and a viable mode of expanding them for tissue 
engineering have yet to be determined. 
To achieve a high number of these cells for tissue engineering, expansion 
must occur prior to construct formation. Identifying a method to expand these 
cells while not compromising their chondroinductive capacity is of paramount 
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importance to their use in tissue engineering strategies. For other cell types, such 
as bone marrow derived mesenchymal stem cells (MSCs), monolayer expansion 
conditions are known to be important for maintaining differentiation capacity. 
Basic fibroblast growth factor (bFGF) has been used to successfully expand 
MSCs while maintaining their chondrogenic differentiation capacity, allowing for 
the production of a large number of cells suitable for tissue engineering.367• 368 
This growth factor may therefore be an important media additive for expansion of 
chondroinducible dermis cells. 
It is unclear, however, whether expansion should occur before or after the 
chondroinduction phase. Previous work used minimal cell expansion, and 
seeded cells onto aggrecan-coated surfaces to form chondroinduced cell 
nodules.302 This mode of chondroinduction has been proven effective, yet 
inconsistencies in nodule formation could be diminished by employing alternative 
methods. Micromass culture of MSCs is an effective mode of achieving 
chondrogenic differentiation.369-371 In this method, a high density of cells is 
seeded in a droplet and allowed to coalesce into a cell mass, which is cultured 
with various stimuli to cause differentiation. Micromass culture alone or on 
bioactive molecule-coated surfaces may therefore provide a more consistent 
mode of chondroinducing dermis cells, though cell dissociation will still be 
necessary to form homogeneous constructs. 
It is unknown whether a chondroinduction step is necessary before 
expanded chondroinducible dermis cells are formed into tissue engineered 
constructs. Self-assembled constructs formed from chondroinducible dermis 
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nodules have shown promising cartilage-like biochemical properties, 302 but 
residual matrix from developed nodules likely inhibits construct homogeneity. Cell 
dissociation following chondroinduction and prior to self-assembly would alleviate 
this problem, as is often performed with human embryonic stem cell (hESC) 
embryoid bodies,372-374 but self-assembling cells immediately after expansion 
would offer the simplest and most advantageous solution. As it is known that 
these cells are sensitive to three-dimensional chondroinduction, self-assembling 
expanded cells in the appropriate medium may simultaneously chondroinduce 
the cells and produce tissue engineered constructs. 
Once tissue engineered constructs are formed, various stimuli can be 
applied to enhance cartilage-like biochemical and biomechanical properties. 
Previously, engineered constructs formed from chondroinduced dermis cell 
nodules were cultured with transforming growth factor J31 (TGF-J31) and insulin-
like growth factor I (IGF-1), but the individual effects of these agents have not 
been determined.302 These tissue engineered constructs may also be sensitive to 
other biomolecules known to be potent promoters of chondrogenesis, such as 
bone morphogenetic protein 2 (BMP-2). 375-379 Understanding the biochemical and 
biomechanical effects of these different growth factors on engineered constructs 
formed from chondroinducible dermis cells will help to identify an effective 
method of using these cells for functional tissue engineering of cartilaginous 
tissues such as the knee meniscus. 
Previously identified chondroinducible dermis cells are a potentially 
abundant cell source for meniscus tissue engineering, motivating more 
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comprehensive development of methods for their expansion, chondroinduction, 
and tissue engineering. Therefore, in phase 1 of this study combinations of 
monolayer expansion, micromass chondroinduction, and self-assembly will be 
applied to a sub-population of adult dermis cells to determine a promising 
expansion and chondroinduction method for further tissue engineering. It is 
hypothesized in phase 1 that expansion will not hinder chondroinductive 
capacity, and that glycosaminoglycan (GAG) coated surfaces will enhance 
chondroinduction compared with non-coated surfaces. In phase 2, the most 
promising cell population from phase 1 will be exposed to a variety of 
mesenchymal differentiation protocols to determine their multilineage 
differentiation capacity. These cells will also be used to form self-assembled 
constructs for cartilage tissue engineering and the effects of various growth 
factors on the phenotypic, biochemical, and biomechanical cartilage-like 
properties of the constructs will be measured. In this phase, it is first 
hypothesized that the population of cells identified in phase 1 will show 
multilineage differentiation capacity. It is also hypothesized that, when used in a 
cartilage tissue engineering modality, constructs formed from these cells will 
show varying cartilage-like biochemical and biomechanical effects in response to 
different growth factors. The results from this phased approach will determine if 
previously identified chondroinducible dermis cells are multipotent stem cells and 
provide a method for expansion and tissue engineering with these cells towards 
the repair of meniscal defects. 
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Materials and Methods 
Cell isolation 
Abdominal skin from 5 six-month-old Spanish goats were obtained from a 
local abattoir [Nature's Bounty, Dixon, CA]. Skins were washed, sub-dermal fat 
and muscle was removed, and dermal tissue was dissected from epidermal 
tissue, and placed in a collagenase solution containing Dulbecco's Modified 
Eagle Medium with Glutamax (DMEM) [Invitrogen, Carlsbad, CA], 1% 
penicillin/streptomycin/fungizone (P/S/F) [Lonza, Basel, Switzerland], 1% non-
essential amino acids (NEAA) [Invitrogen], and 0.2% w/v collagenase type 2 
[Worthington, Lakewood, NJ]. Tissue was digested overnight at 3rc with gentle 
shaking. Following digestion, cells were counted and frozen in liquid nitrogen in 
DMEM containing 20% fetal bovine serum (FBS) [Atlanta Biologicals, 
Lawrenceville, GA] and 10% dimethyl sulfoxide [Sigma-Aldrich, St. Louis, MO]. 
Phase 1 
In Phase 1, cells were thawed and seeded in expansion medium (EM) 
containing 10% FBS, 1% P/S/F, and 1% NEAA and allowed to reach 90% 
confluence. Cells were visually inspected to ensure that no epithelial cells were 
present in the population. Cells were then passaged and an isolated sub-
population of cells with high chondrogenic potential was obtained by rapid 
adherence (RA) to tissue culture-treated plastic (TCP) for 10 minutes in EM, as 
previously described.302 Adherent cells were grown to 90% confluence in EM 
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(RA-20 cells). Three different modes of chondroinduction (chondrogenic 
passaging, self-assembly process, and micromass formation) were then 
evaluated to determine the most promising mode of chondroinduction for further 
tissue engineering using RA-20 cells. Figure 1 depicts a schematic of phase 1, 
with cell populations analyzed shown in dashed boxes. Following expansion, RA-
20 cells were either set aside for quantitative RT-PCR (qRT-PCR), formed into 
micromasses (uM), or plated in monolayer and passaged up to three times. 
Micromass formation 
Non-TCP (NT) 24-well plates were either coated with 0.08% chondroitin 
sulfate (CS) solution or not. In coated wells, 20 IJL of CS solution was placed in 
the center of each well, and allowed to dry overnight. RA-20 cells were then 
seeded at high density (20 IJL of 1 Ox1 06 cells/ml) on coated or non-coated wells 
to form micromasses. After 4 hours, 1 ml of chondrogenic medium (OMEM with 
1% P/S/F, 1% NEAA, 10-7 M dexamethasone, 5mM L-ascorbic acid 2-
phosphate, 0.4 mM L-proline, and 10 mM sodium pyruvate) containing 10 ng/ml 
of transforming growth factor ~1 (TGF-~1), and 100 ng/ml of insulin-like growth 
factor I (IGF-1), was added to each well. Four micromasses were formed per 
group and cultured for 2 weeks in hypoxic conditions (5% 0 2); media was 
changed every other day. The resulting micromasses were termed RA-CS-uM 
and RA-NT-uM, and were either set aside for qRT-PCR analysis, or were 
dissociated into single cells using 0.2% collagenase solution and passaged in 
chondrogenic medium three times to yield cells for tissue engineering. 
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Chondrogenic Passaging 
RA-20 cells were also seeded in monolayer and passaged in 
chondrogenic medium containing 1% FBS and 100 ng/ml of basic fibroblast 
growth factor (bFGF) up to three times. At each passage, cells were grown to 
80% confluence. At passages 2 and 3, cells were set aside (cP2-2D and cP3-2D) 
for qRT-PCR analysis. Passage 3 cells were also used to form micromasses on 
non-TCP and CS-coated surfaces as described above (cP3-NT-uM and cP3-CS-
uM), and resulting micromasses were analyzed with qRT-PCR for cartilage-
specific gene expression. 
Self-assembly 
cP2-2D and cP3-2D cells, and passaged cells from RA-CS-uM and RA-
NT -uM, were also formed into tissue engineered (TE) constructs using the self-
assembling method as described previously.161 • 210 Briefly, 2x106 cells were 
seeded into cylindrical, 3 mm-diameter agarose wells and cultured for 4 weeks in 
normoxic conditions (21% 02) in chondrogenic medium (CM). Four constructs 
were formed from each group and medium was changed every other day. The 
resulting self-assembled constructs were termed cP2-TE, cP3-TE, RA-CS-TE, 
and RA-NT-TE and were analyzed using qRT-PCR for cartilage-specific gene 
expression. 
qRT-PCR 
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RNA from cell populations, micromasses, and constructs in phase 1 was 
extracted using an RNAqueous-Micro Kit [Invitrogen]. Resulting RNA was then 
reverse-transcribed using the SuperScriptTM Ill First-Strand Synthesis System 
[Invitrogen], and then PCR was performed on the resulting eDNA for cartilage-
specific genes using SYBR® Green PCR Mastermix, 80-100 ng of sample eDNA, 
and 900 nM of each primer. PCR analysis was performed using a RotorGene 
3000, with the following protocol: 50°C for 2 min, 95°C for 10 min, followed by 40 
cycles of 95°C for 15 sec and 60°C for 60 sec. Bovine 18s rRNA was used as a 
housekeeping gene for each group. All fold-change calculations were determined 
by normalizing data to RA-2D cells using the formula y = 244ct, where LlLlCt 
represents the difference in take-off cycle between experimental and control 
groups. Forward and reverse primers for Sox9, collagen type I, collagen type II, 
COMP, and aggrecan were obtained from the literature.102• 164-166 Gene expression 
data were analyzed using a one-way ANOVA, with a significance level of p < 
0.05. 
Phase 2 
Based on gene expression data, cP2-2D cells were carried forward from 
phase 1 (termed cP2 cells in phase 2), and subjected to multilineage 
differentiation or tissue engineering. 
Multilineage Differentiation 
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To determine their multipotency, cP2 cells were subjected to adipogenic, 
osteogenic, or chondrogenic differentiation protocols commonly used for 
differentiation of mesenchymal stem cells. For adipogenic and osteogenic 
differentiation, cells were seeded into 6-well plates and allowed to reach 80% 
confluence in base medium (DMEM containing 16.5% FBS, 1% P/S/F, and 1% 
NEAA). Wells were then cultured an additional 3 weeks with base medium 
(control), adipogenic medium (base medium with 0.5 IJM dexamethasone, 0.5 
mM isobutylmethylxanthine and 50 1-JM indomethacin), or osteogenic medium 
(base medium with 10 nM dexamethasone, 20 mM J3-glycerolphosphate, and 50 
1-JM L-ascorbic acid 2-phosphate). For chondrogenic differentiation, cell pellets 
were formed by centrifuging 0.2 x1 06 cells at 450 x g for 10 minutes. Pellets were 
fed with base medium (Control) or chondrogenic medium with 10 ng/ml TGF-J31 
and 100 ng/ml BMP-2. Resulting cell populations or pellets were analyzed 
histologically for adipogenic differentiation (Oil Red 0), osteogenic differentiation 
(Alizarin Red), and chondrogenic differentiation (Safranin-0 and collagen type II 
immunohistochemistry). 
Self-Assembly and Gross Morphology 
Tissue engineered constructs were formed as in phase 1, and cultured for 
5 weeks in chondrogenic medium alone (Control) or with 100 ng/ml IGF-1, 100 
ng/ml bone morphogenetic protein 2 (BMP-2), or 10 ng/ml TGF-J31. Culture 
conditions and medium changes were carried out as in phase 1, and 16 
constructs were formed per group. Pictures were taken of constructs from each 
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group weekly during the culture period to qualitatively assess morphological 
changes. Following the culture period, construct diameter, thickness, wet weight 
and dry weight were measured, and constructs from each group were assessed 
biomechanically, histologically, biochemically, and with qRT-PCR. 
Histology & Immunohistochemistry 
Constructs from each group were cryosectioned and stained with 
Safranin-0 or Picrosirius Red to visualize sulfated glycosaminoglycans (GAGs) 
and total collagen, respectively. Sections were also stained using 
immunohistological methods to visualize collagen types I, II and VI. 
Biochemistry 
Total collagen and glycosaminoglycan content was measured in 
constructs from each group using a hydroxyproline assay or a dimethyl-
methylene blue assay [Biocolor, Carrickfergus, UK], respectively. DNA content 
was also measured in each group using a PicoGreen® Assay Kit [Invitrogen, 
Carlsbad, CA], and normalized to cell number using 7.7 ng DNA/cell. 
Additionally, collagen types I and II were measured using indirect enzyme-linked 
immunosorbent assays (ELISAs). Anti-collagen type I [Accurate Chemical, 
Westbury, NY] and anti-collagen type II [Fitzgerald, Acton, MA] antibodies were 
used to detect collagen types I & II in tissue engineered constructs, and were 
normalized to control constructs. 
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Compressive testing 
Following the 5 week culture period, constructs from each group were 
tested in unconfined compression stress-relaxation. Samples were 
preconditioned with 15 cycles of 0-5% compressive strain, and then stress-
relaxation tests were carried out at 10% and 20% strain. As described previously, 
a Kelvin solid viscoelastic model was fit to the data to yield the following 
compressive material properties at each strain level: instantaneous modulus (Ei), 
modulus of relaxation (Er), and viscosity (~). 156 
Statistics 
One-way ANOVAs were used to analyze quantitative data, with 
significance set at p < 0.05. If warranted, a Tukey's post-hoc test was performed 
to determine differences between groups. 
Results 
Phase 1 
qRT-PCR 
Quantitative RT-PCR analysis of cartilage-specific genes for cells (20), 
micromasses (uM), and constructs (TE) formed in phase 1 showed distinct 
differences (Figure 2). In particular, regardless of pre-treatment, aggrecan gene 
expression in uM groups was significantly higher than the 20 or TE groups (332-
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fold to 788-fold increase over RA-20 cells). Collagen type I gene expression also 
trended higher in the uM groups, and was significantly higher in the RA-NT-uM 
(3.8 ± 0.72 fold change) and cP3-CS-uM (3.8 ± 0.48 fold change) groups 
compared with the 20 and TE groups. In contrast, the TE groups and 
chondrogenically passaged cells (cP2-20 and cP3-20) showed down-regulation 
in collagen type I compared with RA-20 cells. Gene expression for COMP 
trended higher in TE groups and was statistically higher than 20 and uM groups 
in the RA-NT-TE group (132 ± 50 fold change). Similarly, collagen type II 
expression trended higher in the TE group, and was statistically higher in the 
cP2-TE group (28 ± 14 fold change). Little variation in Sox9 gene expression was 
observed, however cP2-20 cells showed statistically lower Sox9 expression 
compared with RA-20 cells. 
Phase 2 
Multilineage Differentiation 
cP2 cells showed the ability to differentiate along the adipogenic, 
osteogenic, and chondrogenic lineages (Figure 3). Cells exposed to adipogenic 
media stained positively for lipids, whereas cells exposed to base media did not. 
Cells in monolayer exposed to osteogenic media formed cell masses over the 4 
week culture period, and stained positively for calcium deposits using Alizarin 
Red. Cell pellets exposed to chondrogenic medium and growth factors also 
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stained positively for sulfated GAGs and collagen type II, while control pellets 
were negative for these markers. 
Gross Morphology 
Over the 5 week culture period, various morphological changes were 
obsereved (Figure 4). At week 1, all groups showed some contraction. 
Contractile behavior was enhanced at week 2 for all groups, but appeared to 
plateau by week 3 in Control and IGF-1 constructs. In TGF-~1 constructs, a slight 
increase in diameter was observed at week 3 compared with week 2 which was 
maintained throughout the rest of the culture period. Between weeks 2 and 3 
BMP-2 constructs also increased in size, and continued to grow throughout the 
rest of the culture period. BMP-2 constructs showed statistically higher diameter 
and thickness measurements at the end of the culture period, as well as higher 
wet weight and dry weight compared to other groups. TGF-~1 constructs had 
statistically smaller diameter and wet weight measurements than other groups, 
but had higher dry weight than control and IGF-1 constructs. 
qRT-PCR 
Gene expression for the starting population of cells (cP2 cells) were 
compared with that of tissue engineered constructs at the end of their 5 week 
culture period (Figure 5). Aggrecan and collagen type I gene expression was up-
regulated for TGF-~1 constructs (77.3 ± 32.9 and 5.82 ± 0.27 fold change, 
respectively) compared with all other constructs and cP2 cells. COMP and 
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collagen type II expression was up-regulated in Control (28.6 ± 20.8 and 67.3 ± 
33.6 fold change, respectively) and IGF-1 (59.2 ± 31.6 and 73.5 ± 15.3 fold 
change, respectively) constructs compared with cP2 cells. Sox9 expression 
trended higher in all tissue engineered constructs compared with cP2 cells, and 
was statistically higher in IGF-1 (27 ± 13.2 fold change) and TGF-~1 (24 ± 2.1 fold 
change) constructs. 
Histology & Immunohistochemistry 
Histological assessment of tissue engineered constructs is shown in 
Figure 6. Collagen types I, II, and VI were present in all tissue engineered 
constructs, though collagen type II was most prominent in BMP-2 and TGF-~1 
constructs. Total collagen staining showed a dense collagenous matrix in TGF-
~1 constructs, loosely packed collagen in BMP-2 constructs, and similar collagen 
densities in Control and IGF-1 constructs. Sulfated GAG was detected in all 
constructs, and was diffusely distributed in BMP-2 constructs. 
Biochemistry 
Analysis of biochemical content and hydration is shown in Figure 7 A-F. 
All constructs contained similar cellularity, though TGF-~1 constructs contained 
statistically fewer cells than BMP-2 constructs. Overall, BMP-2 constructs 
showed the most hydration, while the TGF-~1 constructs were the least hydrated. 
Total GAG and collagen content was statistically higher in BMP-2 and TGF-~1 
constructs compared with control constructs, though TGF-~1 constructs showed 
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the least amount of collagen type I compared with control constructs. All groups 
showed similar amounts of collagen type II. 
Compressive testing 
Results from viscoelastic compressive testing are shown in Figure 7 G-1. 
Compressive properties of TGF-~1 constructs were statistically higher than all 
other groups. Compared with control constructs, TGF-~1 constructs showed 
approximately 14-fold, 5.5-fold, and 7-fold increases in modulus of relaxation, 
instantaneous modulus, and coefficient of viscosity, respectively. 
Discussion 
This study identified a method to expand a sub-population of adult dermis 
cells that showed 1) multilineage differentiation capacity and 2) the ability to form 
tissue engineered constructs with cartilage-like properties. It also evaluated the 
effects of various growth factors on tissue engineered constructs formed from 
these cells, and found that both BMP-2 and TGF-~1 enhance cartilage-like 
compressive and biochemical properties. Given their demonstrated multilineage 
capacity and ability to form cartilaginous tissue, these cells are termed dermis 
isolated adult stem (DIAS) cells. The results from this study show that DIAS cells 
can be used as an alternate, and possibly autologous, cell source for meniscus 
tissue engineering, and may have wider applicability to engineering of other 
mesenchymal tissues. 
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In phase 1 it was found that DIAS cells subjected to chondrogenic 
passaging showed few differences from non-expanded cells, indicating that these 
cells may be expanded without compromising chondrogenic capacity. This was 
further demonstrated as micromasses formed from chondrogenically passaged 
DIAS cells showed nearly identical gene expression profiles to those formed from 
non-expanded DIAS cells. This similarity between non-expanded and 
chondrogenically passaged DIAS cells may be a result of the expansion 
conditions used, and could indicate that these cells are similar to other types of 
stem cells. Chondrogenic passaging was carried out in chondrogenic medium 
supplemented with bFGF, a growth factor used previously to maintain the 
multilineage differentiation capacity of MSCs and hESCs through many 
population doublings.367· 368• 380 Although the mechanism by which bFGF 
maintains differentiation capacity is still under investigation, recent studies have 
drawn correlations between bFGF-treatment and decreased telomerase activity, 
suggesting that bFGF may play a protective role during cell proliferation. 368 The 
present results show that chondrogenic passaging using bFGF is an effective 
mode of achieving a large number of DIAS cells for cartilage tissue engineering. 
Comparing the phenotypic changes of cell populations in phase 1 , it was 
apparent that both three-dimensional culture systems (micromass and self-
assembly) had marked chondroinductive effects on DIAS cells. Cells in 
micromass culture showed increased aggrecan gene expression, while self-
assembly caused up-regulation in collagen type II and COMP. Although not yet 
fully understood, three-dimensional culture systems are thought to have a 
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beneficial effect on chondroinduction of stem cells by forcing a rounded cell 
morphology, similar to chondrocytes in situ. This rounded morphology is known 
to be important for the preservation of articular chondrocyte gene expression, as 
passaged chondrocytes show rapid phenotypic changes upon loss of this 
morphology.166 In fact, beneficial effects of three-dimensional culture have been 
well-documented for the chondroinduction of MSCs369• 371 · 381 · 382 and hESCs,300• 
383 indicating that DIAS cells are similar to these other cell types in their 
sensitivity to three-dimensional culture. 
Although both micromass and self-assembly forced rounded cell 
morphology, their effects on cartilage specific gene expression were distinct. As 
micromass culture was carried out in hypoxic conditions and with growth factors, 
and self-assembled constructs were cultured in blank chondrogenic medium, this 
may have contributed to the difference in gene expression between micromass 
and self-assembled cells. Hypoxia has been shown previously to cause 
increased gene expression for collagen types I and II in meniscus tissue, and 
enhance collagen type II content and compressive properties of meniscus cell-
seeded constructs.384• 385 The growth factors used during micromass culture, 
TGF-~1 and IGF-1, have also caused increased cartilage specific protein content, 
mechanical properties, and cell proliferation in tissue engineered cartilage 
constructs. 108• 229· 298• 308• 348· 386 To begin to understand the contribution of these 
factors in the present study, growth factors were combined with self-assembled 
constructs formed from DIAS cells and phenotypic changes were measured. 
Results from phase 2 suggest that growth factors do have a marked phenotypic 
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effect on the cells, especially on upregulating aggrecan gene expression as seen 
in the TGF-~1 group. This result indicates that the large upregulation in aggrecan 
gene expression seen in micromass culture in phase 1 could be due to the 
application of TGF-~1. Although not tested in this study, hypoxia may also have 
an effect on aggrecan or collagen type II upregulation which could improve 
construct properties beyond those observed with growth factors, as shown in 
previous studies on cartilage explants and tissue engineered constructs.384• 385 
Growth factors such as TGF-~1, therefore, play a role in enhancing OIAS cell 
chondroinduction in three-dimensional culture. 
In contrast to the proposed hypothesis, micromasses formed on GAG-
coated surfaces did not show a general upregulation of cartilage-specific genes 
compared with those formed on non-TCP. In fact, the up-regulation of aggrecan 
gene expression observed in the micromasses was statistically higher for RA-20 
cells on non-TCP than all other groups (Figure 2). Previous work using 
chondroinducible dermis cells has shown increased cartilage-specific gene 
expression of cells on GAG-coated surfaces,302 but the effects of hypoxia in this 
process have not been previously tested. As hypoxia has been shown to 
upregulate TGF-~1 production by dermal fibroblasts,387 and TGF-~1 was shown 
to increase aggrecan gene expression in phase 2, it is possible that the effects of 
surface coating may have been overshadowed by the effect of hypoxia. As 
micromasses formed from RA-20 cells on non-TCP showed the highest 
aggrecan gene expression, surface coating may actually interfere with the effects 
of hypoxia in non-expanded cells. These results indicate that hypoxia may be a 
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useful stimulus to apply during self-assembly in addition to, or in lieu of, TGF-~1 
treatment. 
As hypothesized, in addition to causing phenotypic changes, different 
growth factors caused varying effects on the mechanics and biochemistry of self-
assembled DIAS constructs formed in phase 2. All constructs, regardless of 
growth factor stimulation, showed presence of collagens I, II, and VI, as well as 
sulfated GAG, indicating that self-assembly and culture in chondrogenic medium 
has some chondroinductive effect on DIAS cells. BMP-2 and TGF-~1 further 
enhanced the sulfated GAG content and compressive properties of self-
assembled constructs, while IGF-1 treated constructs were nearly identical to 
controls in almost all measures. Thus it was found that DIAS cells were most 
sensitive to BMP-2 and TGF-~1. 
The biochemical properties of BMP-2 and TGF-~1 self-assembled DIAS 
constructs showed similarity to meniscus tissue. Though both growth factors 
increased glycosaminoglycan (GAG) content, BMP-2 constructs were 
considerably larger and more hydrated than other groups. The increased GAG 
content observed is agreement with other published work, which has shown that 
primary chondrocytes passaged in the presence of bFGF and subjected to tissue 
engineering with BMP-2 causes increased hydration and GAG content.388 Other 
studies have shown TGF-~1 to be a potent enhancer of GAG content in tissue 
engineered constructs formed from many different cell types including 
chondrocytes, meniscus cells, MSCs, and hESCs. 348· 389-391 The GAG content per 
dry weight achieved in the present study for BMP-2 and TGF-~1 constructs was 
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approximately 1.2-1.6%. These values are on par with native values for the 
meniscus, which reportedly contains -3.9% GAG per dry weight. 16 As GAG 
concentration is known to vary in the different meniscus regions,9• 257 the GAG 
content achieved in DIAS cell constructs by applying BMP-2 or TGF-~1 may be 
representative of the middle meniscus region. 
Compressive properties achieved by treating self-assembled DIAS cell 
constructs with TGF-~1 were also much higher than those achieved using other 
growth factors. Although TGF-~1 constructs were more contracted, they showed 
14-fold, 5.5-fold, and 7-fold increases in instantaneous modulus, modulus of 
relaxation, and coefficient of viscosity compared with untreated controls. As TGF-
~ 1 caused substantial contraction of DIAS cell constructs as well as increased 
GAG and collagen content, this increase in compressive properties could be a 
result of both biochemical and biophysical factors. Sulfated GAGs are known to 
be important in resisting compressive loads in cartilaginous tissues, 62-65 so 
increased GAG content in TGF-~1 treated constructs could be partly responsible 
for increased compressive properties. However, increased GAG content was 
also observed in BMP-2 constructs which did not show increased compressive 
properties. The observed contraction and increased total collagen content of 
TGF-~1 constructs could have made the difference between these groups by 
increasing matrix content and density. In fact, the difference in matrix density 
between groups is apparent in the histological sections of TGF-~1 and BMP-2 
constructs (Figure 6). Interestingly, although TGF-~1 constructs showed higher 
total collagen content than all other groups, they contained statistically lower 
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collagen type I content with no difference in collagen type II content. Thus it is 
likely that the increased collagen content was due to other collagenous proteins 
present, such as type VI (Figure 6), or types Ill, IV, V, and XVIII which are also 
present in cartilage.6• 12 The contraction observed in TGF-131 constructs is also 
consistent with prior literature which shows that contraction is a well-documented 
phenomenon of TGF-131-stimulated fibroblasts. 392-396 The observed effects of 
TGF-131 on DIAS constructs are also in agreement with previous work on self-
assembled cartilage cell constructs that show that TGF-131 treatment causes 
increased GAG and collagen content as well as higher compressive 
properties. 229• 348 Comparing the present results with previous literature suggests 
that TGF-131 affects DIAS cell constructs in similar ways as self-assembled native 
cartilage cell constructs, further indicating the cartilaginous nature of DIAS cell 
constructs. Given the promising results seen by adding BMP-2 and TGF-131, 
further studies should investigate the effects of different combinations of these 
growth factors to achieve sufficient size and compressive properties of these 
tissue engineered constructs. 
As well as forming cartilage-like tissue, DIAS cells used to create self-
assembled constructs in phase 2 also showed multilineage differentiation 
capacity. The ability of these cells to differentiate along adipogenic, osteogenic, 
and chondrogenic lineages indicates that these cells are multipotent in nature, 
similar to other dermal stem cell populations. Although dermal multipotent stem 
cells have been identified previously, they have been isolated either from 
rodents355· 360 or humans304· 359· 397-399 but not from mid-sized animal models. 
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DIAS cells, isolated from goat skin, present an abundant source of dermal 
multipotent cells with the potential to be used for both in vitro and in vivo tissue 
engineering experimentation. Given the multipotent nature of DIAS cells, they 
may not only be a useful cell source for cartilage tissue engineering, but also as 
an autologous source for engineering of other mesenchymal tissues such as 
bone and fat, which are often needed for reconstructive surgeries.400-4°4 
Conclusions 
The methods developed in this study demonstrate the ability of DIAS cells 
to not only produce cartilage-like matrix, but also form tissue engineered 
constructs with robust mechanical properties. As determined in this study, DIAS 
cells may be passaged in monolayer without losing their multipotent nature, 
making them appealing for tissue engineering efforts which often require large 
cell numbers for construct formation. Due to the multipotent nature of these cells, 
it is possible that other biochemical or mechanical stimuli could be applied to self-
assembled DIAS constructs to form functional bilayered tissue interfaces such as 
those observed between the meniscal horns and the tibial plateau. 
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Figure 1: Schematic diagram of phases 1 and 2. In phase 1 an optimal 
method of expansion and chondroinduction for tissue engineering is determined 
by testing different combinations of expansion, chondroinduction , and tissue 
engineering. In phase 2, cells are tested for multilineage differentiation capacity, 
and the effects of growth factors tissue engineered constructs are measured. 
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a 
ab 
a 
ab b ab 
Figure 2: Phase 1 quantitative RT -PCR. Fold change in gene expression of 
aggrecan (A}, COMP (B), collagen type I (C), collagen type II (D), and Sox9 (E) 
are compared among all cell populations produced in phase 1. Data were 
analyzed using a one-way ANOVA with Tukey's post-hoc, and significance was 
set at p < 0.05. 
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Figure 3: Phase 2 multilineage differentiation. Cells exposed to adipogenic, 
osteogenic, and chondrogenic differentiation regimens showed positive staining 
for lipids, calcium deposits, and sulfated glycosaminoglycan and collagen type II, 
respectively. Control cells and cell masses were negative for these markers. 
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measurements for each group. Data are presented as mean ± SO, and analyzed 
with a one-way ANOVA, p < 0.05. 
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Figure 5: qRT -PCR of tissue engineered constructs. Fold change in 
expression of aggrecan (A), COMP (B), collagen type I (C), collagen type II (D), 
and Sox9 (E) are normalized to cP2 cells and compared between cP2 cells and 
tissue engineered constructs. Data analyzed with a one-way ANOVA and 
Tukey's post-hoc, p < 0.05. 
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Figure 6: Histological assessment of tissue engineered constructs. Control, 
IGF-1 , BMP-2, and TGF-~1 constructs were sectioned at 14 IJm and stained for 
collagen types I, II , and VI , as well as total collagen and sulfated GAG. 
Photographs were taken at 20x magnification , scale bar= 100 IJm. 
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Figure 7: Biochemical and mechanical evaluation of tissue engineered 
constructs. Biochemical content and viscoelastic compressive properties were 
compared between Control, IGF-1, BMP-2, and TGF-~1 constructs. Results were 
analyzed using a one-way ANOVA with Tukey's post hoc test. Significance was 
set at p < 0.05. 
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Conclusions 
Tissue engineering efforts seeking to create functional replacement tissue 
for the repair of knee meniscus injuries must consider a variety of cellular, 
biochemical, and biomechanical design criteria. While significant progress has 
been made toward the generation of functional replacement meniscus tissue, the 
gaps in characterization of this mechanically important tissue and the lack of an 
abundant cell source for tissue engineering challenge the realization of this goal. 
The reviews of current literature in this thesis identified several key areas of 
meniscus tissue engineering research that warranted further investigation: 
regional variation in meniscus cells and tissue, and alternate cell sources for 
fibrocartilage engineering. Addressing these knowledge gaps, the studies 
presented in this thesis showed that regional variations exist in meniscus cell 
mechanics, and in the effect of isolation on these cells. This thesis also 
demonstrated that meniscus cells may be implanted in an allogeneic or 
xenogeneic animal model without the concern for immediate immune rejection, 
and showed that knee meniscus glycosaminoglycans (GAGs) contribute distinctly 
to regional tissue mechanics. Finally, this thesis established the multilineage 
differentiation capacity of dermis isolated adult stem (DIAS) cells and determined 
a method to expand these cells and tissue engineer with them to form 
fibrocartilaginous tissue. The characterization of meniscus cells and tissue 
performed in this thesis will provide important design criteria for engineering 
functional meniscus replacements which may be created using an alternate cell 
source such as DIAS cells. 
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Reviewing the literature on meniscus cells it was found that little was 
known about regional meniscus cell mechanics and that this information could 
help understand mechanisms of mechanotransduction in the meniscus. 
Therefore, in chapter 4, the cells of the inner and outer meniscus were 
mechanically tested and compared to articular chondrocytes and ligament cells. 
It was found that the meniscus contains two biomechanically distinct cell 
populations, and that meniscus cells are mechanically similar to ligament cells. 
This study was the first to show regional variation in meniscus cell mechanics, 
and the results may have important implications for understanding meniscus cell 
mechanotransduction. As both inner and outer meniscus cells were found to be 
more similar to ligament cells than to articular chondrocytes, these results may 
indicate that meniscus cells respond to circumferential hoop stresses as ligament 
cells respond to axial tension. Interestingly, although inner meniscus cells are 
often regarded as chondrocyte-like due to their rounded morphology and gene 
expression profile, inner meniscus cells were shown to be mechanically distinct 
from articular chondrocytes, perhaps indicating that these cells function less like 
articular chondrocytes than previously hypothesized. The additional finding that 
chondrocytes show more distinct actin cytoskeletal staining than both meniscus 
and ligament cells further demonstrates the difference between hyaline cartilage 
and fibrous tissue, and also supports the possibility that mechanical stimulation 
of meniscus cells may be most effective in tension. 
Although many studies use meniscus cells for fibrocartilage tissue 
engineering, this thesis was the first to investigate the effects of isolation on 
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meniscus cell phenotype (chapter 5). It was found that meniscus cells from all 
regions responded to isolation with increased cartilage-specific gene expression, 
in contrast to chondrocytes which are known to down-regulate their chondrogenic 
genes in response to enzymatic digestion. This difference highlights the distinct 
characteristics of fibrocartilaginous and cartilaginous cells, and may indicate that 
isolated meniscus cells enter a tissue engineering modality synthesizing more 
cartilage-specific proteins than articular chondrocytes. This study was also the 
first to show that using a digestion regimen of pronase followed by collagenase 
allows for the highest cell yield from all meniscus regions, and these cells can be 
used to create engineered meniscus constructs. This is an important finding 
which can improve the ease of obtaining meniscus cells for tissue engineering, 
and may be applicable to cell isolation from other fibrous tissues such as tendon 
and ligament. 
As promising biochemical and biomechanical properties have been 
achieved in constructs formed using primary meniscus cells for tissue 
engineering in vitro, it was important to determine the feasibility of using these 
constructs as allogeneic or xenogeneic meniscus replacements. To this end, 
bovine and leporine meniscus cells were cultured in vitro with leporine immune 
cells. This analysis, described in chapter 7, showed that both bovine and leporine 
meniscus cells failed to activate leporine immune cells, though they showed 
some known immunogenic markers. However, neither of the meniscus cell 
populations studied showed presence of both co-stimulatory factors known to be 
necessary for achieving full activation of immune cells. Therefore, it is possible 
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that these cells lack the appropriate surface markers, or actively produce 
immunomodulatory molecules. Excitingly, the lack of activation observed in this 
study indicates that allogeneic or xenogeneic transplantation of meniscus cells 
may be possible. 
Although much is already known about the types, organization, and 
mechanical contribution of collagens in the knee meniscus, relatively little was 
known about the mechanical contribution of meniscus GAGs until the study 
performed in chapter 8. By comparing the mechanical properties of control 
specimens from different meniscus regions to specimens subjected to GAG-
depletion, it was found that knee meniscus GAGs contribute significantly to the 
tissue's compressive and tensile properties. Notably, GAGs impart viscosity to all 
meniscus regions, but are most mechanically important in the inner region where 
the modulus of relaxation is increased and the tensile stiffness is decreased by 
the presence of these molecules. Given the major contribution of GAGs to inner 
meniscus mechanics and the importance of mechanical integrity to overall 
meniscus functionality, tissue engineered constructs may need to use, produce, 
or mimic these molecules to achieve appropriate mechanical behavior. 
While primary meniscus cells have been used successfully to produce 
engineered fibrocartilaginous tissue, the eventual translatability of this research is 
limited by the scarcity of this cell source. In chapter 11 chondroinducible dermis 
cells were investigated as a possible alternate cell source for meniscus 
engineering. This study was the first to determine that these cells could be 
differentiated along the adipogenic and osteogenic lineages, as well as along the 
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chondrogenic lineage, allowing them to be termed DIAS cells. The multipotent 
nature of DIAS cells increases their applicability to musculoskeletal tissue 
engineering strategies, as they have the potential to be used as a single cell 
source for the generation of bilayered tissues, such as that found between the 
tibial plateau and the horns of the knee meniscus. Expanded DIAS cells also 
showed the ability to self-assemble into tissue engineered constructs, and 
displayed sensitivity to growth factors TGF-~1 and BMP-2. Constructs treated 
with these growth factors showed increased GAG content, but TGF-~1-treated 
constructs were distinct from BMP-2 constructs as they were smaller and showed 
increased collagen content and compressive properties. Further investigation into 
optimal growth factor treatments for cartilage engineering with DIAS cells may 
benefit from combining these two growth factors to form constructs with sufficient 
size and compressive integrity. These results show great promise for cartilage 
tissue engineering with DIAS cells, and because they are isolated from adult 
skin, these cells may also be used for autologous tissue engineering. 
Overall, this thesis 1) presents a comprehensive review of meniscus 
tissue engineering, 2) demonstrates previously unknown regional variations in 
meniscus cell characteristics, 3) elucidates the mechanical importance of knee 
meniscus GAGs, and 4) identifies a method to use DIAS cells to engineer 
fibrocartilaginous tissue. These advances allow for a more complete 
understanding of meniscus tissue, and provide a possible autologous cell source 
for meniscus tissue engineering. 
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